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  Chiral N-heterocyclic carbene (NHC) ligands were prepared and examined in three 
asymmetric syntheses (oxindole synthesis, pyrrolidine synthesis and cyanosilylation of 
aldehydes).  The ligand generated from (4R,5R)-1,3-bis(ortho-cyclohexylphenyl)-4,5-diphenyl-
4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate provided the best asymmetric oxindole 
synthesis: yields of oxindoles up to 99% with enantioselectivities (ee) up to 80% were achieved 
in 3 h; catalyst loadings as low as 1 mol % could be used; the imidazolinium salt can be made 
efficiently in only two steps.  A mechanism for this asymmetric oxindole synthesis was proposed.  
The rotation barrier of the N-aryl bond in the oxidative addition products was found crucial for 
the enantioselectivity.  
A new approach for the convenient synthesis of dibenzazepinones is reported.  The key 
step is the formation of the seven-membered ring through palladium-catalyzed intramolecular 
arylation of an anilide enolate.  The reactions were completed in 10 min at 100 °C with moderate 
to excellent yields.  Aminodibenzazepinone, the core structure in -secretase inhibitor 
LY411575, can be prepared in five steps from 2-bromophenylboronic acid and 2-iodoaniline in 
60% overall yield.  The synthesis reported here compares favorably with presently available 
approaches to this interesting ring system. 
DESIGN AND SYNTHESIS OF CHIRAL N-HETEROCYCLIC CARBENES WITH 
APPLICATIONS TO ASYMMETRIC SYNTHESES AND SYNTHESIS OF 
DIBENZAZEPINONES BY PALLADIUM–CATALYZED INTRAMOLECULAR 
ARYLATION OF O-(2’-BROMOPHENYL)ANILIDE ENOLATES  
 
Xiaohong Pan, Ph. D. 
University of Pittsburgh, 2011
 
  v 
TABLE OF CONTENTS 
PREFACE .................................................................................................................................. XII 
1.0 DESIGN AND SYNTHESIS OF CHIRAL N-HETEROCYCLIC CARBENES 
WITH APPLICATIONS TO ASYMMETRIC SYNTHESES…………………………...…...1 
1.1 EXPLORATION OF IMIDAZOLINIUM SALTS WITH THE ‘ARM’ AND 
‘CORE’ STRUCTURES…………………………………………………………….…..…6  
1.2 EXPLORATION OF (4R,5R)-1,3-BISARYL-4,5-DIPHENYL-4,5-
DIHYDRO-1H-IMIDAZOL-3-IUM TETRAFLUOROBORATES…………….……..14 
1.3 EXPLORATION OF IMIDAZOLINIUM SALTS WITH THE CHIRAL 
CONTROLLING GROUP (3-METHYLBUTAN-2-YL) LOCATED ON THE ORTHO 
POSITION OF THE N-ARYL RING ……………………………………………….…..28 
1.4 EXPLORATION OF NHC LIGANDS IN THE ASYMMETRIC 
SYNTHESIS OF  3-ALKOXY-3-ARYLOXINDOLES………………………….……..31 
1.5 MECHANISM OF ASYMMETRIC OXINDOLE SYNTHESIS ….………..33 
1.6 ASYMMETRIC PYRROLIDINE SYNTHESIS WITH NHC-GOLD 
CATALYSTS……………………………………………………………… ……………..40 
1.7 ASYMMETRIC CYANOSILYLATION OF ALDEHYDES WITH NHC 
CATALYSTS…………………………………………………………………….………..43 
 
  vi 
1.8 HYDROGENATION OF STYRENE DERIVATIVES WITH ET3SIH AND 
TFA………….……………………………………………………………………………..44 
1.9      EXPLORATION OF PALLADIUM-CATALYZED INTRAMOLECULAR 
ARYLATION IN THE SYNTHESIS OF 1,2-DIHYDROISOQUINOLIN-3(4H)-
ONE ……………………………………………………………………………………….47 
2.0 SYNTHESIS OF DIBENZAZEPINONES BY PALLADIUM–CATALYZED 
INTRAMOLECULAR ARYLATION OF O-(2’-BROMOPHENYL)ANILIDE 
ENOLATES ................................................................................................................................. 49 
2.1 SYNTHESIS OF DIBENZAZEPINONE PRECURSORS…………………..50 
2.2 OPTIMIZATION OF REACTION CONDITIONS……………………….…50 
2.3 EXPLORATION OF THE REACTION WITH CHLOROARYL 
SUBSTRATES………………………………………………………………………….…52 
2.4 EXPANSION OF THE SUBSTRATE SCOPE ………...………………….…53 
3.0 CONCLUSIONS ........................................................................................................ 60 
4.0 EXPERIMENTAL ..................................................................................................... 62 
5.0 BIBLIOGRAPHY .................................................................................................... 119 
 
 
 
 
  vii 
 LIST OF TABLES 
 
Table 1. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with imidazolinium salt 40 .... 13 
Table 2. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b and different 
palladium       sources.................................................................................................................... 19 
Table 3. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b in different solvents 20 
Table 4. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b and different 
equivalents of NaOt-Bu ................................................................................................................ 21 
Table 5. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b at different 
temperatures .................................................................................................................................. 21 
Table 6. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48d at different 
temperatures .................................................................................................................................. 23 
Table 7. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48d and different 
equivalents of NaOt-Bu ................................................................................................................ 24 
Table 8. Optimization of the asymmetric oxindole synthesis (eq 1, Ar = phenyl) with 48d ........ 26 
Table 9. Asymmetric oxindole synthesis (eq 1, Ar = phenyl) with different NHC precursors .... 27 
Table 10. Asymmetric synthesis of 3-methoxy-3-phenyloxindole with different NHC precursors
....................................................................................................................................................... 32 
Table 11. Asymmetric synthesis of 3-alkoxy-3-phenyloxindoles with 48j .................................. 33 
  viii 
Table 12. Rotation barrier in anilides 70 and 71 measured by 2D EXSY in THF-d
8
 ................... 39 
Table 13. Asymmetric pyrrolidine synthesis with 73 and 74 ....................................................... 41 
Table 14. Asymmetric pyrrolidine synthesis with 73 and different silver salts............................ 42 
Table 15. Asymmetric pyrrolidine synthesis with 76 in different solvents .................................. 42 
Table 16. Asymmetric cyanosilylation of 4-chlorobenzaldehyde with different NHC precursors
....................................................................................................................................................... 44 
Table 17. Hydrogenation of β,β-dimethylstyrene with different equivalents of Et3SiH and TFA 45 
Table 18. Scope of the hydrogenation of styrene derivatives with Et3SiH and TFA ................... 46 
Table 19. Optimization of the synthesis of dibenzazepinone 106 ................................................ 52 
Table 20. Scope of the intramolecular arylation pathway to dibenzazepinones ........................... 55 
  
  ix 
 LIST OF FIGURES 
 
Figure 1. Structures of N-heterocyclic carbenes ............................................................................. 1 
Figure 2. N-Heterocyclic carbenes with different back bone chirality ........................................... 5 
Figure 3. Crystal structures of imidazolinium salts 48b–48d ....................................................... 18 
Figure 4. Palladium-catalyzed α-arylation of substrates with substituents at the N-aryl ring ...... 35 
  
  x 
LIST OF SCHEMES 
 
Scheme 1. Imidazolinium salts 17 and 21 ...................................................................................... 7 
Scheme 2. Synthesis of bromoarene 22 .......................................................................................... 8 
Scheme 3. Synthesis of imidazolinium salt 26 ............................................................................... 8 
Scheme 4. Efforts for the Suzuki coupling of the „arm‟ and the „core‟ .......................................... 9 
Scheme 5. Synthesis of imidazolinium salt 21 ............................................................................. 10 
Scheme 6. Synthesis of imidazolinium salts 35 and 36 ................................................................ 12 
Scheme 7. Synthesis of imidazolinium salt 40 ............................................................................. 12 
Scheme 8. Synthesis of imidazolinium salt 45 ............................................................................. 14 
Scheme 9. Synthesis of imidazolinium salt 48a ........................................................................... 15 
Scheme 10. Synthesis of imidazolinium salt 48b–48j .................................................................. 16 
Scheme 11. Retrosynthesis of chiral 2-(3-methylbutan-2-yl)aniline ............................................ 29 
Scheme 12. Attempted synthesis of chiral 2-(3-methylbutan-2-yl)aniline ................................... 29 
Scheme 13. Synthesis of imidazolinium salts 56 and 57 .............................................................. 30 
Scheme 14. Proposed mechanism for asymmetric oxindole synthesis ......................................... 36 
Scheme 15. Synthesis of anilides 70 and 71 ................................................................................. 39 
Scheme 16. Synthesis of NHC-gold catalysts 72–76.................................................................... 40 
Scheme 17. Synthesis of 1,2-dihydroisoquinolin-3(4H)-one derivertives.................................... 48 
  xi 
Scheme 18. Synthesis of dibenzazepinones by palladium-catalyzed intramolecular arylation .... 49 
Scheme 19. Synthesis of amides 95–104 ...................................................................................... 51 
Scheme 20. Synthesis of dibenzazepinone 106 from chloroaryl substrates ................................. 53 
Scheme 21. Synthesis of lactam 118............................................................................................. 56 
Scheme 22. Rearrangement of -benzyloxydibenzazepinone 117 ............................................... 59 
 
 
 
  xii 
PREFACE 
 
I‟m honored to express my deepest gratitude to Prof. Craig Wilcox for giving me the 
wonderful opportunity to pursue exciting research under his supervision.  He has offered me 
valuable ideas, suggestions and criticisms with his profound knowledge in science and rich 
research experience.  His patience and kindness are greatly appreciated. Besides, he always puts 
high priority on my dissertation writing and was willing to discuss with me at anytime he was 
available.  
I thank Professors Dennis Curran, Scott Nelson, Alexander Doemling and 
Paul Floreancig for serving on my various different committees over the years and contributing 
to my intellectual growth as a chemist.  
I thank the Wilcox group members for all their advice and help.  Special thanks should go 
to Melissa Liberatore for her patience and guidance for writing.   
I thank the members of chemistry department‟s staff section, especially Fran Nagy, Toni 
Weber, Josh Jones, Sage Bowser and Steven Geib for providing a world-class infrastructure for 
chemical research. 
Special thanks to Pan Pan for her love and support. 
 
 
  1 
1.0  DESIGN AND SYNTHESIS OF CHIRAL N-HETEROCYCLIC CARBENES 
WITH APPLICATIONS TO ASYMMETRIC SYNTHESES 
N-Heterocyclic carbenes (NHCs) were introduced as ligands in 1968 when carbene 
complexes 1
1 
and 2
2
 were prepared.
 
  But the chemistry of NHCs and their application in catalysis 
did not rapidly develop until the first free carbene ligand 3 was isolated.
3
 
 
N-Heterocyclic carbenes, including imidazolylidenes A, imidazolinylidenes B, 
benzimidazolylidenes C and triazolinylidines D, share a common substructure (Figure 1).  Two 
nitrogens are connected by the sp
2
 carbene carbon and donate electron density into the empty p-
orbital of the carbene carbon.  The electronegativity of nitrogen also helps stabilize the N-
heterocyclic carbene. 
 
Figure 1. Structures of N-heterocyclic carbenes 
  2 
This unique structure makes N-heterocyclic carbenes good ligands.  They are similar to 
trialkylphosphines and alkylphosphinates,
4
 but they are better σ donors and poor π acceptors.5   
Free carbene ligands can displace several types of ligands such as halides, alkenes, carbonyls, 
arenes, phosphines, ethers and amines.
6
  Numerous molecular structures based on the 
crystallographic data show that the metal-carbene bonds are rather long (>210 pm).  In Fischer- 
and Schrock-type complexes, these distances are below 200 pm because of backbonding.
6 
 Thus, 
metal-carbene bonds are extremely strong, making these kinds of complexes superior to those of 
trialkylphosphines and alkylphosphinates.  NHCs are easy to make, have versatile structures and 
better air and thermal stability, and due to their high affinity to the metals, do not require excess 
ligand for complete complexation of the metal. 
Most N-heterocyclic carbenes are made from the corresponding azolium salts via 
deprotonation.  Strong bases such as NaOt-Bu are usually used.  Triethylamine can also 
deprotonate the azolium salts.  The deprotonation may be driven by the precipitation of halide 
salts, the formation of complexes or the decomposition of carbenes.
7
 
A number of N-heterocyclic carbenes have been applied in many reactions as either 
ligands of catalysts or catalysts and show promising activity compared to trialkylphosphines and 
alkylphosphinates.
6
  Based on this fact, the application of chiral NHC ligands in asymmetric 
syntheses started in 1995 and the first efficient chiral NHC ligand was published in 2001.
8
  
Although NHC ligands are very similar to phosphines, they may not create an “edge-to-face” 
arrangement of their aryl substitutes which are very common in many chiral diphosphines.
8
  
Based on the structure, they can be categorized as follows:
8
 
1. Carbenes with chiral N-substituents and chiral centers most often on the C atoms 
adjacent to the N atoms.  The main drawback of these carbenes could be a fast rotation of the 
  3 
C-N bond
8
 (complex 4
9
 and carbene 5
10
), making the chiral environment less defined.  The 
trimethylsilyl group in 5 is replaced with a diphenylphosphinyl group (complex 6
11
) which could 
coordinate to the metal, and the rotation of the C-N bond is fixed by this coordination.  This 
rotation is also blocked in triazolium salts 7 and 8 which feature a bicyclic structure.
 12
  Another 
important contribution to this kind of NHC (with controlled rotation of the C-N bond) is 
imidazolinium salts 9
13
 and 10,
14
  in which the steric bulk of the chiral N-substituents is greatly 
increased.   
 
2. Carbenes incorporating 1,1’-binaphthyl units.  The 1,1‟-binaphthyl unit is 
commonly employed as a component in asymmetric catalysts (BINAP and BINOL).  The 
rotation of the inter-ring C-C bond is blocked, making stable atropoisomers possible.  Based on 
the structures of (S)-BINAP and (S)-BINOL, complexes 11
15
 and 12
16
 have been reported. 
 
  4 
3. Carbenes joined by trans-cyclohexane.  Both carbenes are connected by a trans-
cyclohexane in imidazolium salt 13,
17
  and a carbene opposes an imine in imidazolium salt 14.
18
  
When they coordinate to a metal simultaneously, a chiral environment is developed.   
 
4. Carbenes incorporating oxazoline units.  Due to its rigidity, quasi-planarity and 
facile accessibility by condensation of an amino-alcohol with a carboxyl acid derivative,
19,20
 the 
oxazoline ring has been widely used in the ligand design for asymmetric catalysts.  As shown in 
complexes 15
21,22
 and 16,
23
 the nitrogen atom on the oxazoline coordinates to the metal, and the 
stereodirecting substituent is delivered to the metal center.   
 
5. Carbenes with chiral elements within the backbone of the NHC.  Other positions 
on the carbene may also be modified to introduce chirality.  The 4 and 5 positions of the 
imidazolinylidene are sp
3
-hybridized carbon atoms.  It is possible to introduce a chiral carbon by 
appropriate substitutions (t-butyl, phenyl groups and trans-cyclohexane moiety (Figure 2)).  In 
taking this approach, chiral information is expected to be transferred to the metal center by the 
means of a second order response from the R
1
 substituent.   
  5 
 
Figure 2. N-Heterocyclic carbenes with different back bone chirality 
1,3-Bis(ortho-substitutedphenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborates (Figure 2) were introduced as the precursors of chiral NHCs in a ruthenium-
catalyzed olefin metathesis reaction.
24
  The crystal data of the NHC metal complexes show that 
these NHC ligands are approximately C2-symmetric with the ortho-substituents anti to the 
phenyl groups on the imidazole ring, and the stereochemistry of the phenyl groups on the 
imidazole ring is effectively transferred to the metal center.
25
  The rotation of the N-Ar bond in 
these NHCs is hindered which results in strong conformational preferences both in the solution 
and the solid state.
26
  The family of these NHCs has been explored in many asymmetric 
syntheses and gives moderate to excellent results.
27
   
The oxindole is a very important substructure in many biologically active natural 
products and pharmaceutically active candidates.
28
  In 2001, three NHC ligands were employed 
in the palladium-catalyzed α-methyl-α-aryl oxindole synthesis (eq 1) which cannot be achieved 
by the intramolecular Heck reactions, and their outcomes were superior to those of 19 other 
chiral phosphine ligands.
13
  After that, many NHC ligands were tried in this reaction.
29
  Before 
we started our new ligand exploration in 2005, the best results of the oxindole reaction in the 
literature were 69% ee, 91% yield with 1 mol % of the catalyst at 25 °C for 26 h (Ar = 1-
naphthyl)
13
 and 67% ee, 14% yield with 20 mol % of the catalyst at 100 °C for 12 h (Ar = 
phenyl).
29c 
 We believed there was an opportunity to improve the reactivity and enantioselectivity 
of the oxindole reaction and tried to develop a new NHC ligand.   
  6 
A good chiral ligand should be C2 symmetrical in order to reduce the number of 
diastereomeric intermediates and transition states which play a role in the catalytic cycle.
30   
The 
region around the metal center should have a fixed chiral environment, but the environment 
cannot be too restrictive or the desired transition states may be impossible to form.  There is a 
balance to be sought between reactivity and selectivity.  Moreover, the ligand should be easy to 
make and recycle, and have air and thermal stability.  Here we report our efforts toward the 
synthesis of new NHCs and their application in the asymmetric syntheses.  
 
1.1 EXPLORATION OF IMIDAZOLINIUM SALTS WITH THE ‘ARM’ AND 
‘CORE’ STRUCTURES 
In our first investigation, deriving an idea from our torsion balance model 18 (Scheme 1), 
we sought to prepare analogs of imidazolinium salt 17.  The target can be divided into two 
principal parts with 19 as an „arm‟ structure and 20 as a „core‟ structure.  The isopropyl groups 
lock the phenyl ring in a position vertical to the NHC ring.  The external „arm‟ phenyl rings are 
vertical to the internal phenyl rings and, on average, coplanar with the heterocycle.  The idea we 
wanted to explore was to bring the chiral group close to the metal center by directing it from a 
remote position.  We perceived that the chiral R substituent can be changed by esterification of 
the benzyl alcohol in order to provide different chiral environments at the metal center.  Amino 
acids seemed to be a good choice for this modification. To test this idea, imidazolinium salt 21 
  7 
(an analog of 17 in which Boc-L-proline is the R* substituent) was first explored, and its 
synthesis would call for the Suzuki coupling of bromoarene 22 and boronic acid 23. 
Scheme 1. Imidazolinium salts 17 and 21 
 
Synthesis of bromoarene 22.  As shown in Scheme 2, the oxidation of 2,6-
dimethylbromobenzene with KMnO4 provided diacid 24 in 52% yield
31 
which was reduced to 
diol 25 quantitatively with BH3.
32
  The esterification of 25 with Boc-L-proline under standard 
DCC/DMAP conditions afforded 22 in 89% yield.
33
  
Synthesis of imidazolinium salt 26 (an alternative to boronic acid 23).  As shown in 
Scheme 3, the bromination of 2,6-diisopropylaniline with Br2 gave bromoaniline 27 in 87% 
yield.
34
  The treatment of 27 with oxalaldehyde provided diimine 28 in 80% yield.
35
      Further 
reduction of 28 with NaBH4 afforded diamine 29 in 92% yield.
36
  Our synthetic plan called for 
the lithiation-borylation reaction, but neither 28 nor 29 gave a product through this pathway.  
  8 
Finally, borylated diamine 30 was obtained in 88% yield by the Miyaura borylation of 29 with 
bis(pinacolato)diboron in a microwave reactor.
37
  The treatment of 30 with CH(OEt)3 and 
NH4BF4 gave 26, the desired core unit, in 85% yield.
13
  
Scheme 2. Synthesis of bromoarene 22 
 
Scheme 3. Synthesis of imidazolinium salt 26 
 
Efforts for assembling ‘core’ 26 and ‘arms’.  The core unit 26, could function as a 
versatile precursor to a variety of new NHC ligands.  For this to succeed, the core must be 
susceptible to Suzuki coupling.  We attempted coupling of the core 26 and the arm 22 by the 
Suzuki reaction methods.  However, the reaction was unsuccessful – possibly because of the 
bulky and base labile components (ester) on 22.  The Suzuki reaction of 26 and diol 25 also 
failed most likely due to the hydroxyl groups.  Accordingly, the hydroxyl groups on 25 were 
  9 
protected with TBSCl to give TBS ether 31 in 90% yield (Scheme 4).
38
  However, the Suzuki 
coupling of 26 and 31 was also unsuccessful.  Different palladium catalysts (Pd(PPh3)4, 
Pd(OAc)2，Pd(dppf)Cl2, Pd/C, Pd2(dba)3 with P(n-Bu)3 and Pd(OAc)2 with PCy3) and different 
bases (K2CO3, Na2CO3, K3PO4, NaHCO3 and KF) in different solvents (DME, benzene, DMF, 
EtOH, MeOH, CH2Cl2, dioxane and H2O) at 80 °C to 140 °C in an oil bath or a microwave 
reactor were tried but failed in the Suzuki coupling of 26 and 31.  
Scheme 4. Efforts for the Suzuki coupling of the „arm‟ and the „core‟ 
 
2,6-Dimethylbromobenzene, a simple substrate, was also difficult to couple with the core 
26.  Therefore, the problem is probably due to 26.  Diboronate 26 was then transformed to 
diboronic acid 32 in 99% yield with NaIO4 and NH4OAc (Scheme 4).
39
  However, the Suzuki 
coupling of 32 and 31 was also unsuccessful.  We also tried reversing the position of the boronic 
acid and the aryl bromide (Scheme 4).  Unfortunately, the Miyaura borylation of 31 failed.  
 
  10 
Synthesis of imidazolinium salt 21 involving the Suzuki coupling of diamine 30 and 
bromoarene 31 (Scheme 5).  Despite extensive effort, no satisfactory method for the Suzuki 
reaction of the core 26 was found.  Therefore we attempted to couple the arm and diamine 30, 
expecting that the imidazolinium salt could be formed after the coupling.  In the event, diamine 
30 was coupled with 31 successfully in a microwave reactor.
40
  Following deprotection of the 
coupling product by TBAF gave tetraol 33 in 85% yield over these two steps.
41
  We found that 
the coupling could not be achieved directly from diol 25 and 30 under these conditions in the 
microwave reactor.  The esterification of 33 with Boc-L-proline afforded tetraester 34 in 89% 
yield which was cyclized to imidazolinium salt 21 with CH(OEt)3 and NH4BF4 in 77% yield. 
Scheme 5. Synthesis of imidazolinium salt 21 
 
  11 
Testing imidazolinium salt 21 in the asymmetric oxindole synthesis (eq 1, Ar = 1-
naphthyl).  With 21 in hand, we turned to evaluate this ligand in the asymmetric oxindole 
reaction.  Unfortunately, the oxindole reaction did not occur until the temperature was raised to 
80 °C and the product that did form was racemic.  Tests showed that this reaction could take 
place without 21 at 80 °C.   
Exploration of imidazolinium salts 35 and 36.  Imidazolinium salt 21 is not an 
effective ligand possibly because of a bulky group leading to steric hindrance and the base labile 
component.  To test this hypothesis, imidazolinium salts 35 (methyl) and 36 (methoxymethyl) 
were prepared (Scheme 6).  The methylation of diol 25 with MeI provided diether 37 in 92% 
yield.
42 
 The Suzuki coupling of 2,6-dimethylbromobenzene and 30 gave diamine 38 in 99% 
yield which was cyclized with CH(OEt)3 and NH4BF4 to afford imidazolinium salt 35 in 76% 
yield.  The same reaction sequence with bromodiether 37 gave diamine 39 in 95% yield and 
imidazolinium salt 36 in 50% yield.  The asymmetric oxindole reaction (eq 1, Ar = 1-naphthyl) 
proceeded smoothly at room temperature with imidazolinium salts 35 or 36.  This established 
that the remote chiral unit in 21 was interfering with the reaction.   
Exploration of imidazolinium salt 40.  Based on the structure of achiral imidazolinium 
salt 36, imidazolinium salt 40 with chiral benzyl ether groups was designed and prepared 
(Scheme 7).  (R)-2-Phenyloxirane was reduced to benzyl alcohol 41 quantitatively with 
LiAlH4.
43 
 The bromination of 2,6-dimethylbromobenzene with NBS under illumination gave 
benzylbromide 42 in 63% yield.
44
  The treatment of 42 with 41 and NaH afforded diether 43 in 
81% yield.
45
  The Suzuki coupling of 43 and diamine 30 in a microwave reactor gave diamine 44 
in 67% yield.  Finally, cyclization of 44 with CH(OEt)3 and NH4BF4 provided imidazolinium salt 
40 in 68% yield.   
  12 
Scheme 6.  Synthesis of imidazolinium salts 35 and 36 
 
Scheme 7. Synthesis of imidazolinium salt 40 
 
  13 
Imidazolinium salt 40 was then tested in the asymmetric oxindole reaction (eq 1, Ar = 1-
naphthyl, Table 1).  The best results achieved were 12% ee with 97% yield when 10 mol % of 
40, Pd(dba)2 and 1.5 equiv of NaOt-Bu were used in dioxane at 25 °C for 20 h (entry 3).  
Although the reactivity is good, the ee is poor.  The low ee may be due to the relatively large 
distance between the chiral groups and the metal center.   
Table 1. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 40
a
 
Entry Pd Solvent T (°C) Time (h) Yield
b
 (%) Ee
c
 (%) 
1 Pd2(dba)3 DME 50 14 42   4 
2 Pd(dba)2 DME 25 20 35   2 
3 Pd(dba)2 dioxane 25 20 97 12 
a
Reaction run with 10 mol % of 40, Pd(dba)2 and 1.5 equiv of NaOt-Bu.  
b
The yield of oxindole A was calculated from isolated product after 
chromatography.    
c
The ee was determined by chiral OD-H HPLC. 
 
Synthesis of imidazolinium salt 45.  Prior investigations in our laboratory by Dr. Jae 
Kon Kim had resulted in the synthesis of a related chiral NHC, imidazolinium salt 45 (Scheme 
8).  We sought to compare our synthetic methods with his process.  The Suzuki coupling of 
bromobenzene 46 (from Dr. Kim) and 30 provided diamine 47 in 80% yield.  The cyclization of 
47 with CH(OEt)3 and NH4BF4 provided imidazolinium salt 45 in 52% yield.  The steps in this 
new pathway are fewer than those in Dr Kim‟s and of overall higher yield.   
 
 
 
 
 
  14 
Scheme 8. Synthesis of imidazolinium salt 45 
 
1.2 EXPLORATION OF (4R,5R)-1,3-BISARYL-4,5-DIPHENYL-4,5-DIHYDRO-1H-
IMIDAZOL-3-IUM TETRAFLUOROBORATES  
The NHC ligands we made above may be useful for other reactions but are not good in 
the asymmetric oxindole synthesis.  We surmised that the structures of these failed NHC ligands 
were too crowded, and the chiral controlling groups were too far from the reaction center.  
Accordingly, (4R,5R)-1,3-bisaryl-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborates were designed and imidazolinium salt 48a (R = 2,6-dimethylphenyl) was first 
targeted (Scheme 9).  In this design, the 2,6-dimethylphenyl group is moved from the para 
position (imidazolinium salt 35) to the ortho position of the N-benzene ring.  A key idea here is 
that the phenyl groups in the backbone of the NHC would control the conformation of the 
dimethylphenyl group opposite to them.  The chirality is then transferred from the backbone of 
the NHC to the reaction center.   
  15 
Scheme 9.  Synthesis of imidazolinium salt 48a 
 
Synthesis of imidazolinium salt 48a.  As shown in Scheme 9, imidazolinium salt 48a 
would undoubtedly come from the cyclization of diamine 49a, which would call for the 
Hartwig˗Buchwald coupling of iodoarene 50 and (1R,2R)-1,2-diphenylethane-1,2-diamine.  The 
Hart coupling of 2-bromo-iodobenzene and 2,6-dimethylphenylmagnesium bromide with I2 
provided 50 in 75% yield.
46
  Unfortunately, the Hartwig˗Buchwald coupling of 50 and (1R,2R)-
1,2-diphenylethane-1,2-diamine only afforded monocoupled product 51 in 48% yield.
47
  Further 
Hartwig˗Buchwald coupling of 51 and 50 was fruitless.  However, the Hartwig˗Buchwald 
coupling of 51 and 2,6-dimethylbromobenzene furnished diamine 52 in 81% yield.  Therefore 
the failure of the dicoupling is most likely due to the steric bulk of 50.  We envisioned that the 
dimethyl group on 50 could be eliminated and prepared imidazolinium salt 48b (R = phenyl).
 27d
    
Synthesis of imidazolinium salt 48b–48j.  Because of the similarities of (4R,5R)-1,3-
bisaryl-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborates 48b–48j, their syntheses 
are described together in Scheme 10.  The Buchwald–Hartwig coupling of (1R,2R)-1,2-
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diphenylethane-1,2-diamine and bromo- or iodo-arenes provided diamines 49b–49i in 23–96% 
yield.  Further cyclization of 49b–49i with CH(OEt)3 and NH4BF4 afforded imidazolinium salts 
48b–48i in 41–84% yield. 
Scheme 10. Synthesis of imidazolinium salts 48b–48j 
 
By contrast, the synthesis of imidazolinium salt 48j with ortho-2,4-dimethylpentan-3-yl-
phenyl group was a challenge.  The synthesis of the required iodobenzene derivative 53 by direct 
reduction of tertiary benzyl alcohol 54 with TFA and NaBH4
48
 or TFA and Et3SiH
49
 was not 
successful.  Styrene 55 was achieved as the byproduct.  Furthermore, the hydrogenation of 55 
failed with conventional heterogeneous (Pd/C 10% or Pt/C 5%, PtO2 in EtOH, EtOAc or AcOH 
with H2 (1 atm, 35psi or 50 psi) at room temperature or 70 °C) and homogeneous catalysts 
(Wilkinson’s catalyst in THF and t-BuOH with 50 psi H2 at room temperature).  Fortunately, 
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with the addition of BF3·Et2O, TFA and Et3SiH directly reduced 54 to 53.  Efforts were made to 
optimize the reaction. Without TFA, the reduction of 54 to 53 did not occur.  When 55 was 
treated under the same reaction conditions as 54 (BF3·Et2O, TFA and Et3SiH), 53 was also 
achieved (detected from the crude 
1
H NMR spectrum).  The treatment of 54 with BF3·Et2O 
afforded 55 in 96% yield.  Without BF3·Et2O, the reduction of 55 to 53 did not occur.  We 
reasoned that BF3 increased the acidity of TFA which could protonate the double bond, and the 
resulting cation was reduced by Et3SiH and TFA.  Accordingly, TfOH, a strong acid, was used to 
substitute BF3, and 55 was reduced to 53 successfully.  Optimum results were obtained: with a 
drop of TfOH, 4 equiv of TFA and 2 equiv of Et3SiH at room temperature, 55 provided 53 in 
83% yield as a mixture of 55 and 53.   
The amination of this crowded aryl iodide was also challenging.  By the general 
procedure with BINAP/Pd as the catalyst to make the diamine, 55 did not react with (1R,2R)-1,2-
diphenylethane-1,2-diamine, and the mixture of 55 and 53 only gave monocoupled amine (with 
53) most likely because 53 is bulkier than other halobenzenes in our general syntheses.  
Increasing the temperature to 140 °C in toluene or 150 °C in xylene and microwave irradiation at 
140 °C still afforded monocoupled amine.  BINAP is thought to inhibit the formation of both 
catalytically inactive palladium bis(amine) aryl halide complexes and bridging amido complexes 
which resist reductive elimination.
50
  For a bulky aryl iodide, we reasoned that a less bulky 
phosphine ligand might promote this amination.  To test this idea, several catalysts, including 
Pd(dppf)Cl2, 2-(2'-di-tert-butylphosphine)biphenylpalladium(II) acetate, Pd(OAc)2 with 1,3-
bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate,  Pd(OAc)2 with 1,2-
bis(diphenylphosphino)ethane, Pd(OAc)2 with PCy3, Pd(PPh3)4 and Pd(Pt-Bu3)2, were tried in the 
coupling reaction of iodobenzene 53 and monocoupled amine.  The reactions were tracked and 
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compared by TLC, and only Pd(Pt-Bu3)2 catalyzed this reaction.  Moreover, Pd(Pt-Bu3)2 
catalyzed the reaction of 53 and (1R,2R)-1,2-diphenylethane-1,2-diamine directly, and diamine 
49j was achieved in 40% yield.  General cyclization of 49j afforded imidazolinium salt 48j in 
46% yield.   
Crystal data of imidazolinium salts 48b–48d.  As shown in Figure 3, the crystal 
structure of 48b shows that the phenyl groups ortho to the nitrogen orient anti to the phenyl 
groups on the imidazole ring.  However, in the crystal structure, the benzyl groups in 48c and 
cyclohexyl groups in 48d stay cis to the phenyl groups on the imidazole ring.  However, NOE 
spectroscopy of 48d and 48g in CD2Cl2 at room temperature shows some interaction between the 
benzyl hydrogens on the ortho-substituents and the hydrogens on the imidazole ring.  Therefore, 
the cyclohexyl groups in 48d and the isopropyl groups in 48g should somewhat orient anti to the 
phenyl groups on the imidazole ring in the solvent.  This cis conformation may be due to packing 
forces within the crystal or a strong CH- attraction between the benzyl hydrogens on the ortho-
substituents and the phenyl groups on the imidazole ring. 
                 
 
Figure 3. Crystal structures of imidazolinium salts 48b–48d 
 
  19 
Testing imidazolinium salt 48b in the asymmetric oxindole synthesis (eq 1, Ar = 1-
naphthyl).  The palladium sources were screened first (Table 2).  The oxindole reaction was 
carried out in dioxane with 10 mol % equiv of 48b and palladium, 1.5 equiv of NaOt-Bu at 60 °C 
for 17 h.  Pd(dba)2 was the best and provided the oxindole in 63% yield with 34% ee (entry 1).  
Table 2. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b and                            
different palladium sources 
Entry Pd Yield
a
 (%) Ee
b 
(%) 
1 Pd(dba)2 63 34 
2 Pd(PPh3)4 70   2 
3 Pd(OAc)2 42 22 
a
The yield of oxindole A was calculated from isolated product after 
chromatography.  
b
The ee was determined by chiral OD-H HPLC. 
 
Different solvents at different temperatures were also screened for the asymmetric 
oxindole synthesis (eq 1, Ar = 1-naphthyl) with 10 mol % of 48b and Pd(dba)2 for around 14 h 
(Table 3).  THF was the most suitable solvent in this reaction (entry 2, 38% yield and 63% ee at 
room temperature).  The reaction could not take place in DME at room temperature (entry 9), 
although it was effective in Hartwig’s report.13   
Different bases (2 equiv) such as KOt-Bu, LiOt-Bu, NaH, NaOMe were also tested in the 
asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 10 mol % of 48b and Pd(dba)2 in 
THF at room temperature.  Unfortunately, no reaction occurred with these bases.  Therefore 
NaOt-Bu was the best base for this reaction.   
The need for NaOt-Bu was also screened in the asymmetric oxindole synthesis (eq 1, Ar 
= 1-naphthyl) with 10 mol % of 48b and Pd(dba)2 in THF at room temperature for approximately 
22 h (Table 4).  The ee increased when more NaOt-Bu was used.  An enolate intermediate was 
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expected to form and directly be involved in the enantiomer selectivity.  We supposed that NaOt-
Bu created more enolate intermediate.  To test this hypothesis, ZnCl2 was added to the oxindole 
reaction, which could coordinate with the oxygen of the carbonyl and increase formation of the 
enolate intermediate (entry 5).  The ee increased slightly, but the yield did not improve (69% ee 
with 33% yield compared with 63% ee with 38% yield without the addition of ZnCl2).   
Table 3. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b in different solvents 
Entry Solvent NaOt-Bu (equiv)  T (°C) Yield
a
 (%) Ee
b
 (%) 
1 THF 2   5   0 - 
2 THF 3 23 38 63 
3 toluene 3 23 23 60 
4 CH2Cl2 3 23 13 59 
5 Et2O 3 23 19   2 
6 EtOH 3 23   0 - 
7 CHCl3 3 23   0 - 
8 CH3CN 3 23   0 - 
  9
c
 DME   1.5 23   0 - 
10 dioxane   1.5 40 32 26 
11 THF   1.5 40 45 58 
12 toluene   1.5 40 42 57 
a
The yield of oxindole A was calculated from isolated product after 
chromatography.  
b
The ee was determined by chiral OD-H HPLC.  
c
Reaction run with 5% equiv of 48b and Pd(dba)2. 
 
 
 
 
Finally, the asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) was carried out with 
10 mol% 48b and Pd(dba)2 in the presence of 3 equiv of NaOt-Bu in THF at different 
temperatures (Table 5).  When the temperature increased, the yield increased, and the ee reached 
the highest level (68%) at 40
 
°C, but not at 23 °C (lower temperature). 
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Table 4. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b and different 
equivalents of NaOt-Bu 
Entry NaOt-Bu (equiv) Yield
a
 (%) Ee
b
 (%) 
1   1.5 26 48 
2 3 38 63 
3   4.5 29 72 
4 10.5 35 77 
 5
c
 3 33 69 
 6
d
 3 27 65 
a
The yield of oxindole A was calculated from isolated product after chromatography.  
b
The ee was determined by chiral OD-H HPLC. 
c
Reaction run with ZnCl2 (0.17 equiv). 
d
Reaction run with 20 mol % of 48b and 10 mol % of Pd(dba)2. 
 
Table 5. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b at different 
temperatures 
Entry Solvent T (C) Time
c 
(h) Yield
a
 (%) Ee
b 
(%) 
1 THF 23 23 38 63 
2 THF 40 20 35 68 
3 THF 60  2 50 63 
4 THF 80  6 74 53 
 5
d
 THF 40 20 25 49 
6 toluene 80  6 64 46 
a
The yield of oxindole A was calculated from isolated product after chromatography. 
b
The ee 
was determined by chiral OD-H HPLC. 
c
Reaction time was not optimized.  
d
Reaction run with 
0.2 equiv of NaI. 
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With 48b, the optimized results of the asymmetric oxindole synthesis (eq 1, Ar = 1-
naphthyl) were 68% ee and 35% yield at 40 C (Table 5, entry 2).  There were still problems 
with this catalyst – low yields and high catalyst loading.  Several efforts were tried to improve 
this catalyst system.  
1. The ratio of 48b and Pd(dba)2 was increased to 2 (Table 4, entry 6); the ee did not 
change but the yield decreased to 27%.  This may be due to the formation of dicarbene palladium 
complex which is difficult to dissociate to form the effective catalyst.  
2. To the reaction was added 0.2 equiv of NaI (Table 5, entry 5), but the yield (25%) and 
ee (49%) decreased. 
3. Toluene was tried as the solvent, but the reaction was less effective (64% yield, 46% 
ee) than when THF was used (74% yield, 53% ee) at 80 °C (Table 5, entry 6).  
4. To the reaction was added 10 mol % of 48b and Pd(dba)2 in two identical portions; the 
second portion did not improve the yield or show any additional effect on the reaction.   
In conclusion, imidazolinium salt 48b with Pd(dba)2 in THF is a moderately effective 
catalyst system for the asymmetric oxindole reaction.  It is most likely that the ortho phenyl 
group is too close to the reaction center.  Thus the reaction center is too crowded to facilitate 
oxidative addition.  This may also have contributed to a rather low yield in the synthesis of 
imidazolinium salt 48b.  Therefore we sought a new NHC ligand.  For the new design, we chose 
to replace the phenyl group with a group that could move away from the metal coordination site.  
2-Benzyl-bromobenzene and 2-cyclohexyl-bromobenzene are commercially available, and the 
flexibility of the benzyl (imidazolinium salt 48c, Scheme 10) and cyclohexyl (imidazolinium salt 
48d,
27d 
Scheme 10) groups will make the palladium center less crowded.   
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Testing imidazolinium salts 48c and 48d in the asymmetric oxindole synthesis (eq 1, 
Ar = 1-naphthyl).  Salt 48c was used under the same conditions as 48b (Table 4, entry 3), but 
the ee of the product dropped to 39%, almost half of that observed with 48b (72% ee).  The 
benzyl group, the selectivity controlling group, is too flexible and the bulky phenyl part of the 
benzyl group is not close enough to the reaction center.  Accordingly, it is not surprising that the 
NHC ligand from 48d (with a cyclohexyl group) is an excellent ligand.   
As shown in Table 6, the asymmetric oxindole reaction (eq 1, Ar = 1-naphthyl) was 
carried out with 10 mol % of 48d and Pd(dba)2 and 3 equiv of NaOt-Bu in THF at different 
temperatures.  The yields remained in the range of 80% to 90% at all temperatures.  However, 
the best ee was 78% at 60 °C (entry 4) which was close to that at 80 °C (ee 77%, entry 6) but 
superior than those at low temperatures (entries 1-3).  This phenomenon is very similar to that of 
48b which achieved the highest ee at 40 °C but not at room temperature. 
Table 6. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48d at different 
temperatures 
Entry                                      T(C)   Time
c
(h) Yield
a
 (%)   Ee
b
 (%) 
1 23 40 80 65 
2 40 18 88 64 
3 50 16 80 74 
4 60   2 89 78 
5 70   2 87 75 
6 80   2 90 77 
a
The yield of oxindole A was calculated from isolated 
product after chromatography.  
b
The ee was determined by 
chiral OD-H HPLC.  
c
The reaction time was not optimized.  
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We had shown that the amount of NaOt-Bu was important for the enantioselectivity in 
the asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48b, therefore we also tested the 
effect of NaOt-Bu in the same reaction with 10 mol % of 48d and Pd(dba)2 (Table 7).  As 
expected, the yields were almost the same for different amounts of NaOt-Bu, but the ee became 
better when more NaOt-Bu was used.  There was not much difference between the ee achieved 
with 3 and 4.5 equiv of NaOt-Bu (entries 2 and 5), therefore, 3 equiv of NaOt-Bu was chosen as 
the best for this asymmetric oxindole reaction. 
Table 7. Asymmetric oxindole synthesis (eq 1, Ar = 1-naphthyl) with 48d and                          
different equivalents of NaOt-Bu 
Entry                                      NaOt-Bu (equiv)  Time (h)  Yield
a 
(%)   Ee
b
 (%) 
1   1.5    2 88 72 
2 3    2 89 78 
 3
c
 3    3 84 80 
 4
d
 3  14 82 77 
5    4.5   2 91 79 
a
The yield of oxindole A was calculated from isolated product 
after chromatography.  
b
The ee was determined by chiral OD-H 
HPLC. 
c
Reaction run with 5 mol % of 48d and Pd(dba)2.  
d
Reaction run with 1 mol % of 48d and Pd(dba)2 . 
 
In conclusion, the best catalysis process we found for the asymmetric oxindole reaction 
(eq 1, Ar = 1-naphthyl) would utilize 48d and Pd(dba)2 in a ratio of 1:1, with 3 equiv of NaOt-Bu 
in THF at 60 °C.  To probe the reactivity of 48d, the catalyst loading was decreased to 5 mol % 
and 1 mol % (Table 7, entries 3 and 4), and the yield and ee were almost unchanged.  Different 
substrates were tested with 1 mol % of 48d, Pd(dba)2 and 3 equiv of NaOt-Bu in THF at 60 °C 
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for 14 h (oxindole B, Ar = phenyl, ee 51%, yield 99%; oxindole C, Ar = 4-isobutyl phenyl, ee 
58%, yield 97%).  However, we were not satisfied with the results of the substrates with phenyl 
group, and expected more room to optimize them. 
Optimization of the asymmetric oxindole synthesis (eq 1, Ar = phenyl) with 48d.  As 
shown in Table 8, the solvents, the palladium sources, the bases and the temperatures were 
screened.  Toluene, a less polar solvent, was superior to THF in this reaction (entries 4 and 8).  
The equivalent of NaOt-Bu had no effect on the enantioselectivity in toluene because of the low 
solubility of NaOt-Bu in toluene (entries 8 and 12).  Decreasing the temperature slightly 
optimized the ee but prolonged the reaction time from 2 h at 60 C (ee 67%, yield 98%, entry 12) 
to 12 h at room temperature (ee 70%, yield 94%, entry 13) when 5 mol% of 48d and Pd(dba)2 
with 1.5 equiv of NaOt-Bu were used in toluene.  These optimized conditions at room 
temperature also improved the ee of the substrate (oxindole C, Ar = 4-isobutylphenyl) to 66% in 
94% yield in 12 h. 
Exploration of the steric and electronic effects of the ligand toward the asymmetric 
oxindole synthesis (eq 1, Ar = phenyl).  To investigate the steric effect of the NHC ligand on 
the asymmetric oxindole reaction, a series of (4R,5R)-1,3-bis(ortho-substitutedphenyl)-4,5-
diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborates with different ortho-substituents 
48b–48d, 48e (no substituent)27g, 48f (ortho-methyl),25 48g (ortho-isopropyl) 25 and 48h (ortho-
methyl-meta-phenyl) were tested in the oxindole reaction (eq 1, Ar = phenyl, Table 9, entries 1-
7), and their enantioselectivities were compared.  The enantioselectivity and reactivity of the 
NHC ligand increased as the steric bulk of the ortho-substituent increased.  Imidazolinium salt 
48h with the additional meta-phenyl group showed better enantioselectivity and reactivity than 
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48f with the ortho-methyl group.  The enantioselectivity and reactivity of 48g with the ortho-
isopropyl group were similar to those of 48d with ortho-cyclohexyl group.   
Table 8. Optimization of the asymmetric oxindole synthesis (eq 1, Ar = phenyl) with 48d
a
  
Entry Solvent Pd Base T (°C) Time (h) Yield
b
 (%) Ee
c
 (%) 
1 THF Pd(PPh3)4 NaOt-Bu 23 - - - 
2 THF Pd(OAc)2 NaOt-Bu 23 17 44 57 
3 THF Pd(dba)2 NaOt-Bu 23 17 79 59 
4 THF Pd(dba)2 NaOt-Bu 60   3 97 54 
5 DME Pd(dba)2 NaOt-Bu 60   3 - - 
6 dioxane Pd(dba)2 NaOt-Bu 60   3 97 49 
7 heptane Pd(dba)2 NaOt-Bu 60   2 97 60 
8 toluene Pd(dba)2 NaOt-Bu 60   2 98 67 
9 toluene Pd(dba)2 KOt-Bu 60   3 96 48 
10 toluene Pd(dba)2 LiOt-Bu 60   3 trace - 
11 toluene Pd(dba)2 NaOMe 60   3 - - 
 12
d
 toluene Pd(dba)2 NaOt-Bu 60   2 97 67 
 13
d
 toluene Pd(dba)2 NaOt-Bu 23 12 94 70 
a
Reaction run with 5 mol % of 48d, the palladium source and 3 equiv of the base.   
b
The 
yield of oxindole B was calculated from isolated product after chromatography.  
c
The ee 
was determined by chiral OD-H HPLC. 
  d
Reaction run with 1.5 equiv of NaOt-Bu. 
 
To examine the electronic effect of the NHC ligand on this asymmetric oxindole reaction 
(eq 1, Ar = phenyl), imidazolinium salt 48i (o,m,p-trimethoxy) was tested and found to catalyze 
the reaction at 80 °C only in 6% yield and 3% ee.  Therefore the steric bulk of the ortho-
substituent has a large effect on the enantioselectivity and reactivity of the NHC ligand.  We 
decided to make imidazolinium salt 48j with larger o-2,4-dimethylpentan-3-yl group (Scheme 
10).  Unfortunately, the enantioselectivity of 48j in the oxindole reaction (eq 1, Ar = phenyl) was 
only 50% with 94% yield (Table 9, entry 9).   
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Table 9. Asymmetric oxindole synthesis (eq 1, Ar = phenyl) with different NHC precursors
a 
Entry NHC precursor Yield
b
 (%) Ee
c
 (%) 
1 48b (o-phenyl) 29 48 
2 48c (o-benzyl) 38 54 
3 48d (o-cyclohexyl) 94 70 
4 48e (no substituent) 38 11 
5 48f (o-methyl) 63 39 
6 48g (o-isopropyl) 92 68 
7 48h (o-methyl-m-phenyl) 79 48 
 8
d
 48i (o,m,p-trimethoxy)   6   3 
9 48j (o-2,4-dimethylpentan-3-yl) 94 50 
10
e
 56 97 18 
11
f
 57 14   5 
a
Reaction run with 5 mol % of the imidazolinium salt, Pd(dba)2 and 1.5 
equiv of NaOt-Bu in toluene at room temperature for 12 h.  
b
The yield of 
oxindole B was calculated from isolated product after chromatography.   
c
The ee was determined by chiral OD-H HPLC.  
d
Reaction run at 80 °C 
for 3 h.  
e
Reaction run at 60 °C for 1 h.  
f
Reaction run for 6.5 h. 
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1.3 EXPLORATION OF IMIDAZOLINIUM SALTS WITH THE CHIRAL 
CONTROLLING GROUP (3-METHYLBUTAN-2-YL) LOCATED ON THE ORTHO 
POSITION OF THE N-ARYL RING  
Such chiral ortho substituents have not been examined for control in NHC ligands 
(Scheme 11, salts 56 and 57). 
Attempted synthesis of chiral 2-(3-methylbutan-2-yl)aniline (a required reactant for 
the synthesis of 56 and 57). Although 2-(3-methylbutan-2-yl)aniline has  been made by 
Harmata,
51
 we envisioned applying our procedure (hydrogenation of styrenes) toward its 
synthesis.  As shown in Scheme 11, the chiral 2-(3-methylbutan-2-yl)aniline would be achieved 
from (R)-camphorsulfonylamide 58 by crystallization of the diastereomeric sulfonylamide and 
cleavage of the amide bond.  The asymmetric hydrogenation of (R)-camphorsulfonylamide 59 to 
give 58 would call for the tactic we used to construct 53 from 55.  Amide 59 would be formed by 
regular amidation of (R)-camphorsulfonyl chloride and aniline 60.  Aniline 60 would 
undoubtedly call on the general procedure we used to make styrene 55 (from benzyl alcohol 61 
which could be achieved from 1-(2-aminophenyl)ethanone).  Here, (R)-camphorsulfonyl group 
would work as an auxiliary which would not only help separate the diastereomeric 
sulfonylamide, but also enantioselectively hydrogenate the styrene moiety.    
As shown in Scheme 12, the treatment of 1-(2-aminophenyl)ethanone with 
isopropylmagnesium bromide furnished benzyl alcohol 61 in 44% yield.
52
  The dehydration of 
61 with iodine gave styrene 60 in 75% yield.
53
  As expected, the hydrogenation of this bulky 
styrene derivative 60 with conventional heterogeneous (Pd/C 10% in EtOH with 50 psi H2) or 
homogeneous catalysts (Wilkinson‟s catalyst in THF and t-BuOH with 50 psi H2) was not 
successful.  Direct hydrogenation of styrene with Et3SiH, TFA and one drop of TfOH also failed 
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- most likely because of the basic amino group.  As planned in the retrosynthesis, the amino 
group would be protected by a (R)-camphorsulfonyl group.  But before using this complex 
protecting group, p-toluenesulfonyl group was tried for easy structural analysis of the product by 
1
H NMR spectroscopy.  The treatment of styrene 60 with p-toluenesulfonyl chloride afforded 
sulfonylamide 62 in 56% yield.
52
  Interestingly, when sulfonylamide 62 was treated with Et3SiH, 
TFA and one drop of TfOH, indoline derivative 63 was achieved in 95% yield.  This product is 
most likely derived from the protonation of the double bond followed by the intramolecular 
attack of the amino group.  Then we chose to protect the amino group with acetyl group.  Aniline 
60 was treated with acetyl chloride to give acetamide 64 quantitatively.  Unfortunately, under the 
general hydrogenation conditions we had developed, no reaction occurred with 64.  Finally, we 
turned back and made 2-(3-methylbutan-2-yl)aniline with Harmata‟s procedure. 
Scheme 11. Retrosynthesis of chiral 2-(3-methylbutan-2-yl)aniline 
 
Scheme 12. Attempted synthesis of chiral 2-(3-methylbutan-2-yl)aniline 
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Synthesis of imidazolinium salts 56 and 57.  As shown in Scheme 13, anilines 65 and 
66 were resolved by separation (via crystallization) of the amide diastereomers prepared from 
(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid and 2-(3-methylbutan-2-yl)aniline.  The 
treatment of 65 with glyoxal provided the diimine which was reduced with NaBH4 to give 
diamine 67 in 83% overall yield.
 
 General cyclization of 67 afforded imidazolinium salt 56 in 
83% yield.  The amidation of 66 with 2-oxo-2-(phenylamino)acetic acid gave diamide 68 
quantitatively.  Following reduction of 68 with BH3 provided diamine 69 in 97% yield.
54
  
General cyclization of 69 afforded imidazolinium salt 57 in 79% yield. 
Scheme  13. Synthesis of imidazolinium salts 56 and 57 
 
Testing 56 and 57 in the asymmetric oxindole synthesis (eq 1, Ar = phenyl).  The 
catalyst provided by 56 could not catalyze the oxindole reaction at room temperature and 
afforded only 18% ee with 97% yield at 60 °C (Table 9, entry 10).  The low reactivity of 56 at 
room temperature is most likely due to the overcrowding of the ligand.  The less hindered NHC 
precursor 57 with only one ortho substituent did catalyze the oxindole reaction at room 
temperature, but gave disappointing results (14% yield, 5% ee, Table 9, entry 11).   
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1.4  EXPLORATION OF NHC LIGANDS IN THE ASYMMETRIC SYNTHESIS OF  
3-ALKOXY-3-ARYLOXINDOLES     
Optimization of the asymmetric synthesis of α-methoxy-α-phenyloxindoles (eq 2).  
Different solvents were first screened (Table 10).  With 5 mol % of 48d and Pd(dba)2, 3 equiv of 
NaOt-Bu at room temperature for 26 h, the oxindole reaction did not occur in MeCN, DME, 
Et2O and 1,2-dichloroethane, but gave the product in toluene (23% ee, 16% yield) and CH2Cl2 
(racemic, 14% yield).  Different NHC precursors (10 mol %) were then tested in this oxindole 
reaction with 5 mol % of Pd2(dba)3 and 3 equiv of NaOt-Bu in toluene at 60 °C, and the results 
are summarized in Table 10.  NHC precursors 48d and 48g were less effective in this reaction 
(7% and 2% ee, respectively, entries 1 and 2) than in the α-methyl-α-aryl oxindoles reaction.  
Imidazolinium salt 48k with a 1-naphthyl group as the N-substituent provided the product in 
49% yield with 34% ee (entry 9).  Although 48j was not as good as 48d in the α-methyl-α-aryl 
oxindole reaction, it outperformed 48d dramatically in this reaction and provided the product in 
99% yield with 54% ee (entry 5).  With 48j, the ee increased slightly (61% at 40 °C) at lower 
temperatures (entries 5–7), but the yield decreased dramatically (18% at 40 °C).  The ee and 
yield decreased obviously when the equivalent of NaOt-Bu decreased to 1.5 at 60 °C (entry 8).   
Expansion of the substrate scope (3-alkoxy-3-aryloxindoles).  The optimized 
cyclization conditions (5 mol % of Pd2(dba)3, 10 mol % of 48j and 3 equiv of NaOt-Bu in 
toluene at 60 °C) were applied to three more substrates (Table 11).  The ee and yield of the 
product provided by the chloroaryl substrate (20% ee, 29% yield, entry 2) decreased dramatically 
in comparison with those of the bromoaryl substrate (54% ee, 99% yield, entry 1).   The benzyl 
protecting group on the substrates also decreased the ee of the products (entries 3 and 4). 
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Table 10. Asymmetric synthesis of 3-methoxy-3-phenyloxindole with different NHC precursors 
                 
Entry NHC precursor T (°C) Time (h) Yield
a
 (%) Ee
b
 (%) 
1 48d (o-cyclohexylphenyl) 60    2.5   79   7 
2 48g (o-isopropylphenyl) 60    1.5 100   2 
3 48h (o-methyl-m-phenylphenyl) 60 3   51 19 
4 48i (o,m,p-trimethoxyphenyl) 60 4   26 10 
5 48j (o-2,4-dimethylpentan-3-yl-phenyl) 60    2.5   99 54 
6 48j 50 3   65 53 
7 48j 40 4   18 61 
8
c
 48j 60    2.5   10 40 
9 48k  60  3.5 49 34 
a
The yields were based on the crude 
1
H NMR spectra of the reaction mixtures. 
b
The ee was 
determined by chiral OD-H HPLC.  
c
Reaction run with 1.5 equiv of NaOt-Bu. 
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Table 11. Asymmetric synthesis of 3-alkoxy-3-phenyloxindoles with 48j 
Entry Reactant Product Time (h) Yield
a
 (%) Ee
b 
(%) 
1 
 
 
  2.5 99 54 
2 
 
 
 
  1.5 29 20 
3 
  
      1 94 20 
4 
 
 
  0.5 94 12 
a
The yield was calculated from isolated product after chromatography except entry 1 which was 
based on the crude 
1
H NMR spectra of the reaction mixture.  
b 
The ee was determined by chiral 
OD-H HPLC.  
 
 
 1.5 MECHANISM OF ASYMMETRIC OXINDOLE SYNTHESIS  
Imidazolinium salt 48d (o-cyclohexyl group) provided the most efficient catalyst for the 
asymmetric α-methyl-α-aryl oxindole synthesis until 2007, when Kündig‟s ligands increased the 
ee (79–95%) though also increased the reaction time (24–36 h).55  For α-methyl-α-1-naphthyl 
oxindole (more hindered substrate), 48d compared with Kündig‟s ligands.  In 2008, (4S,5S)-1,3-
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bis(substituted-1-naphthyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborates 
(similar to our NHC salts, N-naphthyl vs N-phenyl) were reported by Dorta‟s group and gave 
similar reactivity and enantioselectivity to 48d.
 56
  The diastereomers of palladium complexes 
(NHC)Pd(cin)Cl from Dorta‟s NHC salts (caused by the rotation of the N-naphthyl bond) were 
separated and increased the ee up to 89%.  Therefore, the relatively moderate ee provided by our 
NHC ligands may also be due to the rotation of the N-aryl bond.  In 2009, the NHC ligand with 
IBIOX[(-)-menthyl] group from Glorius‟s group was found complementary to the ones obtained 
by Kündig, and it provided higher ee (>92%) for more hindered substrates.
57
           
Regardless of this progress in improving the enantioselectivity of the oxindole reaction, 
there are still some data that cannot be explained.  A detailed mechanism of the asymmetric 
oxindole synthesis is much needed.  
Some of the facts in hands will now be enumerated: 
(1) The enantioselectivity and reactivity of our NHC ligands increased as the steric bulk 
of the ortho-substituent increased (Table 9).  However, imidazolinium salt 48j (ortho-2,4-
dimethylpentan-3-yl, bulkier) provided lower ee (50%) than 48d (ortho-cyclohexyl, 70% ee). 
(2) With our ligands in THF, the ee reached highest at a certain temperature, but not at a 
lower temperature (Tables 5 and 6). 
(3) With our ligands in THF, the ee increased as the equivalent of NaOt-Bu increased 
(Tables 4 and 7). 
(4) An iodoaryl substrate was reported by the Hartwig group to provide the product with 
lower ee (40%), in comparison with bromoaryl (70%) and chloroaryl (58%) substrates.
13
  We 
also found that NaI, an additive to the oxindole reaction, also decreased the ee from 68 % to 49% 
(Table 5, entries 2 and 5). 
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(5) C(1)-Fluoro and C(1)-methyl substrates were found by the Kündig group to give 
significantly lower ee with their ligand, in comparison with nonsubstituted substrates (Figure 
4).
55b
  
(6) A C(4)-methyl substrate was reported by the Dorta group to provide dramatically 
lower ee (8%) with their ligand, in comparison with nonsubstituted substrates (91%) (Figure 4).
56
 
 
Figure 4. Palladium-catalyzed α-arylation of substrates with substituents at the N-aryl ring 
A mechanism for the oxindole reaction was proposed by Hartwig in 2001,
13
 and the 
oxidative addition was proven to be the rate-determining step.   However, the key step to control 
the asymmetric outcome of the synthesis is still unclear, and determining this is important for 
future ligand design and optimization of the reaction conditions.  Here, we propose that the 
rotation barrier of the N-aryl bond in the oxidative addition products is crucial for the 
enantioselectivity of the oxidole synthesis, and this rotation of the N-aryl bond has been 
discussed by Curran in the asymmetric oxindole synthesis from o-iodoacrylanilides by Heck and 
radical cyclizations.
58
  
As shown in Scheme 14, the oxidative addition provides palladium complexes A and B.  
The NHC ligand orients opposite to the anilide with the NHC-ring vertical to the Pd-phenyl ring.    
By deprotonation of the anilide with NaOt-Bu, A affords Z-enolate C and E-enolate D, and B 
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affords Z-enolate F and E-enolate E.  Z,E-Enolates(C and D, E and F) can be interconverted by 
a protonation–rotation of the C-carbonyl bond–deprotonation cycle.  We propose that the 
reductive elimination step may be faster than the palladacycle formation, and the rates for the 
formation of the S(-) and R(+) oxindoles are 
d[S]/dt = kD[D] + kF[F]         d[R]/dt = kC[C] + kE[E] 
Scheme 14. Proposed mechanism for asymmetric oxindole synthesis 
 
The trajectory for the coordination of the enolate to the palladium is blocked by the R 
group in E and F, which results in higher activation energy for the palladacycle formation from 
E and F than it from C and D; and the coordination of E-enolate to the palladium is prefered 
over Z-enolate because of the steric hinderance from the NHC group.  Thus, the order of the rate 
constants for complexes C, D, E and F to give oxindoles would be kD > (kC, kE) > kF.  This is also 
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supported by the result that S(-) oxindole is the major enantiomer produced.  To increase the 
enantioselectivity of the reaction, the concentration of D should be increased while the 
concentration of E should be decreased.  The direct way to achieve this is the enantioselective 
formation of A in the oxidative addition step, a possibility that was proposed by Curran to be the 
stereocontrolling step in the asymmetric oxindole synthesis from o-iodoacrylanilides by Heck 
cyclization.
58a
  If the oxidative addition is not so enantioselective, the conversion of E to D is 
then crucial for the enantioselectivity of the oxindole reaction.  Complex E will cyclize to give 
R(-) oxindole or convert to D.  To increase the enantioselectivety, the rate of the conversion from 
E to D should be increased (lowering the activation energy) to the point that it is faster than the 
cyclization rate of E. 
Complexes D and E, C and F can be interconverted by more than one pathway. 
Complexes D and E interconvert directly by the rotation of the N-aryl bond, as do complexes C 
and F.  Intermediate pairs C/D and E/F may also interconvert through a protonation–
deprotonation process involving the oxidative addition products A and B, respectively.  Thus 
there are two paths from D to E and from C to F.  For example, intermediates D and E may 
interconvert directly by rotation of the enolate N-aryl bond, or may interconvert through the 
pathway D to A to B to E.  During any required rotation, the NHC ligand may bend to reduce 
steric hindrance.  Because rates of deprotonation and protonation are fast, the rate of the 
formation of D from E (or A from B) is 
d[D]/dt = d[A]/dt = kED[E] + kBA[B] 
The rotation barrier of the N-aryl bond was proposed by Simpkins to be smaller in the 
enolate state than it in the amide state (kED > kBA), due to the easy rotation of the amide C-N bond 
in the enolate state.
59
  Enolate E and amide B can be interconverted by a deprotonation–
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protonation cycle.  Increasing the amount of NaOt-Bu will increase the concentration of E at the 
expense of B, which will result in increasing the rate of the formation of D from E and increase 
the enantioselectivity of the reaction.  This mechanism is appealing because it does explain the 
experimental facts described in Tables 4 and 7: increasing the equivalent of NaOt-Bu increased 
the ee of the oxindole.   
To test the base effect on the rotation barriers of the N-aryl bond in D/E and A/B, we 
prepared bromoacetylanilide 70 and bromophenylacetylanilide 71 from ((1S)-1-phenylethyl)(2-
bromophenyl)amine (Scheme 15).  The rotation barrier of the N-aryl bond in the presence of 
NaOt-Bu in THF was studied with Exchange Spectroscopy (EXSY) using a NOESY sequence 
with the Aguirre et al. phase-cycling method (Table 12).
60
  The 2D EXSY spectroscopy of 
benzyl hydrogen germinal to nitrogen was used to calculate the rotation barrier with Abel’s 
method.
61
  For anilide 70, the rotation barrier at 323 K dropped significantly from 92.7 and 91.4 
kJ/mol to 86.3 and 83.8 kJ/mol when one equivalent of NaOt-Bu was added.  Ten equivalents of 
NaOt-Bu further decreased the rotation barrier to 84.9 and 82.8 kJ/mol.  For anilide 71 with an 
additional phenyl substituent, the rotation barrier can only be measured precisely at higher 
temperature with EXSY (330 K, 95.5 and 93.5 kJ/mol).  At this temperature, the addition of one 
equivalent of NaOt-Bu made a cloudy precipitate with broad 
1
H NMR peaks, most likely due to 
the formation of sodium enolate (several small peaks were around δ5 ppm in 1H NMR 
spectroscopy which may belong to the benzylidene hydrogen) and quick rotation of the N-aryl 
bond (rotation barrier 76.4 and 74.2 kJ/mol).  Compared with anilide 70, the α-hydrogen of 
anilide 71 with an additional phenyl group is more acidic
62
 which results in more enolate 
formation and a lower rotation barrier.   
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Scheme 15. Synthesis of anilides 70 and 71 
 
Table 12. Rotation barrier in anilides 70 and 71 measured by 2D EXSY
a
 in THF-d
8
 
Entry Anilide T (K) 
NaOt-Bu 
(equiv) 
ΔEa(major–minor) 
(kJ/mol) 
ΔEa(minor–major) 
(kJ/mol) 
 1
b
 70 323 0 92.7 91.4 
2 70 323 1 86.3 83.8 
 3
c
 70 323          10 84.9 82.8 
4 70 313 1 86.0 84.3 
 5
b
 71 330 0 95.5 93.5 
 6
d
 71 330 1 76.4 74.2 
a
Measured with 0.5 mol/L anilides, 600 ms mixing time and 8 scans.  
b
32 scans. 
c
0.08 mol/L 
anilides. 
d
50 ms mixing time.
 
 
Higher temperatures may also increase the formation of E from B due to the endothermic 
deprotonation, decrease the rotation barrier and increase the enantioselectivity of the oxindole 
reaction.  However, the rotation barrier of anilide 70 in the presence of one equivalent of NaOt-
Bu does not change so obviously at 313 K and 323K (Table 12, entries 2 and 4).  The 
decreasement of the rotation barrier caused by the enolate formation at higher temperature may 
be offset by the entropy effect, which may increase the rotation barrier at higher temperature.   
Increasing the rotation barrier from E to D decreases the enantioselectivity of the 
oxindole reaction.  The bulkier ligand from 48j (ortho-2,4-dimethylpentan-3-yl), in comparison 
with the ligand from 48d (ortho-cyclohexyl)); the incorporation of bulky iodide ligand in 
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palladium complex B; the C(1) substituent
58
 and C(4) substituent (prevents the bending of the 
NHC ligand) on the N-aryl ring,  all may increase the rotation barrier and result in the low ee of 
the products.   
In conclusion, the rotation barrier of the N-aryl bond in the oxidative addition products 
could be important for the enantioselectivity of the oxindole reaction, which supports our 
hypothesis that the reductive elimination may be faster than the palladacycle formation and not 
the stereocontrolling step.  If the ligand cannot provide a good enantioselectivity in the oxidative 
addition step, lowering the rotation barrier of the N-aryl bond in the oxidative addition products 
could also increase the enantioselectivity of the oxindole synthesis.   
1.6 ASYMMETRIC PYRROLIDINE SYNTHESIS WITH NHC-GOLD CATALYSTS  
Synthesis of NHC-gold catalysts 72–76.  As shown in Scheme 16, the required NHC-
gold catalysts 72–76 were achieved in 34%–91% yield from imidazolinium salts and AuCl·SMe2 
with NaH or NaOt-Bu in CH2Cl2 at room temperature. 
63
  
Scheme 16. Synthesis of NHC-gold catalysts 72–76 
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Testing NHC-gold catalysts in the asymmetric cyclization of Cbz-aminoallenes to N-
Cbz-pyrrolidines.
 64
  As shown in Table 13, both 73 and 74 catalyzed two reactions (eq 3 and 4) 
quantitatively, but provided 2-vinyl-N-Cbz-pyrrolidine with only 22% and 13% ee, respectively 
(entry 1).  Both ligands gave racemic 2-((E)hept-1-enyl)-4,4-diphenyl-N-Cbz-pyrrolidine (entry 
2).  Complex 73 was then examined in the reaction of 2-vinyl-4,4-diphenyl-N-Cbz-pyrrolidine 
(eq 5), and the silver salts were screened (Table 14).  All silver salts catalyzed the reaction 
quantitatively, and AgClO4 was the best choice (13% ee).  Under the same conditions (AgClO4 in 
toluene), 76 compared with 73 and gave 2-vinyl-4,4-diphenyl-N-Cbz-pyrrolidine with 12% ee.  
We were interested in the application of 76 in this reaction and screened the solvents with 76 
(Table 15).   The best results were 15% ee (yield > 95%) in o-xylene at room temperature for 90 
min.  Imidazolinium salt 56 was also examined in this reaction, and to our surprise, it 
outperformed other NHC precursors.  With only 1.7 mol % of NHC-gold catalyst 75 and 
AgClO4, the reaction in toluene at room temperature for 24 h provided 2-vinyl-4,4-diphenyl-N-
Cbz-pyrrolidine almost quantitatively with 21% ee.   
Table 13.  Asymmetric pyrrolidine synthesis with 73 and 74 
Entry Reaction 
Ee
b
 with 
73 (%) 
Ee
b
 with 
74 (%) 
1 
                          
22 13 
2 
  
 0  0 
a
The yield was calculated from the 
1
H NMR spectroscopy of the crude reaction mixture.  
b
The ee was determined by chiral OD-H HPLC. 
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Table 14.  Asymmetric pyrrolidine synthesis with 73 and different silver salts 
 
Entry Ag Ee
b
 (%) 
1 AgClO4 13 
2 AgBF4 10 
3 AgPF6   5 
4 AgOTf 10 
5 AgAsF6   3 
6 AgSbF6   1 
a
The yield was calculated from isolated product after 
chromatography. 
 b
The ee was determined by chiral OD-H HPLC. 
 
Table 15. Asymmetric pyrrolidine synthesis with 76 in different solvents 
 
Entry Solvent Time (min) Ee
b
 (%) 
1 toluene 90 12 
2 CH2Cl2 15  4 
3 THF 15  0 
4 o-xylene 90 15 
5 p-xylene 90 12 
6 m-xylene 90 11 
7 benzene 90 13 
8 mesitylene 90  9 
a
The yield was calculated from isolated product after 
chromatography or the 
1
H NMR spectroscopy of the crude 
reaction mixture.  
b
The ee was determined by chiral OD-H HPLC. 
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In conclusion, imidazolinium salts 45, 48d, 48h, 56 were examined in the gold-catalyzed 
asymmetric cyclization of Cbz-aminoallenes to N-Cbz-pyrrolidines.   Their reactivities were 
excellent, and the yields of the products were almost quantitative.  However, their 
enantioselectivities were moderate or very poor.         
1.7 ASYMMETRIC CYANOSILYLATION OF ALDEHYDES WITH NHC 
CATALYSTS   
As shown in Table 16, different NHC precursors were examined in the asymmetric 
cyanosilylation of 4-chlorobenzaldehyde at 60 °C.
 65
  Imidazolinium salt 57 was the best (90% 
yield, 12% ee (entry 4)).  When the reaction temperature was decreased to 23 °C, both yield and 
ee of the reaction with 57 decreased to 17% and 10%, respectively (entry 5).  Imidazolinium salt 
77
29c
 (entry 8) outperformed 48b and 48c (entries 6 and 7) in this reaction at 23 °C and gave the 
product in 88% yield with 4% ee. 
In conclusion, imidazolinium salts 48b, 48c, 48d, 48h, 56, 57 and 77 were examined in 
the asymmetric cyanosilylation of 4-chlorobenzaldehyde.  Unfortunately, the enantioselectivities 
of these ligands in this reaction were poor. 
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Table 16.  Asymmetric cyanosilylation of 4-chlorobenzaldehyde with different NHC precursors 
 
Entry NHC precursor T (°C) Time (h) Yield
a
 (%) Ee
b
 (%) 
1 48d (o-cyclohexyl) 60 6 23 0 
2 48h (o-methyl-m-phenyl) 60 6 36 6 
3 56 60 6 26 0 
4 57 60   0.5 90     12 
5 57 23 1 17     10 
6 48b (o-phenyl) 23     24 16 0 
7 48c (o-benzyl) 23     24 20 0 
8 77  23 3 88 4 
a
The yield was calculated from isolated product after chromatography.  
 b
The ee was 
determined by chiral OD-H HPLC. 
 
1.8 HYDROGENATION OF STYRENE DERIVATIVES WITH ET3SIH AND TFA  
Optimization of reaction conditions.  In our synthesis of imidazolinium salt 48j, the 
procedure from 55 to 53 with Et3SiH and TFA is efficient to hydrogenate bulky styrenes.  To test 
the possibility of applying the procedure to other styrene derivatives, the equivalents of Et3SiH 
and TFA were optimized (Table 17).  Because of its accessibility, β,β-dimethylstyrene was used 
in this optimization.  1.05 Equiv of Et3SiH and 2.1 equiv of TFA with one drop of TfOH (0.04 
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mL) in CH2Cl2 at room temperature for 40 min were found the most suitable conditions, and 1-
isobutylbenzene was formed in 93% yield.   
Table 17. Hydrogenation of β,β-dimethylstyrene with different equivalents of Et3SiH and TFA 
 
Entry Et3SiH (equiv) TFA (equiv) Yield
a
 (%) 
1 5 5 100 
2   1.2   2.4   96 
3   1.2   1.2   78 
4   1.5   1.5   88 
5     1.05   2.1   93 
aReaction run with β,β-dimethylstyrene (0.25 mmol) and TfOH (one 
drop, 0.04 mL) in CH2Cl2 (0.6 mL) for 40 min, and the yield was 
calculated from the 
1
H NMR spectroscopy of the crude mixture. 
 
Expansion of the substrate scope.  With these optimized conditions in hand, the 
substrate scope was then explored (Table 18).  Styrene and monosubstituted styrenes 
polymerized easily and gave the corresponding products in only approximately 34% yield 
(entries 2–4).  Disubstituted styrenes reacted efficiently and furnished the products almost 
quantitatively (entries 1 and 5).  1,2-Dihydronaphthalene also gave a quantitative yield of 
1,2,3,4-tetrahydronaphthalene (entry 6), but 1H-indene provided 2,3-dihydro-1H-indene in only 
33% yield probably because the benzyl cation intermediate cannot adopt a conformation to be 
coplanar with the benzene ring, which will stabilize the benzyl cation (entry 7).  Styrene 55 is 
also too bulky to develop a stable benzyl cation and provided 53 in only 38% yield (entry 8).  
Cyclohexenone and cyclohexene did not react most likely due to the difficulty to develop a 
stable cation (entries 9 and 10).  
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Table 18. Scope of the hydrogenation of styrene derivatives with Et3SiH and TFA 
Entry Reactant Product Yield
a
 (%) 
1 
  
  93 
2 
  
  35 
3 
  
  33 
4 
  
  34 
5 
  
100 
6 
  
100 
7 
  
  33 
  8 
 
55 
 
53 
  38 
9 
 
- - 
10 
 
- - 
 a
The yield was calculated from the 
1
H NMR 
spectroscopy of the crude mixture.
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In conclusion, the procedure of the hydrogenation of styrene 55 to 53 by Et3SiH, TFA 
and TfOH can be applied to other styrene derivatives.  High yield will be achieved if the 
substrate can develop a stable cation.  It is a simple and efficient procedure to hydrogenate bulky 
styrene derivatives.    
1.9 EXPLORATION OF PALLADIUM-CATALYZED INTRAMOLECULAR 
ARYLATION IN THE SYNTHESIS OF 1,2-DIHYDROISOQUINOLIN-3(4H)-ONE  
The palladium-catalyzed intramolecular arylation of anilide enolates has been developed 
for the synthesis of oxindoles
13, 66
 and other five- and six-membered ring compounds.
67
  After 
having studied NHC ligands in the asymmetric synthesis, we turned our interest in the 
application of this procedure in a six-membered ring formation (additional methylene group 
between phenyl and amino groups compared to the oxindole).  As shown in Scheme 17, the 
amidation of (2-bromophenyl)methanamine with 2-phenylpropanol chloride provided amide 78 
quantitatively.  The methylation of 78 with MeI gave N-methyl amide 79 in 80% yield, and the 
benzylation of 78 with benzyl bromide afforded N-benzyl amide 80 in 78% yield.
13
  Under the 
oxindole reaction conditions (1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium 
tetrafluoroborate, Pd2(dba)3 and NaOt-Bu in toluene at 150 °C overnight), 79 afforded 
cyclization product 81 in 32% yield, while no reaction occurred with 80.  The yield of 81 
increased to 38% in only 2 h when the solvent was changed to THF.   
Expecting that the sp
2
 hybridized carbon would bring two reactive components in the 
molecular together to facilitate the cyclization, we prepared amide 82 and 83 (Scheme 17).  The 
treatment of 1-(2-bromophenyl)ethanone with methanamine afforded imine 84
68
 which gave 
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acetamide 82 in 79% yield and 2-phenylpropanamide 83 in 94% yield.  Unfortunately, under the 
oxindole reaction conditions (1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium 
tetrafluoroborate, Pd2(dba)3 and NaOt-Bu in toluene at 200 °C or in dioxane at 120 °C), no 
reactions occurred with amides 82 or 83.   
Scheme 17. Synthesis of 1,2-dihydroisoquinolin-3(4H)-one derivertives 
 
 
In conclusion, the procedure of palladium-catalyzed intramolecular arylation was applied 
to the synthesis of 1,2-dihydroisoquinolin-3(4H)-one.  This procedure is not as efficient as it in 
the synthesis of oxindoles. 
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2.0  SYNTHESIS OF DIBENZAZEPINONES BY PALLADIUM–CATALYZED 
INTRAMOLECULAR ARYLATION OF O-(2’-BROMOPHENYL)ANILIDE 
ENOLATES 
γ-Secretase inhibitor LY411575,69,70 a potential drug candidate for Alzheimer’s disease, 
is known to reduce brain and CSF levels of β-peptides.  As the core structure of LY411575, α-
substituted dibenzazepinones have an interesting gear-like structure.
71 ,72
  Prior syntheses of 
dibenzazepinones have been based upon the Friedel-Crafts alkylation,
73 a,73b
 the palladium-
catalyzed borylation-Suzuki reaction,
72
 the cyclization of hydroxylamide in neat 
trifluoromethanesulfonic acid,
73c
 the intramolecular Staudinger-aza-Wittig reaction of α-azido 
pentafluorophenyl ester,
73d
 and the hydrogenation of methyl 2-nitro-2’-biphenylacetate.73e   Some 
of these methods suffer from low yields, or produce byproducts that are difficult to separate from 
the target molecule.  We became interested in exploring the potential of palladium-catalyzed 
intramolecular arylation for the seven-membered ring formation and its utility in the synthesis of 
aminodibenzazepinone 85 (Scheme 18). 
Scheme 18. Synthesis of dibenzazepinones by palladium-catalyzed intramolecular arylation 
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2.1 SYNTHESIS OF DIBENZAZEPINONE PRECURSORS 
As shown in Scheme 19, the Suzuki coupling of 2-bromophenylboronic acid and 2-
iodoaniline afforded 2-amino-2‟-bromobiphenyl 86 in 90% yield.  The amidation of 86 with acyl 
chlorides or carboxylic acids gave amides 87–94 in generally excellent yields.  The methylation 
of 87–94 with methyl iodide or the benzylation of 87 with benzyl bromide provided the desired 
N-alkyl amides 95–103 as dibenzazepinone precursors in uniformly excellent yields.  However, 
the synthesis of N-methyl-4-oxopentanamide 104 was challenging.  The amidation of 86 with 4-
oxopentanoic acid and DCC was not successful.  To make a more reactive acyl chloride, 4-
oxopentanoic acid was treated with SOCl2, but only 5-chloro-5-methyl-dihydrofuran-2(3H)-one 
was achieved.  This lactone is most likely derived from intramolecular lactonizaion of acyl 
chloride.  An alternative route was explored.  The treatment of amide 95 with 2-methyloxirane 
and n-BuLi afforded alcohol 105 in 35% yield
74
 which was oxidized with PCC to give ketone 
104 in 96% yield.
75
   
2.2 OPTIMIZATION OF REACTION CONDITIONS 
As shown in Table 19, two general catalysis systems were screened with acetamide 95.  
The treatment of 95 with 1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium 
tetrafluoroborate,
13 
palladium acetate, and NaOt-Bu in toluene at 100 °C for 20 min gave 
dibenzazepinone 106 in 78% yield (entry 1).  The use of tricyclohexylphosphonium 
tetrafluoroborate
67a
 with palladium acetate increased the yield of 106 to 90% in 10 min (entry 2), 
and generated a byproduct identified as 9-methyl-9H-carbazole 107 (6% yield).  This byproduct 
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is presumed to arise by cleavage of the amide to the aniline by NaOt-Bu followed by the 
palladium-catalyzed intramolecular amination.  Changing the solvent to dioxane decreased the 
yield of 106 to 45% (entry 3).  To further explore the efficiency of the catalysis system of 
tricyclohexylphosphonium tetrafluoroborate, the catalytic loading was lowered to 5 mol % with 
1.5 equiv of NaOt-Bu (entry 4).  However, the yield of 106 dropped to 61%. 
Scheme 19. Synthesis of amides 95–104 
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N N
+
BF4
Table 19. Optimization of the synthesis of dibenzazepinone 106 
 
Entry Ligand Precursor Solvent Time (min) Yield
a
 (%) 
1 
        
toluene 20 78 
2 HPCy3BF4 toluene 10 90 
3
b
 HPCy3BF4 toluene 10 61 
4 HPCy3BF4 dioxane 10 45 
a
The yield of 106 was calculated from isolated product after 
chromatography.  
b
Reaction run with 5 mol % of the catalyst. 
 
2.3  EXPLORATION OF THE REACTION WITH CHLOROARYL SUBSTRATES  
For reasons related to materials cost, the possibility of using a chloroaryl substrate in 
place of the bromoaryl substrate was explored.  As shown in Scheme 20, the synthesis of 2’-
chloro-2-aminobiphenyl 108 from 2-chlorophenylboronic acid and 2-bromoaniline, which are 
less expensive starting materials, proceeded with the same efficiency as found for the bromoaryl 
analog (82% yield).  Following amidation of 108 with acetyl chloride and methylation of amide 
109 with methyl iodide gave N-methyl amide 110 in quantitative overall yield.  Unfortunately, 
with chloroaryl substrate 110, the catalysis system of tricyclohexylphosphonium 
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tetrafluoroborate provided no product; 1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium 
tetrafluoroborate under the same conditions for 20 min gave 106 in only 21% yield.      
Scheme 20. Synthesis of dibenzazepinone 106 from chloroaryl substrates 
 
2.4  EXPANSION OF THE SUBSTRATE SCOPE  
The optimized cyclization conditions were applied to more substrates (Table 20).  A 
phenyl group in the alpha position of the amide was well tolerated; the yield of α-
phenyldibenzazepinone 111 was almost quantitative (entry 2).  In contrast, α-methyl and α-
methoxy substrates 97 and 98 (entry 3 and 4) afforded relatively low yields of the 
dibenzazepinone and the product was accompanied by the byproduct 9-methyl-9H-carbazole.  
The incorporation of two methyl groups at the alpha position inhibited the reaction; α,α-
dimethyldibenzazepinone 114 was formed in only 8% yield and 54% conversion (entry 5).  The 
N-benzyl amide 103 was investigated as an alternative to N-methyl amide 95 because the product 
amide may be readily deprotected.  The benzyl and methyl amides behaved similarly.  N-Benzyl 
protected dibenzazepinone 115 was isolated in 84% yield along with 9-benzyl-9H-carbazole in 
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16% yield (entry 6).  Interestingly, amide 104 with 2-oxopropyl group on the alpha position of 
the amide did not give the desired dibenzazepinone derivative, but provided an eight-membered 
ring product 116 in 20% yield most likely because the intermediate anion is more stable on 
carbon 5 than on carbon 6 (entry 7).    
Under the standard conditions using 3 equiv of base, an interesting byproduct was formed 
(47% yield) in the reaction of α-benzyloxyamide 100.  This byproduct has a chemical 
composition identical to that of the desired product 117.  At first thought, it could be a benzyl C-
H bond activation product 118 (Scheme 21).   A nitro group at the para position of the benzyl 
group will increase the acidity of benzyl hydrogen, therefore the yield of the benzyl C-H bond 
activation product was expected to increase.  However, amide 101, a para-nitro benzyl analog of 
100, did not give the desired benzyl C-H bond activation product but afforded formylamide 119 
in 24% yield and 9-methyl-9H- carbazole in 47% yield.  To further prove the structure of 118, 
we decided to prepare it by an alternative route.   
As shown in Scheme 21, the amidation of 2-bromoaniline with α-chloroacetyl chloride 
afforded amide 120 in 98% yield.  The methylation of 120 with MeI followed by the treatment 
with NaI in acetone gave N-methylamide 121 in total 30% yield.  The treatment of amide 121 
with (2-bromophenyl)(phenyl)methanol furnished α-ether-aceticamide 122 in 98% yield.  
Unfortunately, further cyclization of 122 with the Ullmann coupling procedures (Pd(PPh3)4 and 
Cu in DMSO at 85 °C,
76
 Cu in solvents (DMSO, DMF or pyridine) at 110 °C or 150 °C, 
Pd(PPh3)4 and Sn2Me6 in dioxane at 150 °C,
77
 Zn and CuBr·SMe2 in THF) was unsuccessful.  
We proposed that the amide structure in 122 prevented the approaching of the two bromoarene 
moieties.  Thus, 122 was reduced with BH3·SMe2
78
 to give amine 123 in 99% yield.  The 
unknown byproduct was reduced to the amine as well with BH3·SMe2 in 98% yield.  We 
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Table 20. Scope of the intramolecular arylation pathway to dibenzazepinones 
 
Entry Reactant Product Yield
a
 (%) 107
a
 (%) Conversion
b
 (%) 
1 95 106 90  6  96 
2 96 111 99 - 100 
3 97 112 45 34  80 
4 98 113 56 15  86 
5 99 114  8 15  54 
6 103 115 84 16 100 
 7
c
 104 116 20 17  97 
 8
d
 100  117 81 7 100 
9 101 119 24 47 100 
10 102 135 93 - 100 
 11
e
 102 135 91 -  98 
a
The
 
yield was calculated from isolated product after chromatography. 
b
The conversion 
was based on the isolated starting material. 
c
Reaction run for 20 min.  
d
Reaction run with 
1.5 equiv of NaOt-Bu. 
e
Reaction run with 3 mol% of the catalyst for 15 min. 
  56 
Scheme 21.  Synthesis of lactam 118 
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expected that the intramolecular Ullmann coupling of 123 would provide a product with the 
same 
1
H NMR spectrum as that of the amine produced from the reduction of the unknown 
byproduct.  However, the intramolecular Ullmann coupling of 123 still failed with the common 
methods (Cu in DMF at 150 °C; Pd(PPh3)4 and Sn2Me6 in dioxane at 150 °C; Zn and CuBr·SMe2 
in THF; t-BuLi, CuCN and 1,3-dinitrobenzene in MeTHF).  We then proposed that the 
monoborylation of 123 followed by the intramolecular Suzuki coupling would cyclize the ring.  
However, no reaction occurred under the Miyaura borylation reaction conditions (Pd(dppf)Cl2 
and KOAc in DME at 150 °C).   
The amine from the reduction of the unknown byproduct was then expected to react with 
a strong acid to give a salt which can be recrystallized and characterized by X-ray diffraction.  
However, no reaction occurred with p-toluenesulfonic acid, and fluoboric acid etherate provided 
a salt which could not be recrystallized with MeOH and DME.   
We then sought a new synthesis of 118 (Scheme 21).  The treatment of (2-
bromophenyl)(phenyl)methanol with ethyl 2-bromoacetate afforded ether 124 in 53% yield.  The 
Suzuki coupling of 124 and 2-aminophenylboronate gave 1,1‟-disubstituted biphenyl 125 in only 
14% yield.  Because of this low yield, we chose phenylboronic acid 126 as the substitution for 2-
aminophenylboronate, and the Suzuki coupling reaction furnished 1,1‟-disubstituted biphenyl 
127 in 90% yield.  Unfortunately, the deprotection of the amino group on 127 with concentrated 
HCl at 70 °C and room temperature only afforded 6-phenylphenanthridine
79
 and 5-pivaloyl-5,6-
dihydro-6-phenyl-phenanthridine, respectively.  6-Phenylphenanthridine is most likely derived 
from the cleavage of the pivaloyl amide moiety in 5-pivaloyl-5,6-dihydro-6-phenyl-
phenanthridine followed by the oxidation with molecular oxygen, and 5-pivaloyl-5,6-dihydro-6-
phenyl-phenanthridine is most likely achieved from intramolecular SN1 substitution of 127.  
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Fortunately, the hydrolysis of 127 with KOH deprotected the amino and carboxylic acid groups 
successfully, and the resulting intermediate 128 was cyclized with DCC to provide lactam 129 in 
20% yield.  Further methylation of 129 with MeI gave N-methyl-lactam 118 quantitatively.  We 
found that the 
1
H NMR spectrum of the unknown byproduct from the reaction of -
benzyloxyamide 100 is different from that of 118.  The unknown byproduct is not 118.   
The IR spectra of the unknown byproduct exhibits a broad peak at 3387 cm
-1
. Therefore it 
could be -hydroxy--benzyl dibenzazepinone 130, a 1,2 Wittig rearrangement product.80  This 
byproduct was also produced by the reaction of the desired product 117 with NaOt-Bu alone in 
toluene at 100 °C (Scheme 22). To confirm the structure of 130, 117 was reduced to amine 131 
(Scheme 22).  Following debenzylation of 131,
81
 Dess-Martin oxidation
82
 of alcohol 132 and the 
treatment of aldehyde 133 with benzylmagnesium chloride afforded amine 134, which was 
identical to the amide reduction product of 130.  The reaction conditions were then modified for 
the formation of 117. -Benzyloxydibenzazepinone 117 was formed in 81% yield with 4% 130 
when the amount of NaOt-Bu was reduced to 1.5 equiv, and the reaction was run in toluene for 
10 min (Table 20, entry 8). 
Because of our interest in the -secretase inhibitor, it was significant to find that -
dibenzylaminoamide 102 cyclized efficiently to afford -dibenzylaminodibenzazepinone 135 in 
93% yield (Table 20, entry 10).  Lowering the catalyst loading to 3 mol% had little effect, and 
provided the desired product in 15 min in 91% yield (Table 20, entry 11).   
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Scheme 22. Rearrangement of -benzyloxydibenzazepinone 117 
 
-Dibenzylaminodibenzazepinone 135 was debenzylated quantitatively through 
hydrogenolysis to afford -aminodibenzazepinone 85 (eq 6).  The complete synthesis of -
aminodibenzazepinone 85 by this approach requires five steps from 2-bromophenylboronic acid 
and 2-iodoaniline and proceeds in 60% overall yield.  Significant increases in overall yield can 
be achieved by optimizing the step involving coupling of 2’-bromo-2-aminobiphenyl 86 with 
dibenzylaminoacetic acid. 
         
 
 
 
 
 
  60 
3.0  CONCLUSIONS 
Chiral N-heterocyclic carbene (NHC) ligands were designed and explored in three 
asymmetric syntheses (oxindole synthesis, pyrrolidine synthesis and cyanosilylation of 
aldehydes).  The NHC ligands with the chiral controlling group located on the ortho position of 
the N-aryl ring were introduced but need further improvement.  The ligand generated from 
(4R,5R)-1,3-bis(ortho-cyclohexylphenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborates 48d provided the best asymmetric oxindole synthesis in this study: yields of 
oxindoles up to 99% with enantioselectivities (ee) up to 80% were achieved in 3 h; 48d can be 
prepared in only two steps; with only 1 mol % of 48d, the reaction still afforded oxindoles with 
good ee and yield. 
Although the NHC ligands from Kündig and Glorius’s groups provided better 
enantioselectivities than 48d in the oxindole synthesis, there are some data (low ee) that cannot 
be explained.  A mechanism for this asymmetric oxindole synthesis was proposed.  The rotation 
barrier of the N-aryl bond in the oxidative addition products was found crucial for the 
enantioselectivity.  These data can be explained that increasing the rotation barrier would 
decrease the enantioselectivity, and vice versa.  Future work will be focused on the optimization 
of the mechanism which will provide a guide for the ligand design and optimization of the 
reaction conditions.   
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The intramolecular α-arylation of amide enolates has been applied successfully to the 
formation of seven-membered ring compounds.  These reactions provide a new route to the 
synthesis of substituted dibenzazepinones.  The procedure is efficient, and especially useful for 
the synthesis of α-aminodibenzazepinone.  We anticipate that with the appropriate asymmetric 
ligand or chiral amino protecting group, α-aminodibenzazepinone may be made directly with 
high enantiomeric excess, thus eliminating the need for resolution of this important target.   
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4.0  EXPERIMENTAL 
General Information. Commercially available reagents and solvents were used as 
received without further purification.  Reactions at “room temperature” were conducted under 
ambient laboratory conditions T = 20–27 °C, p = 720–770 mmHg.  References to “removal of 
volatile components” refer to rotary evaporation of the sample at 25–65 °C in vacuo (18–25 
mmHg).  Thin layer chromatography (TLC) was performed on silica gel 60 F254 glass backed 
plates with a layer thickness of 0.25 mm manufactured by EMD.  Silica gel columns for flash 
chromatography, according to the method of Still, were prepared with SILICYCLE silica gel 
(SiliaFlash P60, 230-240 mesh).  
1
H NMR spectra were recorded on a Bruker Avance 300 at 300 
MHz, a Bruker Avance III 400 at 400 MHz, a Bruker Avance III 500 at 500 MHz and a Bruker 
DRX 500 at 500 MHz, and chemical shifts were given in parts per million (ppm) on the delta 
scale () using solvent peak as a reference value (Me4Si = 0.00, CD2Cl2 = 5.32, CDCl3 = 7.24 or 
7.27).  
13
C NMR spectra were recorded on a Bruker Avance 300, a Bruker Avance III 400 and a 
Bruker Avance III 500 at 75 MHz, and chemical shifts are given in parts per million (ppm) on 
the delta scale () using deuterated solvents as internal standards (CDCl3 = 77.23; CD2Cl2 = 
53.80), and the coupling constant values (J) are in Hertz.  Abbreviations for NMR data: s = 
singlet; d = doublet; t = triplet; q = quartet; dd = doublet of doublets; dt = doublet of triples; dq = 
doublet of quartets; tt = triplet of triplets; m = multiplet; br = broad.  2D EXSY data were 
acquired with Bruker Avance III 500 at 500 MHz, and peak volumes were integrated using 
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Bruker TopSpin 3.0.  Optical rotations were measured with Perkin-Elmer 241 digital polarimeter 
with sodium lamp.  High resolution and low resolution mass spectra were recorded of a VG 7070 
spectrometer.  Infrared (IR) spectra were collected on an Avatar 360 Nicolet FT-IR spectrometer.  
Samples for IR were prepared as a thin film on a NaBr plate by dissolving the sample in CH2Cl2 
and then evaporating the CH2Cl2.  
Examination of Imidazolinium Salts in the Asymmetric Synthesis of Oxindoles 
(Chapters 1.1–1.4).  The detailed synthesis and characterization of substrates and oxindoles are 
described in the papers from Hartwig
13 
and Marsden groups.
67a
  To a flask in a dry box was 
added Pd(dba)2 (4.3 mg, 0.0075 mmol), imidazolinium salt (0.0075 mmol) and NaOt-Bu (0.225–
1.575 mmol).  The flask was sealed with a septum, removed from the dry box and added the 
solvent (1 mL).  After being stirred at rt for 10 min, a solution of 2-bromoanilide (0.15 mmol) in 
the solvent (1 mL) was added, and the resulting mixture was degassed in a dry ice-acetone bath, 
back filled with nitrogen and stirred at the temperature indicated in Chapters 1.1–1.4.  After the 
reaction was over (as determined by TLC), the solvent was evaporated under reduced pressure.  
The resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) 
and analyzed by HPLC (Chiralcel OD-H, hexanes/i-PrOH = 90/10, detection at 254 nm).  For 
1,3-dimethyl-3-(1-naphthyl)oxindole, flow rate = 0.92 mL/min: tR = 12.28 min, 27.99 min; for 
1,3-dimethyl-3-phenyloxindole, flow rate = 0.92 mL/min: tR = 7.46 min, 8.46 min; for 1,3-
dimethyl-3-(4-isobutylphenyl)oxindole, flow rate = 0.92 mL/min: tR = 5.80 min, 6.38 min; for 1-
methyl-3-methoxy-3-phenyloxindole, flow rate = 0.3 mL/min: tR = 25.34 min, 26.15 min; for 1-
methyl-3-benzoxy-3-phenyloxindole, flow rate = 1 mL/min: tR = 6.68 min, 8.06 min; for 1-
benzyl-3-methoxy-3-phenyloxindole, flow rate = 1 mL/min: tR = 7.96 min, 8.48 min. 
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Examination of NHC catalysts in the Asymmetric Cyclization of Cbz-Aminoallenes 
to N-Cbz-Pyrrolidines (Chapter 1.6).  The detailed synthesis and characterization of Cbz-
aminoallenes and N-Cbz-pyrrolidines are described in the paper from Windenhoefer group.
64
  A 
solution of NHC-AuCl (0.005 mmol) and AgClO4 (0.005 mmol) in CH2Cl2 (0.5 mL) covered by 
an aluminum foil was stirred at rt for 10 min and cooled to 0 °C.  A solution of Cbz-
aminoallenes (0.1 mmol) in CH2Cl2 (0.5 mL) was added, and the mixture was stirred at the 
temperature indicated in Chapter 1.6.  After the reaction was over (as determined by TLC), the 
solvent was evaporated under reduced pressure.  The resulting crude product was examined by 
NMR spectroscopy (yield) and analyzed by HPLC (Chiralcel OD-H, flow rate = 1 mL/min, 
detection at 254 nm).  For 2-vinyl-N-Cbz-pyrrolidine, hexanes/i-PrOH = 99/1: tR = 12.94 min, 
14.09 min; for 2-((E)hept-1-enyl)-4,4-diphenyl-N-Cbz-pyrrolidine, hexanes/i-PrOH = 99/1: tR = 
14.93 min, 19.68 min; for 2-vinyl-4,4-diphenyl-N-Cbz-pyrrolidine, hexanes/i-PrOH = 95/5: tR = 
9.87 min, 11.26 min.      
Examination of NHC Catalysts in the Asymmetric Cyanosilylation of 4-
Chlorobenzaldehyde (Chapter 1.7).
65
  To a solution of imidazolinium salt (0.0075 mmol) in 
THF (0.9 mL) was added KOt-Bu (0.1 M in THF, 75 μL), and the mixture was stirred at rt for 30 
min.  A solution of 4-chlorobenzaldehyde (42 mg, 0.3 mmol) in THF (0.6 mL) was added, 
followed by TMSCN (33 mg, 0.33 mmol), and the mixture was stirred at the temperature 
indicated in Chapter 1.7.  After the reaction was over (as determined by TLC), the mixture was 
quenched with HCl solution (0.1 M, 0.5 mL) and extracted with ethyl acetate.  The extracts were 
combined, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
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= 3/1) and analyzed by HLPC (Chiralcel OD-H, hexanes/ i-PrOH = 95/5, flow rate = 1 mL/min, 
detection at 254 nm):  tR = 16.62 min, 18.40 min. 
2-Methyl-3-phenyl-bromobenzene.  To a solution of phenylboronic acid (210 mg, 1.73 
mmol), 2,6-dibromotoluene (410 mg, 1.64 mmol), Pd(PPh3)4 (95 mg, 0.082 mmol) in DME (2 
mL) was added a solution of NaHCO3 (414 mg, 4.92 mmol) in H2O (2 mL), and the mixture was 
degassed in a dry ice-acetone bath and back filled with nitrogen.  After being stirred at 110 °C 
for 23 h, the mixture was cooled to rt and extracted with Et2O.  The extracts were combined, 
dried over MgSO4 and filtered.  After removal of volatile components from the filtrate, the crude 
product was purified by flash chromatography (SiO2, pentane) to give the product (261 mg, 65%) 
as an oil: IR (cm
-1
) 3059, 2360, 1452, 1425, 1041, 759; 
1
H NMR (300 MHz, CDCl3)  7.60 (dd, 
J = 7.8, 0.9 Hz, 1H), 7.47–7.35 (m, 3H), 7.32–7.29 (m, 2H), 7.21 (dd, J = 7.5, 1.2 Hz, 1H), 7.13 
(t, J = 7.5 Hz, 1H), 2.36 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  143.9, 141.6, 135.3, 131.8, 131.5, 
129.1, 129.0, 128.1, 127.1, 126.7, 126.2, 21.0; HRMS (EI) m/e calcd for C13H11Br (M
+
) 
246.0044, found 246.0039.  
2-Bromoisophthalic acid (24).
83
  A solution of 2-bromo-1,3-dimethylbenzene (24.88 g, 
134.4 mmol) and KMnO4 (45 g, 283 mmol) in t-BuOH/H2O (1/1, 250 mL) was refluxed for 1 h 
and cooled to rt.  Additional KMnO4 (45 g, 283 mmol) and t-BuOH/H2O (1/1, 100 mL) were 
added, and the mixture was refluxed overnight.  After being cooled to rt, the mixture was 
filtered.  The solvent was evaporated under reduced pressure until most alcohol was removed, 
and H2O was added to bring the volume to 150 mL.  Concentrated HCl was added slowly, and 
the resulting white precipitate was filtered and dissolved in a saturated aqueous Na2CO3 solution.   
The solution was washed with Et2O and acidified with concentrated HCl.  The white precipitate 
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was filtered and dried to afford 24 (17 g, 52%) as a white solid: 
1
H NMR (300 MHz, DMSO)  
7.70 (dd, J = 0.6, 7.6 Hz, 2H), 7.54 (dd, J = 7.1, 8.1 Hz, 1H).  
2,6-Dihydroxymethylbromobenzene (25).
84
  To a solution of 2-bromoisophthalic acid 
24 (10.27 g, 41.93 mmol) in THF (220 mL) at 0 °C was added BH3 in THF (1.0 M , 109 mL, 109 
mmol) dropwise.  The resulting mixture was agitated by ultrasound at rt for 2 h.  THF/H2O (1/1, 
100 mL) was added, and the H2O layer was saturated with K2CO3 and extracted with THF.  The 
extracts were combined, dried over K2CO3 and filtered.  Removal of volatile components from 
the filtrate afforded 25 (9.06 g, 99%) as a white solid: 
1
H NMR (300 MHz, DMSO)  7.43 (m, 
3H), 5.39 (t, J = 5.6 Hz, 2H), 4.52 (d, J = 5.6 Hz, 4H). 
4-Bromo-2,6-diisopropylbenzenamine (27).
85
  To a solution of 2,6-
diisopropylbenzenamine (32.5 g, 183 mmol) in CH2Cl2/MeOH (1/1, 173 mL) at rt was added a 
solution of bromine (9.57 mL, 187 mmol) in CH2Cl2/MeOH (1/1, 86 mL) dropwise over 1.5 h, 
and the mixture was stirred for 22 h.  The solvent was evaporated under reduced pressure, and 
the resulting crystalline residue was washed with hexanes/CH2Cl2 (2/1, 240 mL), neutralized 
with 20% aqueous NaOH solution (200 mL), and extracted with Et2O.  The extracts were 
combined, dried over MgSO4 and filtered.  Removal of volatile components from the filtrate 
provided 27 (40.5 g, 87%) as an oil: 
1
H NMR (300 MHz, CDCl3)  7.20 (s, 2H), 3.69 (s, 2H), 
2.88 (heptet, J = 6.8 Hz, 2H), 1.24 (d, J = 6.8 Hz, 12H).   
N-(4-Bromo-2,6-diisopropylphenyl)ethane-1,2-diimine (28).  To a solution of aniline 
27 (18.4 g, 71.8 mmol) in n-propanol (50 mL) at rt was added 40% aqueous oxalaldehyde (5.21 
g, 35.9 mmol), n-propanol (5 mL) and H2O (12.5 mL), and the mixture was stirred at rt for 14 h 
and 70 °C for 4 h.  H2O (50 mL) was added, and the mixture was cooled to rt.  The resulting 
yellow precipitate was filtered, washed with H2O/n-propanol (1/1, 30 mL) and dried in vacuo to 
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afford 28 (15.2 g, 80%) as a yellow solid: IR (cm
-1
) 2963, 1629, 1461, 1175, 865, 720; 
1
H NMR 
(300 MHz, CDCl3)  8.06 (s, 2H), 7.27 (s, 4H), 2.94 (heptet, J = 6.9 Hz, 4H), 1.19 (d, J = 7.5 Hz, 
24H); 
13
C NMR (75 MHz, CDCl3)  163.5, 147.1, 139.3, 126.7, 119.0, 28.6, 23.6; HRMS (EI) 
m/e calcd for C26H34N2Br2 (M
+
) 532.1089, found 532.1066.  
N-(4-Bromo-2,6-diisopropylphenyl)ethane-1,2-diamine (29).  To a solution of diimine 
28 (7.0 g, 13.1 mmol) in THF (45 mL) and EtOH (45 mL) at 0 °C was added NaBH4 (2.0 g, 52.4 
mmol) slowly over 1 h, and the mixture was stirred at rt for 12 h, 70 °C for 0.5 h and cooled in 
an ice bath.  H2O (10 mL) was added, followed by HCl (3 M, 60 mL) slowly, and the resulting 
white precipitate was filtered, washed with Et2O and dissolved in an aqueous NaOH solution.  
The solution was extracted with Et2O, and the extracts were combined, dried over MgSO4 and 
filtered.  Removal of volatile components from the filtrate gave 29 (6.5 g, 92%) as a white solid: 
IR (cm
-1
) 3363, 2961, 1580, 1461, 1198, 1092, 726; 
1
H NMR (300 MHz, CDCl3)  7.23 (s, 4H), 
3.39 (heptet, J = 6.9 Hz, 4H), 3.30 (br, 2H), 3.13 (s, 4H), 1.28 (d, J = 6.9 Hz, 24H); 
13
C NMR 
(75 MHz, CDCl3)  145.0, 142.2, 126.8, 117.4, 52.0, 27.9, 24.2; HRMS (EI) m/e calcd for 
C26H38N2Br2 (M
+
) 536.1402, found 536.1425.  
N-(4-Pinacolatoboronyl-2,6-diisopropylphenyl)ethane-1,2-diamine (30).  A mixture 
of bis(pinacolato)diboron (533 mg, 2.1 mmol), diamine 29 (517 mg, 0.96 mmol), KOAc (565 
mg, 5.76 mmol), Pd(dppf)Cl2 (54.9 mg, 0.067 mmol) and DME (6 mL) in a 10 mL microwave 
tube was degassed at -15 °C and irradiated in a microwave reactor at 150 °C, 250 W for 35 min.  
After being cooled to rt, the mixture was filtered.  After removal of volatile components from the 
filtrate, the crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 8/1) to 
give 30 (537 mg, 88%) as a white solid: IR (cm
-1
) 2966, 1603, 1462, 1373, 1144, 966, 850, 732; 
1
H NMR (300 MHz, CDCl3)  7.51 (s, 4H), 3.51 (s, 2H), 3.32 (heptet, J = 6.6 Hz, 4H), 3.19 (s, 
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4H), 1.33 (s, 24H), 1.29 (d, J = 6.6 Hz, 24H); 
13
C NMR (75 MHz, CDCl3)  146.7, 140.9, 130.5, 
83.4, 52.1, 27.9, 24.9, 24.2; HRMS (EI) m/e calcd for C38H62B2N2O4 (M
+
) 632.4896, found 
632.4905. 
2,6-Bis((tert-butyldimethylsilyloxy)methyl)bromobenzene (31). To a solution of 
imidazole (15.0 mg, 0.22 mmol) and diol 25 (21.7 mg, 0.10 mmol) in DMF (1 mL) at 0 °C was 
added TBSCl (33.2 mg, 0.22 mmol), and the mixture was stirred at rt for 1 h.  Saturated aqueous 
NH4Cl solution (1 mL) was added and the resulting mixture was extracted with hexanes.  The 
extracts were combined, dried over MgSO4 and filtered.  Removal of volatile components from 
the filtrate afforded 31 (40 mg, 90%) as a white solid: IR (cm
-1
) 2952, 2929, 2856, 1468, 1254, 
1120, 909, 838, 778; 
1
H NMR (300 MHz, CDCl3)  7.46 (m, 2H), 7.37 (m, 1H), 4.74 (s, 4H), 
0.96 (s, 18H), 0.19 (s, 12H); 
13
C NMR (75 MHz, CDCl3)  140.1, 127.1, 126.0, 119.7, 64.9, 
26.0, 18.4, 4.9; HRMS (EI) m/e calcd for C19H34O2Si2Br (M
+
) 429.1281, found 429.1286.  
N-(4-(2,6-Bis(Boc-L-proline-carboxyl-methylene))phenyl-2,6-diisopropyl-
phenyl)ethane-1,2-diamine (34).  To a solution of Boc-L-proline (580 mg, 2.70 mmol), DMAP 
(10.6 mg), tetraol 33 (400 mg, 0.61 mmol) in THF (4 mL) at -10
 
°C was added a solution of 
DCC (556 mg, 2.70 mmol) in THF (3 mL) over 1 h, and the mixture was stirred at rt for 1 h.  
Et2O (5 mL) was added, and the resulting precipitate was filtered and washed with Et2O.  After 
removal of volatile components from the filtrate, the crude product was purified by flash 
chromatography (SiO2, CH2Cl2, then hexanes/EtOAc = 1/1) to afford 34 (780 mg, 89%) as a 
white solid: IR (cm
-1
) 2967, 1747, 1698, 1452, 1398, 1162, 917, 732; 
1
H NMR (300 MHz, 
CD2Cl2)  7.49 (m, 4H), 7.41 (m, 2H), 6.97 (m, 4H), 5.03 (m, 8H), 4.40–4.19 (m, 4H), 3.48–3.33 
(m, 12H), 3.20 (s, 4H), 2.20–2.16 (m, 4H), 1.92–1.81 (m, 12H), 1.43 (s, 14H), 1.30–1.27 (m, 
46H); 
13
C NMR (75 MHz, CD2Cl2) . 173.2, 173.0, 154.6, 154.0, 143.3, 143.1, 135.2, 135.1, 
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134.9, 132.6, 128.6, 128.4, 128.1, 127.9, 127.8, 125.1, 125.0, 80.1, 64.8, 59.5, 59.4, 52.7, 47.0, 
46.7, 31.2, 30.3, 28.5, 28.4, 28.2, 24.8, 24.5, 24.4, 23.9; HRMS (ES) m/e calcd for 
C82H116N6O16Na (MNa
+
) 1463.8346, found 1463.8356.  
2,6-Bis(Boc-L-proline-carboxylmethylene))bromobenzene (22).  By the same 
procedure as 34, diol 25 (543 mg, 2.5 mmol), Boc-L-proline (1098 mg, 5.1 mmol), DMAP (23 
mg) and DCC (1057 mg, 5.1 mmol) in THF (20 mL) at -10 °C for 5.5 h, 0 °C for 0.5 h and rt for 
1 h gave 22 (1.35 g, 89%) as a white solid: IR (cm
-1
) 2976, 1751, 1700, 1398, 1161; 
1
H NMR 
(300 MHz, CDCl3)  7.42 (m, 3H), 5.31 (m, 4H), 4.38 (m, 2H), 3.53–3.47 (m, 4H), 2.21–2.02 
(m, 2H), 2.02–1.89 (m, 6H), 1.44 (s, 8H), 1.35 (s, 10H); 13C NMR (75 MHz, CDCl3)  172.9, 
172.8, 154.6, 154.0, 136.3, 136.1, 135.8, 129.8, 129.6, 127.7, 124.5, 80.2, 80.1, 77.4, 66.5, 59.4, 
59.1, 46.8, 46.5, 31.2, 30.2, 28.6, 28.5, 24.6, 23.8; HRMS (ES) m/e calcd for C28H39N2O8NaBr 
(MNa
+
) 633.1787, found 633.1799. 
General procedure for the Suzuki Coupling.
60  
A solution of Pd(PPh3)4 (31 mg, 0.027 
mmol), bromobenzene (0.54 mmol), pinacolatoboronylbenzene (0.60 mmol) in DME (3 mL) in a 
10 mL microwave tube was degassed in an dry ice-acetone bath and warmed to rt.  A solution of 
NaHCO3 (151 mg, 1.8 mmol) in H2O (2 mL) was added, and the mixture was degassed again in 
the dry ice-acetone bath and irradiated in a microwave reactor at 140 °C, 250 W for 20 min.  
After being cooled to rt, the mixture was extracted with Et2O.  The extracts were combined, 
dried over MgSO4 and filtered.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 8/1).  
N-(4-(2,6-Bishydroxylmethyl)phenyl-2,6-diisopropylphenyl)ethane-1,2-diamine (33).  
By the general procedure, after irradiation in a microwave reactor at 140 °C, 250 W for 20 min, 
diamine 30 (190 mg, 0.3 mmol), Pd(PPh3)4 (31 mg, 0.027 mmol), bromobenzene 31 (240 mg, 
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0.54 mmol) and NaHCO3 (151 mg, 1.8 mmol) provided a crude product.  The crude product was 
added a solution of TBAF (640 mg, 2.03 mmol) in THF (3 mL), and the mixture was stirred at rt 
for 2 h.  The solvent was evaporated under reduced pressure, and the residue was washed with 
Et2O and dissolved in EtOAc.  The solution was washed with H2O and brine, dried over MgSO4 
and filtered.  Removal of volatile components from the filtrate afforded 33 (150 mg, 85%) as a 
white solid: IR (cm
-1
) 3319, 2961, 1461, 1443, 1063, 731; 
1
H NMR (300 MHz, CD2Cl2)  7.51 
(m, 4H), 7.44 (m, 2H), 6.97 (s, 4H), 4.41 (s, 8H), 3.53 (heptet, J = 6.9 Hz, 4H), 3.26 (s, 4H), 1.26 
(d, J = 7.2 Hz, 24H); 
13
C NMR (75 MHz, CD2Cl2)  143.3, 142.9, 140.7, 139.9, 133.3, 127.9, 
126.9, 124.8, 63.6, 52.6, 28.1, 24.4; HRMS (EI) m/e calcd for C42H56N2O4 (M
+
) 652.4240, found 
652.4266. 
N-(4-(2,6-Bismethyl)phenyl-2,6-diisopropylphenyl)ethane-1,2-diamine (38).  By the 
general procedure, after irradiation in a microwave reactor at 140 °C, 250 W for 20 min, N-(4- 
diamine 30 (44 mg, 0.070 mmol), Pd(PPh3)4 (7 mg, 0.006 mmol), 2,6-dimethylbromobenzene  
(22 mg, 0.119 mmol) and NaHCO3 (30 mg, 0.36 mmol) gave 38 (35 mg, 99%) as a white solid: 
1
H NMR (300 MHz, CDCl3)  7.10 (m, 6H), 6.89 (s, 4H), 3.69 (heptet, J = 6.9 Hz, 4H), 3.50 (s, 
4H), 1.98 (s, 12H), 1.26 (d, J = 6.6 Hz, 24H). 
N-(4-(2,6-Bismethoxymethyl)phenyl-2,6-diisopropylphenyl)ethane-1,2-diamine (39).  
By the general procedure, after irradiation in a microwave reactor at 140 °C, 250 W for 20 min, 
diamine 30 (63 mg, 0.099 mmol), bromobenzene 37 (43.5 mg, 0.178 mmol), NaHCO3 (49.6 mg, 
0.59 mmol) and Pd(PPh3)4 (10.2 mg, 0.0089 mmol) afforded 39 (60 mg, 95%) as a white solid: 
1
H NMR (300 MHz, CDCl3)  7.51 (m, 4H), 7.44 (m, 2H), 6.97 (s, 4H), 4.41 (s, 8H), 3.53 
(heptet, J = 6.9 Hz, 4H), 3.26 (s, 4H), 1.26 (d, J = 7.2 Hz, 24H). 
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N-(4-(2,6-Bis(((S)-1-phenylethoxy)methyl)phenyl)-2,6-diisopropyl-phenyl)ethane-
1,2-diamine (44).  By the general procedure, after irradiation in a microwave reactor at 140 °C, 
250 W for 22 min, diamine 30 (260 mg, 0.41 mmol), Pd(PPh3)4 (48 mg, 0.041 mmol), 
bromobenzene 43 (350 mg, 0.82 mmol) and NaHCO3 (207 mg, 2.47 mmol) provided 44 (298 
mg, 67%) as a white solid: 
1
H NMR (300 MHz, CD2Cl2)  7.47–7.15 (m, 26H), 6.85 (s, 4H), 
4.33 (q, J = 6.4 Hz, 4H), 4.15 (d, J = 11.6 Hz, 2H), 4.04 (d, J = 11.6 Hz, 2H), 3.46 (heptet, J = 
6.9 Hz, 4H), 3.23 (s, 4H), 1.34 (d, J = 6.4 Hz, 12H), 1.19 (d, J = 2.4 Hz, 12H), 1.16 (d, J = 2.4 
Hz, 12H).  
N-(4-(2,6-Bis(2-(1S,2S,5S)-myrtylethyl))phenyl-2,6-diisopropylphenyl)ethane-1,2–
diamine (47).  By the general procedure, after irradiation in a microwave reactor at 140 °C, 250 
W for 30 min, diamine 30 (329 mg, 0.52 mmol), Pd(PPh3)4 (48 mg, 0.041 mmol), 2,6-bis(2-
(1S,2S,5S)-myrtyl-ethyl)phenyl bromide 46 (458 mg, 1.0 mmol) and NaHCO3 (262 mg, 3.12 
mmol) afforded 47 (450 mg, 80%) as a white solid: []20D +3.83 (c 73, CHCl3); IR (cm
-1
) 2959, 
2927, 2865, 1459, 759 cm
-1
; 
1
H NMR (300 MHz, CDCl3)  7.21–7.16 (m, 2H), 7.10 (d, J = 6.9 
Hz, 4H), 6.93 (s, 4H), 3.50 (heptet, J = 6.8 Hz, 4H), 3.23 (s, 4H), 2.45–2.26 (m, 8H), 1.91–1.84 
(m, 4H), 1.80–1.58 (m, 16H), 1.53–1.40 (m, 10H), 1.29 (dd, J = 6.7, 2.2 Hz, 24H), 1.23–1.20 (m, 
8H), 1.13 (s, 12H), 0.98–0.83 (m, 8H), 0.73 (s, 12H); 13C NMR (75 MHz, CDCl3)  141.8, 
141.7, 141.5, 135.1, 127.0, 126.6, 125.2, 52.8, 45.9, 40.9, 39.3, 38.8, 34.9, 32.1, 27.8, 26.8, 24.5, 
23.5, 22.0, 20.1; HRMS (ES) m/e calcd for C82H121N2 (MH
+
) 1133.9530, found 1133.9510. 
2,6-Bis(methoxymethyl)bromobenzene (37).
86
  A solution of diol 25 (87 mg, 0.4 
mmol), 60% NaH in mineral oil (48 mg, 1.2 mmol) in THF (2 mL) was stirred at rt for 1 h.  MeI 
(60 μL, 0.96 mmol) was added, and the mixture was stirred at rt for 14 h.  H2O (0.5 mL) was 
added, and the mixture was extracted with Et2O.  The extracts were combined, dried over MgSO4 
  72 
and filtered.  After removal of volatile components from the filtrate, the resulting crude product 
was purified by flash chromatography (SiO2, hexanes/EtOAc = 20/1) to provide 37 (90 mg, 92%) 
as an oil: 
1
H NMR (300 MHz, CDCl3)  7.39–7.28 (m, 3H), 4.53 (s, 4H), 3.45 (s, 6H).
 
 
(S)-1-Phenylethanol (41).
87
  To a suspension of LiAlH4 (0.7 g, 18.3 mmol) in THF (25 
mL) at 0 °C was added a solution of (R)-styrene oxide (2.0 g, 16.6 mmol) in THF (25 mL) 
slowly, and the mixture was stirred at rt for 1.5 h and cooled in an ice bath.  H2O (10 mL) was 
added, followed by HCl (3 M, 25 mL) slowly, and the resulting mixture was extracted with Et2O.  
The extracts were combined, dried over MgSO4 and filtered.  Removal of volatile components 
from the filtrate afforded 41 (2.0 g, 99%) as an oil: 
1
H NMR (300 MHz, CDCl3)  7.36–7.11 (m, 
5H), 5.92 (m, 1H), 1.50 (d, J = 7.2 Hz, 3H).  
2,6-Bis(bromomethyl)bromobenzene (42).
88
  A solution of 2,6-dimethylbromobenzene 
(200 mg, 1.08 mmol), NBS (424 mg, 2.38 mmol) in MeOAc (5.4 mL) was irradiated to reflux by 
an incandescent light for 18 h.  The solvent was evaporated under reduced pressure, and the 
residue was washed with hot hexanes.  The hexanes solution was concentrated to 10 mL and put 
in an ice-acetone bath.  The resulting white crystalline precipitate was filtered and washed with 
cold hexanes.  Further purification of the crude crystalline product by flash chromatography 
(SiO2, hexanes/EtOAc = 20/1) provided 42 (230 mg, 63%) as a white solid: 
1
H NMR (300 MHz, 
CD2Cl2)  7.45 (m, 2H), 7.34 (m, 1H), 4.67 (s, 4H). 
2,6-Bis(((S)-1-phenylethoxy)methyl)bromobenzene (43).  To a suspension of 60% NaH 
in mineral oil (196 mg, 4.9 mmol) in THF (10 mL) at 0 °C was added a solution of (S)-1-
phenylethanol 41 (287 mg, 2.34 mmol) in THF (5 mL) dropwise, and the mixture was stirred at 
rt for 25 min and cooled in an ice bath.  To this solution was added a solution of benzylbromide 
42 (365 mg, 1.07 mmol) and Bu4I (10 mg) in THF (10 mL) which was previously stirred at rt for 
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50 min, and the resulting mixture was stirred at rt for 30 min, 70 °C for 16 h and cooled to rt.  
Saturated aqueous NH4Cl solution (1.5 mL) was added, followed by H2O (20 mL), and the 
mixture was extracted with Et2O.  The extracts were combined, dried over MgSO4 and filtered.  
After removal of volatile components from the filtrate, the resulting crude product was purified 
by flash chromatography (SiO2, hexane/EtOAc = 20/1) to give 43 (368 mg, 81%) as a white 
solid: 
1
H NMR (300 MHz, CD2Cl2)  7.37–7.20 (m, 13H), 4.60 (q, J = 6.5 Hz, 2H), 4.37 (s, 4H), 
1.50 (d, J = 6.5 Hz, 6H). 
2-(2,6-Dimethyl)phenyl-iodobenzene (50).  To flame dried Mg (510 mg, 21 mmol) was 
added THF (35 mL), followed by 2,6-dimethylbromobenzene (1.47 mL, 11 mmol) and 1,2-
dibromoethane (10 μL), and the mixture was stirred at 40 °C for 1 h.  A solution of 2-bromo-
iodobenzene (1.29 mL, 10 mmol) in THF (15 mL) was added over 5 h, and the mixture was 
stirred for 1 h.  After being cooled in an ice bath, I2 (3810 mg, 15 mmol) was added, and the 
mixture was warmed to rt for 1 h.  Aqueous Na2S2O3 solution was added to consume unreacted 
I2, and the resulting colorless mixture was extracted with Et2O.  The extracts were combined, 
dried over MgSO4 and filtered.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes) to provide 50 
(2.30 g, 75%) as a white solid: IR (cm
-1
) 3046, 2940, 2914, 2852, 1581, 1555, 1460, 1377, 1013, 
1000, 778, 762; 
1
H NMR (300 MHz, CD2Cl2)  8.01 (d, J = 7.8 Hz, 1H), 7.50 (t, J = 7.5 Hz, 1H), 
7.26–7.06 (m, 4H), 1.99 (s, 6H); 13C NMR (75 MHz, CD2Cl2)  139.5, 136.0, 130.0, 129.0, 
128.9, 128.1, 127.6, 20.5; HRMS (EI) m/e calcd for C14H13I (M
+
) 308.0062, found 308.0073. 
General Procedure for the Buchwald–Hartwig Coupling of Bromobenzenes with 
(1R,2R)-1,2-Diphenylethane-1,2-diamine.  A solution of BINAP (622 mg, 1 mmol) in toluene 
(80 mL) was degassed in a dry ice-acetone bath, back filled with nitrogen and stirred at 80 °C 
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until BINAP was dissolved.  After being cooled to rt, a solution of Pd(OAc)2 (112 mg, 0.5 
mmol) in toluene (10 mL) was added, and the resulting mixture was stirred for 10 min.  A 
solution of (1R,2R)-1,2-diphenylethane-1,2-diamine (1061 mg, 5 mmol) and iodobenzenes or 
bromobenzenes (10 mmol) in toluene (30 mL) was added, followed by NaOt-Bu (1920 mg, 20 
mmol), and the resulting mixture was degassed in a dry ice-acetone bath, back filled with 
nitrogen and stirred at 110 °C.  After the reaction was over (as determined by TLC), hexanes 
(400 mL) was added, and the resulting mixture was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 1/1).  
N1-(2-(2,6-Dimethyl)phenylphenyl)-N1-N2-(1R,2R)-1,2-diphenylethane-1,2-diamine 
(51).  By the general procedure, BINAP (5.6 mg, 0.009 mmol), Pd(OAc)2 (1 mg, 0.0045 mmol), 
(1R,2R)-1,2-diphenylethane-1,2-diamine (31.8 mg, 0.15 mmol), iodobenzene 50 (46.2 mg, 0.15 
mmol) and NaOt-Bu (29 mg, 0.3 mmol) in toluene (2.7 mL) at 150 °C for 4.5 h gave 51 (28 mg, 
48%) as an oil after chromatography (SiO2, hexanes/EtOAc = 5/1): 
1
H NMR (300 MHz, CD2Cl2) 
 7.34–7.20 (m, 11H), 7.11 (dd, J = 5.1, 2.0 Hz, 2H), 6.97 (td, J = 8.1, 1.6 Hz, 1H), 6.82 (dd, J = 
7.4, 1.6 Hz, 1H), 6.63 (td, J = 7.4, 1.1 Hz, 1H), 6.20 (d, J = 8.1 Hz, 1H), 4.65 (d, J = 5.6 Hz, 1H), 
4.44 (dd, J = 5.8, 3.6 Hz, 1H), 4.24 (d, J = 3.5 Hz, 1H), 2.13 (s, 3H), 1.64 (s, 3H); LRMS (API-
ES) (MH
+
) 393.  
N1-(2-(2,6-Dimethyl)phenylphenyl)-N2-2,6-dimethyl)phenyl-N1-N2-(1R,2R)-1,2-
diphenylethane-1,2-diamine (52).  By the general procedure, BINAP (6.2 mg, 0.01 mmol), 
Pd(OAc)2 (1.1 mg, 0.005 mmol), 2,6-dimethylbromobenzene (18.7 mg, 0.1 mmol), diamine 51 
(20 mg, 0.05 mmol) and NaOt-Bu (10 mg, 0.1 mmol) in toluene (2.0 mL) at 120 °C for 13 h 
afforded 52 (20 mg, 81%) as an oil after flash chromatography (SiO2, hexanes/EtOAc = 20/1): 
1
H NMR (300 MHz, CD2Cl2)  7.21–6.72 (m, 18H), 6.64 (t, J = 7.4 Hz, 1H), 4.95 (d, J = 0.3 Hz, 
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1H), 4.74 (dd, J = 7.5, 3.0 Hz, 1H), 4.40 (d, J = 6.0 Hz, 1H), 3.55 (s, 1H), 2.09 (s, 3H), 1.96 (s, 
3H), 1.88 (s, 6H).  
N-(2-Benzylphenyl)-N-(1R,2R)-1,2-diphenylethane-1,2-diamine (49c).  By the general 
procedure, BINAP (144 mg, 0.23 mmol), Pd(OAc)2 (26 mg, 0.115 mmol), 2-
benzylbromobenzene (1000 mg, 4.0 mmol), (1R,2R)-1,2-diphenylethane-1,2-diamine (409 mg, 
1.93 mmol) and NaOt-Bu (556 mg, 5.79 mmol) in toluene (60 mL) at 110 °C for 18 h gave 49c 
(950 mg, 91%) as an oil after flash chromatography: [α]23D +157 (c 2.65, CH2Cl2); IR (cm
-1
) 
3400, 3026, 2906, 1603, 1585, 1506, 1452, 1310, 1267, 908, 732; 
1
H NMR (300 MHz, CDCl3)  
7.25–7.17 (m, 6H), 7.11–6.97 (m, 12H), 6.95 (t, J = 7.8 Hz, 2H), 6.78 (d, J = 7.8 Hz, 4H), 6.65 
(t, J = 7.2 Hz, 2H), 6.29 (d, J = 8.1 Hz, 2H), 4.52 (S, 2H), 4.25 (br, 2H), 3.80 (m, 4H); 
13
C NMR 
(75 MHz, CDCl3)  144.7, 139.6, 139.4, 131.4, 130.8, 130.2, 129.7, 129.3, 129.2, 129.0, 128.8, 
128.7, 128.5, 128.4, 128.3, 127.7, 127.5, 127.3, 126.8, 126.6, 126.1, 125.9, 125.7, 122.4, 117.7, 
112.5, 63.0, 38.3; HRMS (EI) m/e calcd for C40H37N2 (MH
+
) 545.2957, found 545.2934. 
N-(2-Methyl-3-phenylphenyl)-N-(1R,2R)-1,2-diphenylethane-1,2-diamine (49h).  By 
the general procedure, BINAP (27.4 mg, 0.044 mmol), Pd(OAc)2 (5.0 mg, 0.022 mmol), 
(1R,2R)-1,2-diphenylethane-1,2-diamine (93.5 mg, 0.44 mmol), 2-methyl-3-phenyl-
bromobenzene (229 mg, 0.926 mmol) and NaOt-Bu (127 mg, 1.32 mmol) in toluene (10 mL) at 
110 °C for 4 h gave 49h (223 mg, 93%) as a white solid after flash chromatography (SiO2, 
hexanes/EtOAc = 10/1): [α]23D +170 (c 1.0, CH2Cl2); IR (cm
-1
) 3415, 3027, 1583, 1467, 760; 
1
H 
NMR (300 MHz, CDCl3)  7.39–7.23 (m, 20H), 6.95 (t, J = 8.1 Hz, 2H), 6.61 (d, J = 7.2 Hz, 
2H), 6.32 (d, J = 8.1 Hz, 2H), 4.76 (s, 2H), 4.61 (br, 2H); 2.04 (s, 6H); 
13
C NMR (75 MHz, 
CDCl3)  145.2, 142.5, 142.4, 140.0, 129.4, 128.7, 127.9, 127.7, 127.2 , 126.6, 125.9, 120.3, 
119.7, 110.8, 64.2, 14.4; HRMS (ES) m/e calcd for C40H37N2 (MH
+
) 545.2957, found 545.2955. 
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N-(2,3,4-Trimethoxyphenyl)-N-(1R,2R)-1,2-diphenylethane-1,2-diamine (49i).  By 
the general procedure, BINAP (62.2 mg, 0.1 mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol), 2,3,4-
trimethoxybromobenzene
89
 (519 mg, 2.1 mmol), (1R,2R)-1,2-diphenylethane-1,2-diamine (212 
mg, 1.0 mmol) and NaOt-Bu (288 mg, 3.0 mmol) in toluene (10 mL) at 115 °C for 5 h gave 49i 
(123 mg, 23%) as a pale yellow solid after flash chromatography: [α]23D +96 (c 0.85, CH2Cl2); 
IR (cm
-1
) 3380, 2936, 1497, 1269, 1094; 
1
H NMR (300 MHz, CDCl3)  7.28–7.17 (m, 10H), 
6.35 (d, J = 9.0 Hz, 2H), 5.96 (d, J = 9.0 Hz, 2H), 4.97 (s, 2H), 4.52 (s, 2H), 3.85 (s, 6H), 3.73 (s, 
6H), 3.68 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  145.5, 142.8, 141.5, 140.6, 135.8, 128.6, 128.3, 
127.6, 127.4, 107.8, 106.5, 64.6, 61.0, 60.6, 56.6; HRMS (EI) m/e calcd for C32H36N2O6 (M
+
) 
544.2573, found 544.2571. 
General Procedure for the Cyclization of Diamines to Imidazolinium Salts.  A 
mixture of CH(OEt)3 (5 mL, 30 mmol), NH4BF4 (189 mg, 1.8 mmol) and the diamine (1.5 
mmol) was stirred at 125 °C.  After the reaction was over (as determined by TLC), the crude 
product was purified by flash chromatography (SiO2, CH2Cl2/EtOH = 20/1). 
N,N-(4-(2,6-Bis(Boc-L-proline carboxylmethylene))phenyl-2,6-diisopropylphenyl) 
imidazolinium tetrafluoroborate (21).  By the general procedure, diamine 34 (500 mg, 0.35 
mmol), CH(OEt)3 (2.0 mL, 10.4 mmol) and NH4BF4 (37 mg, 0.35 mmol) at 125 °C for 1.5 h 
afforded 21 (410 mg, 77%) as a white solid: IR (cm
-1
) 2972, 2879, 2253, 1747, 1695, 1629, 
1453, 1400, 1367, 1301, 1265, 1162, 915, 771, 731; 
1
H NMR (300 MHz, CD2Cl2)  8.94–8.81 
(m, 1H), 7.62–7.52 (m, 2H), 7.52–7.40 (m, 4H), 7.37–7.22 (m, 4H), 5.22–4.78 (m, 8H), 4.78–
4.58 (m, 4H), 4.32–3.78 (m, 4H), 3.50–2.95 (m, 12H), 2.28–1.76 (m, 16H), 1.51–1.13 (m, 60H); 
13
C NMR (75 MHz, CD2Cl2)  173.1, 173.0, 172.6, 172.0, 171.5, 159.8, 159.5, 154.8, 154.7, 
154.5, 153.8, 147.0, 146.8, 146.6, 146.4, 141.4, 141.2, 140.4, 140.0, 139.6, 135.1, 134.8, 134.4, 
  77 
134.2, 134.0, 130.2, 129.8, 129.7, 129.4, 129.2, 128.7, 127.3, 127.1, 126.0, 125.3, 79.8, 79.6, 
72.1, 66.1, 65.4, 64.3, 59.4, 59.3, 58.9, 58.8, 58.4, 54.7, 46.9, 46.7, 31.2, 30.2, 29.9, 29.7, 28.4, 
28.3, 25.5, 25.1, 24.7, 24.3, 24.0, 23.8; HRMS (ES) m/e calcd for C83H115N6O16 (M
+
BF4
 
) 
1451.8370, found 1451.8365. 
N,N-(4-Pinacolatoboronyl-2,6-diisopropylphenyl)imidazolinium tetrafluoroborate 
(26).  By the general procedure, diamine 30 (127 mg, 0.2 mmol), CH(OEt)3 (1 mL, 6 mmol) and 
NH4BF4 (27 mg, 0.26 mmol) at 125 °C for 0.5 h provided 26 (126 mg, 85%) as a white solid 
after washing with hexanes: IR (cm
-1
) 2969, 1628, 1597, 1373, 1321, 1265, 1148, 1058, 724; 
1
H 
NMR (300 MHz, CD2Cl2)  7.91 (s, 1H), 7.71 (s, 4H), 4.56 (s, 4H), 3.03 (heptet, J = 6.9 Hz, 
4H), 1.43 (d, J = 6.9 Hz, 12H), 1.35 (s, 24H), 1.28 (d, J = 6.6 Hz, 12H); 
13
C NMR (75 MHz, 
CD2Cl2)  158.4, 146.6, 131.8, 131.6, 84.8, 54.5, 29.6, 25.2, 25.1, 24.0; HRMS (ES) m/e calcd 
for C39H61N2O4B2 (M
+
BF4
-
) 643.4817, found 643.4777. 
N,N-(4-(2,6-Bismethyl)phenyl-2,6-diisopropylphenyl)imidazolinium 
tetrafluoroborate (35).  By the general procedure, diamine 38 (18 mg, 0.031 mmol), CH(OEt)3 
(0.2 mL, 0.92 mmol) and NH4BF4 (3.2 mg, 0.031 mmol) at 125 °C for 1 h afforded 35 as a white 
solid after washing with hexanes: 
1
H NMR (300 MHz, CD2Cl2)  7.94 (s, 1H), 7.22–7.11 (m, 
10H), 4.71 (s, 4H), 3.12 (heptet, J = 6.8 Hz, 4H), 2.06 (s, 6H), 1.99 (s, 6H), 1.44 (d, J = 6.8 Hz, 
12H), 1.31 (d, J = 6.8 Hz, 12H). 
N,N-(4-(2,6-Bismethoxymethyl)phenyl-2,6-diisopropylphenyl)imidazolinium 
tetrafluoroborate (36).  By the general procedure, diamine 39 (58 mg, 0.082 mmol), CH(OEt)3 
(0.4 mL, 2.4 mmol) and NH4BF4 (9.5 mg, 0.09 mmol) at 125 °C for 1 h afforded 36 (30 mg, 
50%) as a white solid after washing with Et2O: IR (cm
-1
) 3048, 2966, 2928, 2823, 1630, 1449, 
1264, 1194, 1095, 1061, 729; 
1
H NMR (300 MHz, CD2Cl2)  8.15 (s, 1H), 7.53–7.40 (m, 6H), 
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7.22 (s, 4H), 4.71 (s, 4H), 4.08 (s, 4H), 4.02 (s, 4H), 3.24 (s, 6H), 3.20 (s, 6H), 3.13 (heptet, J = 
6.6 Hz, 4H), 1.49 (d, J = 6.6 Hz, 12H), 1.37 (d, J = 6.9 Hz, 12H); 
13
C NMR (75 MHz, CD2Cl2)  
158.4, 145.7, 141.8, 140.0, 136.4, 136.2, 128.3, 128.2, 128.0, 127.9, 126.7, 72.5, 72.4, 58.2, 58.0, 
54.5, 29.3, 24.9, 23.6; HRMS (ES) m/e calcd for C47H63N2O4 (M
+
BF4
-
) 719.4788, found 
719.4725. 
N,N-(4-(2,6-Bis(((S)-1-phenylethoxy)methyl)phenyl)-2,6-
diisopropylphenyl)imidazolinium tetrafluoroborate (40).  By the general procedure, diamine 
44 (270 mg, 0.25 mmol), CH(OEt)3 (1.3 mL, 7.6 mmol) and NH4BF4 (32 mg, 0.3 mmol) at 125 
°C for 1.75 h afforded 40 (200 mg, 68%) as a white solid: IR (cm
-1
) 3031, 2969, 2929, 2871, 
1629, 1452, 1264, 1093, 911, 762, 732; 
1
H NMR (300 MHz, CD2Cl2)  7.84 (s, 1H), 7.53–7.42 
(m, 6H), 7.36–7.20 (m, 20H), 7.15 (s, 4H), 4.73 (s, 4H), 4.42 (heptet, J = 6.6 Hz, 4H), 4.13–3.97 
(m, 8H), 3.07–3.01 (m, 4H), 1.42–1.32 (m, 24H), 1.23–1.20 (m, 12H); 13C NMR (75 MHz, 
CD2Cl2)  158.4, 146.2, 144.3, 144.0, 142.2, 139.6, 137.0, 136.8, 128.7, 128.6, 128.4, 128.3, 
128.2, 128.1, 127.8, 127.6, 126.9, 126.7, 126.5, 126.4, 78.0, 77.6, 68.5, 68.4, 54.9, 29.5, 25.2, 
25.1, 24.3, 24.2, 24.0, 23.9; HRMS (ES) m/e calcd for C75H87N2O4 (M
+
BF4
-
) 1079.6666, found 
1079.6709. 
N,N-(2-Phenylphenyl)-(4R,5R)-4,5-diphenylimidazolinium tetrafluoroborate (48b).
 90
  
By the general procedure, diamine 49b
91
 (826 mg, 1.6 mmol), CH(OEt)3 (2.4 mL, 14.4 mmol) 
and NH4BF4 (202 mg, 1.92 mmol) at 120 °C for 5 h afforded 48b (396 mg, 41%) as a white solid 
after flash chromatography and recrystallization from DME and CH2Cl2: mp 245–267 °C
 
.   
N,N-(2-Benzylphenyl)-(4R,5R)-4,5-diphenylimidazolinium tetrafluoroborate (48c).  
By the general procedure, 49c (816 mg, 1.5 mmol), CH(OEt)3 (5.0 mL, 30.0 mmol) and NH4BF4 
(189 mg, 1.8 mmol) at 120 °C for 5 h provided 48c (802 mg, 84%) as a white solid after flash 
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chromatography and recrystallization from EtOAc and CH2Cl2: mp 184–186 °C; 
 
[α]23D +290 (c 
2.5, CH2Cl2);. IR (cm
-1
) 3063, 1616, 1059, 762; 
1
H NMR (300 MHz, CD2Cl2)  7.99 (s, 1H), 
7.47–7.38 (m, 8H), 7.36–7.29  (m, 8H), 7.27–7.16 (m, 8H), 7.08–7.04 (m, 4H), 5.71 (s, 2H), 4.06 
(s, 4H); 
13
C NMR (75 MHz, CD2Cl2)  157.7, 139.2, 136.3, 133.1, 133.0, 132.8, 130.7, 129.9, 
129.4, 128.8, 128.7, 128.6, 128.5, 127.3, 76.1, 37.8; HRMS (ES) m/e calcd for C41H35N2 
(M
+
BF4
-
) 555.2800, found 555.2789.  
N,N-(2-Cyclohexylphenyl)-(4R,5R)-4,5-diphenylimidazolinium tetrafluoroborate 
(48d).
27d  
By the general procedure, diamine 49d
27d
 (678 mg, 1.28 mmol), CH(OEt)3 (4.3 mL, 
25.6 mmol) and NH4BF4 (162 mg, 1.54 mmol) at 120 °C for 5 h afforded 48d (580 mg, 72%) as 
a white solid after flash chromatography and recrystallization from dioxane: mp 118–138 °C. 
N,N-(2-Methyl-3-phenylphenyl)-(4R,5R)-4,5-diphenylimidazolinium 
tetrafluoroborate (48h).  By the general procedure, 49h (218 mg, 0.4 mmol), CH(OEt)3 (1.4 
mL, 8 mmol) and NH4BF4 (42 mg, 0.4 mmol) at 125 °C for 3 h gave 48h (201 mg, 79%) as a 
hard foam after flash chromatography: [α]23D +237 (c 1.24, CH2Cl2); IR (cm
-1
) 3061, 1616, 1058, 
762; 
1
H NMR (300 MHz, CD2Cl2)  8.77 (s, 1H), 7.49–7.36 (m, 18H), 7.30–7.24 (m, 8H), 5.91 
(s, 2H), 2.35 (s, 6H); 
13
C NMR (75 MHz, CD2Cl2)  158.2, 145.1, 140.6, 133.8, 133.7, 132.0, 
130.9, 130.1, 129.5, 128.7, 127.9, 127.3, 126.6, 76.5, 16.7; HRMS (ES) m/e calcd for C41H35N2 
(M
+
BF4
-
) 555.2800, found 555.2803. 
N,N-2,3,4-Trimethoxyphenyl-(4R,5R)-4,5-diphenylimidazolinium tetrafluoroborate 
(48i).  By the general procedure, 49i (100 mg, 0.184 mmol), CH(OEt)3 (0.77 mL, 4.6 mmol) and 
NH4BF4 (21 mg, 0.2 mmol) at 125 °C for 3 h gave 48i (81 mg, 69%) as a hard foam after flash 
chromatography: [α]23D +286 (c 1.5, CH2Cl2); IR (cm
-1
) 2943, 1620, 1493, 1271, 1057; 1H NMR 
(300 MHz, CDCl3)  8.71 (s, 1H), 7.45–7.37 (m, 10H), 7.09 (d, J = 9.0 Hz, 2H), 6.57 (d, J = 9.0 
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Hz, 2H), 5.74 (s, 2H), 4.08 (s, 6H), 3.84 (s, 6H), 3.79 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  
157.8, 155.0, 148.3, 142.0, 135.5, 130.2, 129.8, 127.9, 122.0, 120.1, 107.2, 75.8, 61.9, 61.2, 
56.2; HRMS (ES) m/e calcd for C33H35N2O6 (M
+
BF4
-
) 555.2495, found 555.2499.  
N,N-2-(2,4-Dimethylpentan-3-yl)phenyl-(4R,5R)-4,5-diphenylimidazolinium 
tetrafluoroborate (48j).  By the general procedure, 49j (220 mg, 0.392 mmol), CH(OEt)3 (2 
mL, 11.76 mmol), NH4BF4 (42 mg, 0.4 mmol) and 1 drop of HCOOH at 125 °C for 3 h provided 
48j (118 mg, 46%) as a white solid with some impurity after flash chromatography which is 
difficult to be purified: [α]23D +214 (c 2.8, CH2Cl2); IR (cm
-1
) 2964, 1615, 1058, 758; 
1
H NMR 
(300 MHz, CDCl3)  8.82 (s, 1H), 7.50–7.38 (m, 10H), 7.36 (d, J = 7.5 Hz, 4H), 7.28–7.20 (m, 
4H), 5.61 (s, 2H), 2.59 (dd, J = 9.0, 5.4 Hz, 2H), 2.38–2.27 (m, 2H), 2.23–2.12 (m, 2H), 1.04 (d, 
J = 6.6 Hz, 6H), 0.96 (d, J = 6.6 Hz, 6H), 0.77 (d, J = 6.9 Hz, 6H), 0.75 (d, J = 6.9 Hz, 6H); 
13
C 
NMR (75 MHz, CDCl3)  159.8, 139.6, 134.8, 133.2, 131.0, 130.5, 130.2, 130.1, 129.5, 128.0, 
127.6, 78.1, 52.1, 30.2, 30.0, 22.3, 21.6, 18.0; HRMS (ES) m/e calcd for C41H51N2 (M
+
BF4
-
) 
571.4052, found 571.4011.  
1,3-Bis((R)-1-(3-methylbutan-2-yl)phenyl)imidazolinium tetrafluoroborate (56). By 
the general procedure, diamine 67 (150 mg, 0.425 mmol), CH(OEt)3 (2.1 mL, 12.75 mmol) and 
NH4BF4 (49 mg, 0.468 mmol) at 125 °C for 4 h gave 56 (159 mg, 83%) as a pale yellow foam 
after flash chromatography: [α]23D -106 (c 7.7, CH2Cl2); IR (cm
-1
) 3064, 2964, 2874, 2360, 1638, 
1489, 1266, 1038, 766, 734; 
1
H NMR (300 MHz, CDCl3)  7.76 (dd, J = 7.8, 0.9 Hz, 2H), 7.65 
(s, 1H), 7.46–7.7.41 (m, 2H), 7.35–7.32 (m, 2H), 7.29–7.23 (m, 2H), 4.66–4.47 (m, 4H), 2.55–
2.45 (m, 2H), 1.89–1.80 (m, 2H), 1.28 (d, J = 6.9 Hz, 6H), 1.09 (d, J = 6.6 Hz, 6H), 0.73 (d, J = 
6.6 Hz, 6H); 
13
C NMR (75 MHz, CDCl3)  157.2, 144.1, 133.4, 131.0, 128.0, 127.9, 127.7, 54.2, 
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41.2, 34.6, 22.1, 20.6, 20.5; HRMS (ES) m/e calcd for C25H35N2 (M
+
BF4
-
) 363.2800, found 
363.2836.  
1-((S)-(2-(3-Methylbutan-2-yl)phenyl)-3-phenylimidazolinium tetrafluoroborate 
(57).  By the general procedure, diamine 69 (126 mg, 0.447 mmol), CH(OEt)3 (2.3 mL, 13.41 
mmol) and NH4BF4 (51.6 mg, 0.492 mmol) at 125 °C for 2 h gave 57 (134 mg, 79%) as a crystal 
after flash chromatography and recrystallization with EtOAc: mp 174–176 °C ; [α]23D +62 (c 1.1, 
CH2Cl2); IR (cm
-1
) 3069, 2962, 2360, 2340, 1061, 753; 
1
H NMR (300 MHz, CDCl3)  8.27 (s, 
1H), 7.63 (dd, J = 8.1, 1.2 Hz, 1H), 7.47–7.22 (m, 8H), 4.71–4.64 (m, 2H), 4.54–4.35 (m, 2H), 
2.48–2.39 (m, 1H), 1.86–1.74 (m, 1H), 1.27 (d, J = 6.9 Hz, 3H), 1.04 (d, J = 6.6 Hz, 3H), 0.71 
(d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  154.2, 144.2, 135.6, 133.7, 131.3, 130.4, 
128.4, 128.1, 127.9, 127.8, 119.6, 77.4, 54.2, 50.0, 41.2, 34.7, 22.1, 20.5; HRMS (ES) m/e calcd 
for C20H25N2 (M
+
BF4
-
) 293.2018, found 293.2038.  
N,N-(4-Boronic acidic-2,6-diisopropylphenyl)-imidazolinium tetrafluoroborate (32).  
A solution of NaIO4 (205 mg, 0.96 mmol), imidazolinium salt 26 (117 mg, 0.16 mmol) and 
NH4OAc (55 mg, 0.70 mmol) in acetone (6.4 mL) and H2O (6.4 mL) was stirred at rt for 19 h.  
Acetone was evaporated under reduced pressure, and the residue was added CH2Cl2 (10 mL).  
The resulting precipitate was filtered, washed with H2O and CH2Cl2 to afford 32 (90 mg, 99%) 
as a white solid: IR (cm
-1
) 3405, 2964, 1618, 1590, 1368, 846; 
1
H NMR (300 MHz, DMSO)  
9.40 (s, 1H), 8.30 (s, 4H), 7.80 (s, 4H), 4.52 (s, 4H), 3.08 (heptet, J = 6.6 Hz, 4H), 1.36 (d, J = 
6.6 Hz, 12H), 1.19 (d, J = 6.6 Hz, 12H); 
13
C NMR (75 MHz, MeOD) 145.9, 131.0, 72.7, 59.1, 
55.0, 30.2, 25.6, 24.1; HRMS (ES) m/e calcd for C27H41B2N2O4 (M
+
BF4
-
) 479.3252, found 
479.3206.  
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2-(2,4-Dimethylpent-2-en-3-yl)iodobenzene (55).  To a solution of 3-(2-iodophenyl)-
2,4-dimethylpentan-3-ol
9
 (1.59 g, 5 mmol) in CH2Cl2 (5 mL) was added BF3
.
Et2O (0.63 mL, 5.02 
mmol) dropwise at 0 °C, and the mixture was stirred at rt for 10 min.  After removal of volatile 
components from the mixture, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes) to provide 55 (1.44 g, 96%) as a colorless liquid: IR (cm
-1
) 2961, 2928, 1461, 
1012, 754; 
1
H NMR (300 MHz, CDCl3)  7.85 (dd, J = 7.8, 1.2 Hz, 1H), 7.28 (td, J = 7.5, 1.2 
Hz, 1H), 7.01 (dd, J = 7.5, 1.5 Hz, 1H), 6.91 (td, J = 7.8, 1.8 Hz, 1H), 3.06 (heptet, J = 6.9 Hz, 
1H), 1.82 (S, 3H), 1.35 (S, 3H), 1.05 (d, J = 6.9 Hz, 3H), 0.83 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 
MHz, CDCl3)  146.3, 141.6, 139.0, 129.7, 128.9, 127.5, 127.4, 103.0, 30.4, 22.8, 22.4, 20.4, 
19.4; HRMS (EI) m/e calcd for C13H17I (M
+
) 300.0375, found 300.0372. 
2-(2,4-Dimethylpentan-3-yl)iodobenzene (53).  To a solution of CF3COOH (0.75 mL, 
10 mmol), Et3SiH (0.8 mL, 5 mmol), CF3SO3H (0.02 mL) in CH2Cl2 (2.5 mL) was added a 
solution of styrene 55 (750 mg, 2.5 mmol) in CH2Cl2 (2.5 mL) slowly at 0 °C for 5 min, and the 
mixture was stirred at rt for 1 h.  After removal of volatile components from the mixture, the 
residue was filtered through a pad of silica gel with hexanes to give a mixture (0.74 g, 98%) of 
53 (83%) and 55 (15%) as a colorless liquid which was used directly in the next step: 
1
H NMR 
(300 MHz, CDCl3)  7.87 (d, J = 7.8 Hz, 1H), 7.27 (t, J = 7.2 Hz, 1H), 7.12 (dd, J = 7.8, 1.2 Hz, 
1H), 6.88 (td, J = 8.1, 1.5 Hz, 1H), 2.83 (t, J = 7.5 Hz, 1H), 2.17 (heptet, J = 6.9 Hz, 2H), 0.94 
(d, J = 6.9 Hz, 6H), 0.78 (d, J = 6.9 Hz, 6H); 
13
C NMR (75 MHz, CDCl3)  139.8, 128.7, 127.7, 
127.6, 60.5, 30.7, 21.3, 19.5; HRMS (EI) m/e calcd for C13H19I (M
+
) 302.0532, found 302.0539. 
N-(2-(2,4-Dimethylpentan-3-yl)phenyl)-N-(1R,2R)-1,2-diphenylethane-1,2-diamine 
(49j).  A solution of (1R,2R)-1,2-diphenylethane-1,2-diamine (255 mg, 1.2 mmol), the mixture 
of 53 and 55 from last step (976 mg, 2.52 mmol), NaOt-Bu (346 mg, 3.6 mmol), Pd(Pt-Bu3)2 
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(245 mg, 0.48 mmol) in toluene (24 mL) was degassed in a dry ice-acetone bath, back filled with 
nitrogen and stirred at 110 °C for 6 h.  After being cooled to rt, brine (10 mL) was added, and the 
organic layer was separated, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(florisil, hexanes) to provide 49j (268 mg, 40%) as a white foam with some impurity which is 
difficult to be purified: 
1
H NMR (300 MHz, CDCl3)  7.48 (d, J = 7.2 Hz, 4H), 7.34 (t, J = 7.2 
Hz, 6H), 7.26–7.20 (m, 4H), 6.93 (dd, J = 6.9, 0.9 Hz, 2H), 6.86 (t, J = 6.9 Hz, 2H), 6.63 (t, J = 
7.2 Hz, 2H), 6.18 (d, J = 8.1 Hz, 2H), 4.72 (s, 2H), 4.57 (s, 2H), 2.33 (t, J = 7.5 Hz, 2H), 2.24 
(heptet, J = 6.6 Hz, 2H), 2.08 (heptet, J = 6.6 Hz, 2H), 1.05 (d, J = 6.6 Hz, 6H), 0.83 (d, J = 6.6 
Hz, 6H), 0.81 (d, J = 6.6 Hz, 6H), 0.47 (d, J = 6.6 Hz, 6H); 
13
C NMR (75 MHz, CDCl3)  145.7, 
140.7, 129.1, 128.4 , 128.2, 127.8, 127.1, 126.0, 117.5, 113.1, 64.4, 50.2, 30.2, 29.9, 22.0, 21.6, 
20.3, 18.6; HRMS (ES) m/e calcd for C40H53N2 (MH
+
) 561.4209, found 561.4229.  
2-(2-Aminophenyl)-3-methylbutan-2-ol (61).
92
  To a mixture of frame-dried 
magnesium turning (438 mg, 18 mmol) and THF (40 mL) was added isopropylbromide (2.77 g, 
22.5 mmol), and the mixture was stirred at rt until magnesium turning was dissolved.  2-
Aminophenylmethylketone (2.03 g, 15 mmol) was added slowly, and the mixture was stirred for 
2 h.  HCl (0.1 N, 5 mL) was added, and the resulting mixture was extracted with ethyl acetate.  
The extracts were combined, washed with H2O, brine, dried over MgSO4 and filtered.  After 
removal of volatile components from the filtrate, the resulting crude product was purified by 
flash chromatography (SiO2, hexanes/EtOAc = 2/1) to give 61 (1.18 g, 44%) as a white solid: 
1
H 
NMR (300 MHz, CDCl3)  7.06–7.02 (m, 2H), 6.69–6.61 (m, 2H), 4.68 (br, 2H), 2.05 (s, 1H), 
1.53 (s, 3H), 1.28 (heptet, J = 7.2 Hz, 1H), 1.04 (d, J = 6.9 Hz, 3H), 0.67 (d, J = 6.9 Hz, 3H). 
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2-(3-Methylbut-2-en-2-yl)aniline (60).  A solution of benzyl alcohol 61 (1.11 g, 6.17 
mmol) and I2 (18 mg, 0.07 mmol) in toluene (5 mL) was refluxed for 43 h.  After being cooled to 
rt, Na2SO3 (44 mg, 0.35 mmol) was added, and the mixture was stirred for 10 min, washed with 
H2O, brine, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
= 3/1) to give 60 (0.76 g, 75%) as an oil: 
1
H NMR (300 MHz, CDCl3)  7.07 (t, J = 7.5 Hz, 1H), 
6.91 (d, J = 7.5 Hz, 1H), 6.75 (d, J = 7.5 Hz, 1H), 6.71 (d, J = 7.5 Hz, 1H), 3.61 (br, 2H), 1.89 (s, 
3H), 1.83 (s, 3H), 1.52 (s, 3H).  
4-Methyl-N-(2-(3-methylbut-2-en-2-yl)phenyl)benzenesulfonamide (62).  To a 
solution of aniline 60 (370 mg, 2.2 mmol) and p-tosyl chloride (504 mg, 2.64 mmol) in CH2Cl2 
(10 mL) was added Et3N (668 mg, 6.6 mmol), and the mixture was stirred at rt for 30 min.  
Saturated aqueous NH4Cl solution (10 mL) was added, and the mixture was extracted with Et2O.  
The extracts were combined, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 10/1) to give 62 (390 mg, 56%) as a solid: 
1
H NMR (300 MHz, CDCl3) 
 7.69 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 1H), 7.26–7.15 (m, 3H), 7.04 (t, J = 7.2 Hz, 1H), 
6.90 (d, J = 7.2 Hz, 1H), 6.62 (s, 1H), 2.36 (s, 3H), 1.80 (s, 3H), 1.53 (s, 3H), 1.32 (s, 3H).  
2,2,3-Trimethyl-1-p-tosylindoline (63).  To a solution of CF3COOH (199 mg, 1.75 
mmol) and Et3SiH (203 mg, 1.75 mmol) in CH2CH2 (1 mL) was added a drop of CF3SO3H at 0 
°C, followed by a solution of amide 62 (370 mg, 1.16 mmol) in CH2CH2 (2 mL), and the mixture 
was stirred at rt for 10 min.  The solvent was evaporated under reduced pressure, and the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 10/1) to 
give 63 (345 mg, 95%): 
1
H NMR (300 MHz, CDCl3)  7.79 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.1 
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Hz, 1H), 7.26–7.21 (m, 2H), 7.17 (t, J = 7.5 Hz, 1H), 7.10 (d, J = 7.2 Hz, 1H), 7.00 (t, J = 7.5 
Hz, 1H), 3.02 (q, J = 6.9 Hz, 1H), 2.38 (s, 3H), 1.64 (s, 3H), 1.39 (s, 3H), 1.16 (d, J = 6.9 Hz, 
3H).  
N-(2-(3-Methylbut-2-en-2-yl)phenyl)acetamide (64).  To a solution of aniline 60 (430 
mg, 2.62 mmol) and Et3N (478 mg, 4.72 mmol) in CH2Cl2 (10 mL) was added acetyl chloride 
(309 mg, 3.93 mmol) slowly, and the mixture was stirred at rt for 30 min.  Saturated aqueous 
NH4Cl solution (10 mL) was added, and the organic layer was separated, washed with H2O, 
brine, dried over MgSO4 and filtered.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to 
give 64 (540 mg, 100%) as an oil: 
1
H NMR (300 MHz, CDCl3)  8.22 (d, J = 8.1 Hz, 1H), 7.42 
(br, 1H), 7.28 (t, J = 7.5 Hz, 1H), 7.15 (t, J = 7.5 Hz, 1H), 7.05 (d, J = 6.6 Hz, 1H), 2.23 (s, 3H), 
1.91 (s, 3H), 1.89 (s, 3H), 1.49 (s, 3H).  
Resolution of 2-(3-methylbutan-2-yl)benzenamine 65 and 66.  To a solution of 
racemic 2-(3-methylbutan-2-yl)benzenamine (820 mg, 5.0 mmol), (S)-2-(6-methoxynaphthalen-
2-yl)propanoic acid (1265 mg, 5.5 mmol) and 1-hydroxybenzotriazole (HOBT) (744 mg, 5.5 
mmol) in CH2Cl2 (45 mL) was added a solution of DCC (1139 mg, 5.5 mmol) in CH2Cl2 (5 mL) 
slowly at 0 °C for 30 min.  After being warned to rt slowly in 30 min, the mixture was filtered.  
After removal of volatile components from the filtrate, the crude product was purified by flash 
chromatography (SiO2, CH2Cl2) to give (2S)-2-(6-methoxynaphthalen-2-yl)-N-(2-(3-
methylbutan-2-yl)phenyl)propanamide (1.32 g, 71%) as a white solid.  This amide  was 
recrystallized (CH2Cl2/hexanes = 1/5) several times (the purity was determined by the 
1
H NMR 
spectroscopy) to give (S)-2-(6-methoxynaphthalen-2-yl)-N-(2-((S)-3-methylbutan-2-yl)phenyl) 
propanamide as a crystal (the configuration of the amide was determined by the X-ray 
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diffraction): mp 147–148 °C; [α]23D +53 (c 3.76, CH2Cl2); IR (cm
-1
) 3267, 2966, 1651, 1515, 
1029, 764; 
1
H NMR (300 MHz, CDCl3)  7.80–7.72 (m, 4H), 7.46 (dd, J = 8.4, 1.5 Hz, 1H), 
7.20–7.11 (m, 3H), 7.09–7.02 (m, 2H), 7.00 (br, 1H), 3.95–3.88 (m, 4H), 1.81–1.74 (m, 1H), 
1.73 (d, J = 7.2 Hz, 3H), 1.36–1.26 (m, 1H), 0.89 (d, J = 6.9 Hz, 3H), 0.48 (d, J = 6.6 Hz, 3H), 
0.33 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  172.7, 158.2, 138.7, 136.3, 134.8, 134.2, 
129.4, 129.3, 128.2, 127.0, 126.7, 126.5, 126.2, 125.5, 123.8, 119.7, 105.9, 55.5, 48.2, 40.2, 33.6, 
21.2, 19.5, 18.1, 18.0; HRMS (ES) m/e calcd for C25H29NO2 (MNa
+
) 398.2096, found 398.2059; 
(S)-2-(6-methoxynaphthalen-2-yl)-N-(2-((R)-3-methylbutan-2-yl)phenyl)propanamide as a 
feather-like white solid: [α]23D +17 (c 1.7, CH2Cl2); 
1
H NMR (300 MHz, CDCl3)  7.83–7.73 (m, 
4H), 7.47 (d, J = 8.4 Hz, 1H), 7.21–7.11 (m, 3H), 7.08–7.04 (m, 2H), 6.97 (br, 1H), 3.97–3.90 
(m, 4H), 1.89–1.76 (m, 1H), 1.75 (d, J = 7.2 Hz, 3H), 1.38–1.27 (m, 1H), 0.90 (d, J = 6.9 Hz, 
3H), 0.50 (d, J = 6.6 Hz, 3H), 0.30 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  172.7, 
158.2, 138.2, 136.1, 134.8, 134.3, 129.4, 129.3, 128.3, 127.0, 126.7, 126.6, 126.3, 125.3, 123.5, 
119.7, 105.9, 55.6, 48.3, 40.2, 33.5, 21.2, 19.4, 18.0, 17.8.  
A solution of (S)-2-(6-methoxynaphthalen-2-yl)-N-(2-((R)-3-methylbutan-2-yl)phenyl) 
propanamide (490 mg, 1.3 mmol) and NaOH (2080 mg, 52 mmol) in EtOH (13 mL) was 
refluxed at 100 °C for 40 h and concentrated under reduced pressure.  H2O was added, and the 
mixture was extracted with hexanes.  The extracts were combined, dried over MgSO4 and 
filtered.  After removal of volatile components from the filtrate, the crude product was purified 
by flash chromatography (SiO2, Et2O/hexanes = 1/2) to give aniline 65 (172 mg, 81%) as an oil: 
[α]23D +3.8 (c 1.64, CH2Cl2); HPLC, Chiralcel OD-H, hexanes/i-PrOH = 95/5, flow rate = 0.95 
mL/min, detection at 254 nm, tR = 7.68 min (minor), 8.20 min (major), ee = 95%. 
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By the same procedure as aniline 65, (S)-2-(6-methoxynaphthalen-2-yl)-N-(2-((S)-3-
methylbutan-2-yl)phenyl)propanamide (410 mg, 1.09 mmol) and NaOH (2180 mg, 54.5 mmol) 
in EtOH (12 mL) at 100 °C for 40 h provided aniline 66 (160 mg, 90%) as an oil: [α]23D -2.3 (c 
5.4, CH2Cl2); HPLC, Chiralcel OD-H, hexanes/i-PrOH = 95/5, flow rate = 0.95 mL/min, 
detection at 254 nm, tR = 7.68 min (major), 8.20 min (minor), ee = 98%. 
N1,N2-Di((R)-1-(3-methylbutan-2-yl))phenylethane-1,2-diamine (67).  To a solution 
of aniline 65 (172 mg, 1.05 mmol) in PrOH (0.7 mL) was added a solution of glyoxal (40% H2O 
solution, 76 mg, 0.524 mmol) in PrOH (0.1 mL) and H2O (0.23 mL), and the mixture was stirred 
at rt for 5 h.  Hexanes was added, and the organic layer was separated, washed with H2O, dried 
over MgSO4 and filtered.  After removal of volatile components from the filtrate, the crude 
product was dissolved in THF (1.5 mL) and EtOH (1.5 mL).  NaBH4 (93 mg, 2.47 mmol) was 
added slowly at 0 °C in 1 h, and the resulting mixture was stirred at rt for 4 h.  H2O (0.3 mL) was 
added, followed by HCl (3 M, 2.5 mL), and the resulting white precipitate was collected and 
dissolved in a mixture of NaOH (1 M, 10 mL) and Et2O (10 mL).  The organic layer was 
separated, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the crude product was purified by flash chromatography (SiO2, EtOAc/hexanes = 1/10) 
to give 67 (152 mg, 83%) as an oil: [α]23D +1.7 (c 7.7, CH2Cl2); HPLC, Chiralcel OD-H, 
hexanes/i-PrOH = 95/5, flow rate = 0.95 mL/min, detection at 254 nm, tR = 5.98 min (major), 
6.58 min (minor), ee = 99%; 
1
H NMR (300 MHz, CDCl3)  7.15–7.07 (m, 4H), 6.79–6.72 (m, 
4H), 3.90 (br, 2H), 3.50–3.43 (m, 4H), 2.49–2.40 (m, 2H), 1.90–1.79 (m, 2H), 1.19 (d, J = 6.9 
Hz, 6H), 0.92 (d, J = 6.6 Hz, 6H), 0.83 (d, J = 6.6 Hz, 6H); 
13
C NMR (75 MHz, CDCl3)  145.4, 
132.0, 127.0, 126.7, 118.0, 111.2, 44.0, 39.5, 32.8, 21.8, 19.6, 17.4; HRMS (ES) m/e calcd for 
C24H37N2 (MH
+
) 353.2957, found 353.2939.  
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(S)-N1-(2-(3-Methylbutan-2-yl)phenyl)-N2-phenyloxalamide (68).  To a solution of 
aniline 66 (80 mg, 0.487 mmol), 2-anilino-2-oxoacetic acid (97 mg, 0.585 mmol) and HOBT (80 
mg, 0.585 mmol) in CH2Cl2 (6 mL) was added a solution of DCC (121 mg, 0.585 mmol) in 
CH2Cl2 (4 mL) slowly in 10 min, and the resulting precipitate was filtered.  After removal of 
volatile components from the filtrate, the crude product was purified by flash chromatography 
(SiO2, EtOAc/hexanes = 1/3) to give 68 (151 mg, 100%) as a white solid: [α]
23
D +2.5 (c 1.6, 
CH2Cl2); IR (cm
-1
) 3269, 1666, 1512, 1444, 756; 
1
H NMR (300 MHz, CDCl3)  9.49 (br, 1H), 
9.39 (br, 1H), 8.00–7.96 (m, 1H), 7.71 (d, J = 7.8 Hz, 2H), 7.43 (t, J = 7.8 Hz, 2H), 7.30–7.20 
(m, 4H), 2.74–2.65 (m, 1H), 1.90–1.79 (m, 1H), 1.29 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.6 Hz, 
3H), 0.85 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  158.1, 157.9, 138.7, 136.5, 133.6, 
129.5, 127.7, 126.7, 126.4, 125.8, 122.8, 120.1, 40.7, 34.3, 21.4, 20.0, 18.2; HRMS (EI) m/e 
calcd for C19H22N2O2 (M
+
) 310.1681, found 310.1679.  
N1-(S)-2-(3-Methylbutan-2-yl)phenyl-N2-phenylethane-1,2-diamine (69).  A mixture 
of diamide 68 (150 mg, 0.482 mmol) and BH3 (1M in THF, 3.86 mL, 3.86 mmol) was refluxed 
for 20 h.  After being cooled to rt, MeOH (2 mL) was added, and the resulting mixture was 
stirred for 10 min.  After removal of volatile components from the mixture, the crude product 
was purified by flash chromatography (SiO2, EtOAc/hexanes = 1/5) to give 69 (132 mg, 97%) as 
an oil: [α]23D -8.1 (c 1.75, CH2Cl2); HPLC, Chiralcel OD-H, hexanes/i-PrOH = 95/5, flow rate = 
1.0 mL/min, detection at 254 nm, tR = 14.40 min (major), 17.16 min (minor), ee = 99%; IR (cm
-
1
) 3408, 2960, 1602, 1504, 1310, 1257, 748; 
1
H NMR (300 MHz, CDCl3)  7.23–7.17 (m, 2H), 
7.14–7.07 (m, 2H), 6.78–6.65 (m, 5H), 3.88 (br, 2H), 3.43 (br, 4H), 2.49–2.39 (m, 1H), 1.90–
1.75 (m, 1H), 1.19 (d, J = 6.9 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H); 
13
C 
NMR (75 MHz, CDCl3)  148.3, 145.3, 132.0, 129.6, 127.0, 126.7, 118.0, 117.9, 113.3, 111.2, 
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43.9, 43.4, 39.2, 33.0, 21.8, 19.6, 17.2; HRMS (EI) m/e calcd for C19H26N2 (M
+
) 282.2096, found 
282.2087.  
N-(2-Bromophenyl)-N-((S)-1-phenylethyl)-acetamide (70).  A solution of (S)-2-bromo-
N-(1-phenylethyl)-aniline (552 mg, 2.0 mmol) and NaH (60% in mineral oil, 82 mg, 2.04 mmol) 
in THF (20 mL) was stirred at 50 °C for 10 min and cooled to room temperature.  Acetyl 
chloride (171 μL, 2.4 mmol) was added drop wise, and the resulting mixture was stirred for 16 h.  
After being quenched with saturated NH4Cl solution (H2O), the mixture was extracted with Et2O.  
The extracts were combined, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 3/1) to provide 70 (421 mg, 66%) as an oil: IR (cm
-1
) 3493, 3306, 2978, 
1662, 1382, 1310, 1091, 1030, 772, 728; 
1
H NMR (500 MHz, CDCl3)  7.70 (dd, J = 7.5, 1.0 
Hz, 0.7H), 7.47 (dd, J = 8.0, 1.5 Hz, 0.3H), 7.40 (td, J = 7.5, 1.5 Hz, 0.3H), 7.33–7.28 (m, 3.7H), 
7.20–7.07 (m, 3.3H), 6.45 (dd, J = 8.0, 1.5 Hz, 0.7H), 6.31 (q, J = 7.5 Hz, 0.7H), 5.96 (q, J = 7.0 
Hz, 0.3H), 1.82 (s, 2.1H), 1.80 (s, 0.9H), 1.66 (d, J = 7.0 Hz, 0.9H), 1.40 (d, J = 7.0 Hz, 2.1H); 
13
C NMR (75 MHz, CDCl3)  170.6, 170.1, 142.4, 139.3, 139.0, 138.9, 134.0, 133.9, 131.8, 
131.7, 129.8, 129.4, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 126.6, 126.4, 55.7, 53.2, 
23.6, 23.4, 19.8, 16.4; HRMS (ES) m/e calcd for C16H17NOBr (MH
+
) 318.0494, found 318.0482.  
N-(2-Bromophenyl)-N-((S)-1-phenylethyl)-phenylacetamide (71).  A solution of (S)-2-
bromo-N-(1-phenylethyl)-aniline (670 mg, 2.42 mmol) and NaH (60% in mineral oil, 99 mg, 
2.47 mmol) in THF (20 mL) was stirred at 50 °C for 10 min and cooled to room temperature.  2-
Phenylacetyl chloride (0.38 mL, 2.91 mmol) was added drop wise, and the reulting mixture was 
stirred for 24 h.  After being quenched with saturated NH4Cl solution (H2O), the mixture was 
extracted with Et2O.  The extracts were combined, dried over MgSO4 and filtered.  After removal 
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of volatile components from the filtrate, the resulting crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc = 10/1) to afford 71 (756 mg, 79%) as an oil: IR (cm
-1
) 
3030, 2979, 1731, 1660, 1473, 1383, 1240, 1030, 769, 727; 
1
H NMR (300 MHz, CDCl3)  7.76 
(dd, J = 8.1, 1.5 Hz, 0.7H), 7.53 (dd, J = 7.8, 1.5 Hz, 0.3H), 7.34–7.01 (m, 12.3H), 6.37 (q, J = 
7.2 Hz, 0.7H), 6.29 (dd, J = 7.8, 1.5 Hz, 0.7H),  6.01 (q, J = 7.2 Hz, 0.3H), 3.56 (d, J = 15.3 Hz, 
0.7H), 3.50 (d, J = 15.3 Hz, 0.3H), 3.29 (d, J = 15.0 Hz, 0.7H), 3.28 (d, J = 15.3 Hz, 0.3H), 1.67 
(d, J = 6.9 Hz, 0.9H), 1.43 (d, J = 7.2 Hz, 2.1H); 
13
C NMR (75 MHz, CDCl3)  171.1, 170.5, 
142.3, 139.0, 138.6, 138.1, 135.3, 135.2, 133.9, 133.8, 132.4, 129.9, 129.4, 129.3, 128.4, 128.3, 
128.0, 127.9, 127.9, 127.8, 127.6, 126.7, 126.5, 56.2, 53.5, 42.6, 42.5, 19.7, 16.4; HRMS (ES) 
m/e calcd for C22H21NOBr (MH
+
) 394.0807, found 394.0816.  
Gold, [1,3-bis[2,6-diisopropylphenyl]-2-imidazolidinylidene]chloro- (72).
93
 A solution 
of 1,3-Bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate (4.8 mg, 0.01 
mmol), AuCl·SMe2 (3.1 mg, 0.0105 mol) and NaH (0.26 mg, 0.0105 mmol) in CH2Cl2 (1 mL) 
covered by aluminum foil was stirred at rt for 18 h and filtered through celite.  After removal of 
volatile components from the filtrate, the resulting crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc = 3/1) to give 72 (80%) as a white solid:  
1
H NMR (300 
MHz, CDCl3)  7.44 (t, J = 7.8 Hz, 2H), 7.28 (d, J = 7.8 Hz, 4H), 4.08 (s, 4H), 3.15 (heptet, J = 
6.6 Hz, 4H), 1.43 (d, J = 6.6 Hz, 12H), 1.35 (d, J = 6.6 Hz, 3H). 
Gold, [1,3-bis(2-cyclohexylphenyl)-(4R,5R)-4,5-diphenylimidazolidinylidene]chloro- 
(73).  A solution of imidazolinium salt 48d (300 mg, 0.32 mmol), AuCl·SMe2 (100 mg, 0.352 
mmol) and NaH (12 mg, 0.48 mmol) in CH2Cl2 (10 mL) covered by aluminium foil was stirred 
at rt for 18 h and filtered through celite.  To the filtrate was added activated carbon, and the 
mixture was stirred for 20 min and filtered through celite.  After removal of volatile components 
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from the filtrate, the resulting crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 3/1) to give 73 (179 mg, 73%) as a white solid: IR (cm
-1
) 2926, 2850, 1468, 
911, 732; 
1
H NMR (300 MHz, CDCl3)  7.40–7.19 (m, 15.5H), 7.05–6.85 (m, 2.5H), 5.40–5.34 
(m, 0.6H), 5.28–5.21 (m, 0.5H), 5.12 (s, 0.9H), 3.16–3.09 (m, 0.5H), 2.97–2.94 (m, 0.9H), 2.72–
2.66 (m, 0.5H), 2.55–2.52 (m, 0.7H), 2.35–2.31 (m, 1.4H), 2.08–0.86 (m, 18H); 13C NMR (75 
MHz, CDCl3)  194.1, 194.0, 146.4, 145.0, 138.1, 137.8, 137.1, 136.7, 135.9, 131.2, 131.1, 
129.7, 129.6, 129.4, 129.3, 128.8, 128.4, 128.0, 127.9, 127.8, 127.7, 127.0, 126.7, 79.5, 78.8, 
39.4, 39.2, 38.8, 35.0, 34.9, 34.6, 34.5, 27.8, 27.5, 27.3, 27.2, 27.0, 26.4, 26.3; HRMS (ES) m/e 
calcd for C39H42N2Au (M
+
Cl) 735.3014, found 735.3038.  
Gold, [1,3-bis(2-methyl-3-phenylphenyl)-(4R,5R)-4,5-diphenylimidazolidinylidene] 
chloro- (74).  A solution of imidazolinium salt 48h (97 mg, 0.15 mmol), AuCl·SMe2 (49 mg, 
0.165 mol) and NaH (27 mg, 1.125 mmol) in CH2Cl2 (5 mL) covered by aluminum foil was 
stirred at rt for 16 h and filtered through celite.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
= 2/1) to give 74 (107 mg, 91%) as a white solid: IR (cm
-1
) 3061, 3032, 2236, 1473, 911, 762, 
727; 
1
H NMR (300 MHz, CDCl3)  7.40–7.23 (m, 20H), 7.23–7.04 (m, 6H), 5.41–5.31 (br, 2H), 
2.42 (br, 4H), 2.06 (br, 2H); 
13
C NMR (75 MHz, CDCl3)  194.1, 144.7, 144.1, 141.1, 138.0, 
137.6, 135.8, 134.4, 132.5, 130.7, 130.4, 129.6, 129.4, 128.3, 127.7, 127.4, 126.4, 125.0, 78.9, 
75.0, 60.5, 21.2, 17.4, 17.0, 14.4; HRMS (ES) m/e calcd for C41H34N2Au (M
+
Cl) 751.2388, 
found 751.2418.  
Gold, [1,3-bis[2-(R)-1-(3-methylbutan-2-yl)phenyl] imidazolidinylidene]chloro- (75).  
A solution of imidazolinium salt 56 (4.5 mg, 0.01 mmol), AuCl·SMe2 (3.5 mg, 0.012 mol) and 
NaOt-Bu (1.5 mg, 0.015 mmol) in CH2Cl2 (0.6 mL) covered by aluminum foil was stirred at rt 
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for 10 min and filtered through celite.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to 
give 75 (2 mg, 34%) as a white solid: 
1
H NMR (300 MHz, CDCl3)  7.38–7.28 (m, 8H), 4.20–
3.93 (m, 4H), 2.70–2.55 (m, 1.78H), 2.36 (br, 0.22H), 1.98–1.82 (m, 2H),  1.46–0.76 (m, 18H). 
Gold, [1,3-bis[4-(2,6-bis(2-(1S,2S,5S)-myrtylethyl))phenyl-2,6-diisopropylphenyl] 
imidazolidinylidene]chloro- (76).  A solution of imidazolinium salt 45 (142 mg, 0.115 mmol), 
AuCl·SMe2 (38 mg, 0.127 mol) and NaOt-Bu (33 mg, 0.345 mmol) in CH2Cl2 (2 mL) covered 
by aluminum foil was stirred at rt for 30 min and filtered through celite.  After removal of 
volatile components from the filtrate, the resulting crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc = 10/1) to give 76 (121 mg, 77%) as a white solid: 
1
H 
NMR (300 MHz, CDCl3)  7.26–7.20 (m, 2H), 7.13–7.09 (m, 8H), 4.14 (s, 4H), 3.18 (heptet, J = 
6.6 Hz, 4H), 2.39–2.20 (m, 8H), 1.96–0.74 (m, 92H); 13C NMR (75 MHz, CDCl3)  146.3, 
142.1, 142.0, 141.0, 140.8, 132.8, 127.7, 127.0, 126.6, 126.4, 126.3, 53.8, 46.5, 46.1, 41.4, 41.2, 
39.8, 39.6, 39.4, 38.8, 35.1, 34.7, 32.4, 31.8, 29.3, 27.1, 27.0, 25.3, 25.2, 24.8, 24.6, 24.5, 23.8, 
22.4, 22.2, 20.5, 20.3. 
N-(2-Bromobenzyl)-2-phenylpropanamide (78).  To a solution of (2-bromophenyl) 
methanamine (558 mg, 3 mmol) and Et3N (310 mg, 3.06 mmol) in CH2Cl2 (10 mL) was added a 
solution of 2-phenylpropanoyl chloride (518 mg, 3.06 mmol) in CH2Cl2 (5 mL) slowly at 0 °C, 
and the mixture was stirred at rt for 10 min.  Saturated aqueous NH4Cl solution was added, and 
the resulting mixture was extracted with Et2O.  The extracts were combined, washed with H2O, 
brine, dried over MgSO4 and filtered.  The filtrate was evaporated under reduced pressure to give 
78 (950 mg, 100%) as an oil which was used directly in the next step: IR (cm
-1
) 3287, 3063, 
1650, 1545, 1234, 1026, 747; 
1
H NMR (300 MHz, CDCl3)  7.50 (d, J = 7.8 Hz, 1H), 7.37–7.20 
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(m, 7H), 7.14–7.08 (m, 1H), 5.88 (br, 1H), 4.44 (dd, J = 6, 0.9 Hz, 2H), 3.63 (q, J = 7.2 Hz, 1H), 
1.55 (d, J = 7.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  174.3, 141.3, 137.4, 132.9, 130.2, 129.2, 
129.1, 127.9, 127.8, 127.6, 123.7, 47.3, 44.1, 18.6.  
N-(2-Bromobenzyl)-N-methyl-2-phenylpropanamide (79).  By the general procedure, 
amide 78 (475 mg, 1.5 mmol), NaH 60% in mineral oil (36 mg, 1.5 mmol), MeI (256 mg, 1.8 
mmol) in THF (7.5 mL) for 1 h afforded 79 (398 mg, 80%) as a white solid after flash 
chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 2927, 1642, 1404, 1288, 748; 
1
H NMR 
(300 MHz, CDCl3)  7.61 (dd, J = 7.2, 1.2 Hz, 0.48H), 7.53 (dd, J = 7.8, 1.2 Hz, 0.52H), 7.37–
7.11 (m, 6.5H), 7.11 (td, J = 7.5, 1.8 Hz, 0.5H), 7.00 (dd, J = 7.5, 1.5 Hz, 0.56H), 6.92 (d, J = 7.5 
Hz, 0.44H), 4.91 (d, J = 7.2 Hz, 0.5H), 4.84 (d, J = 18 Hz, 0.55H), 4.66 (d, J = 17.4 Hz, 0.5H), 
4.32 (d, J = 18 Hz, 0.45H), 4.00 (q, J = 6.6 Hz, 0.54H), 3.74 (q, J = 6.9 Hz, 0.46H), 3.00 (s, 
1.38H), 2.87 (s, 1.62H), 1.51 (d, J = 6.9 Hz, 1.62H), 1.44 (d, J = 6.9 Hz, 1.38H); HRMS (EI) m/e 
calcd for C17H18NOBr (M
+
) 331.0572, found 331.0579.  
N-(2-Bromobenzyl)-N-benzyl-2-phenylpropanamide (80).  By the general procedure, 
amide 78 (475 mg, 1.5 mmol), NaH 60% in mineral oil (36 mg, 1.5 mmol), BnBr (308 mg, 1.8 
mmol) in THF (7.5 mL) for 2 h afforded 80 (478 mg, 78%) as an oil after flash chromatography 
(SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 2973, 1653, 1452, 1214, 1028, 752; 
1
H NMR (300 MHz, 
CDCl3)  7.58 (dd, J = 7.8, 1.2 Hz, 0.54H), 7.49 (dd, J = 7.8, 1.2 Hz, 0.46H), 7.38–6.95 (m, 
13H), 5.21 (t, J = 15 Hz, 1H), 4.72 (d, J = 17.4 Hz, 0.46H), 4.64 (d, J = 18.6 Hz, 0.54H), 4.29–
4.12 (m, 2H), 3.93 (q, J = 6.6 Hz, 0.46H), 3.74 (q, J = 6.9 Hz, 0.54H), 1.50 (d, J = 6.9 Hz, 
1.38H), 1.47 (d, J = 6.9 Hz, 1.62H); 
13
C NMR (75 MHz, CDCl3)  174.9, 174.8, 141.8, 141.6, 
137.4, 136.8, 136.6, 136.0, 133.3, 133.0, 129.2, 129.1, 128.8, 128.7, 128.2, 128.0, 127.8, 127.7, 
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127.6, 127.3, 127.2, 127.1, 126.4, 123.7, 122.8, 50.8, 50.6, 49.5, 49.2, 43.6, 43.5, 21.2, 21.1; 
HRMS (ES) m/e calcd for C16H16NONaBr (MNa
+
) 340.0313, found 340.0288.  
2,4-Dimethyl-4-phenyl-1,2-dihydroisoquinolin-3(4H)-one (81).  A solution of 1,3-
bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate (3.6 mg, 0.0075 mmol), 
Pd2(dba)3 (3.5 mg, 0.00375 mmol) and NaOt-Bu (22 mg, 0.225 mmol) in THF (1 mL) was 
stirred at rt for 10 min.  A solution of amide 79 (25 mg, 0.075 mmol) in THF (0.5 mL) was 
added, and the mixture was degassed by an oil pump in a dry ice-acetone bath.  After being 
stirred at 120 °C for 2h, the mixture was cooled to rt and purified by flash chromatography 
(SiO2, hexanes/EtOAc = 3/1) to give 81 (7.2 mg, 38%) as an oil: 
1
H NMR (300 MHz, CDCl3)  
7.46–7.18 (m, 7H), 7.02–6.98 (m, 2H), 4.21–4.06 (m, 2H), 3.10 (s, 3H), 1.92 (s, 3H).     
N-(1-(2-Bromophenyl)vinyl)-N-methylacetamide (82).  A mixture of molecular sieves 
(0.5 g), 2-bromoacetophenone (100 mg, 0.5 mmol) and methylamine (2 M in MeOH, 1.5 mL, 3 
mmol) was stirred at rt for 12 h and filtered.  The filtrate was concentrated under reduced 
pressure, and the residue was dried by an oil pump.  CH2Cl2 (3 mL) and Et3N (61 mg, 0.6 mmol) 
was added at rt, followed by acetyl chloride (47 mg, 0.6 mmol) slowly at 0 °C, and the mixture 
was stirred at rt for 5 min, quenched with saturated aqueous NH4Cl solution and extracted with 
Et2O.  The extracts were combined, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 3/1) to give 82 (100 mg, 79%) as an oil: IR (cm
-1
) 3493, 3305, 2936, 
1660, 1373, 1025, 902, 768; 
1
H NMR (300 MHz, CDCl3)  7.61 (d, J = 7.8 Hz, 1H), 7.35–7.33 
(m, 2H), 7.24–7.19 (m, 1H), 5.38 (br, 1H), 5.30 (s, 1H), 2.97 (br, 3H), 2.18 (s, 3H); 13C NMR 
(75 MHz, CDCl3)  174.8, 141.8, 136.6, 136.0, 133.2, 133.0, 129.1, 129.0, 128.8, 128.7, 128.0, 
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127.8, 127.7, 127.6, 127.1, 127.0, 123.7, 122.7, 53.8, 51.32, 43.7, 43.4, 35.4, 35.0, 21.0; HRMS 
(EI) m/e calcd for C11H12NOBr (M
+
) 253.0102, found 253.0100.  
N-(1-(2-Bromophenyl)vinyl)-N-methyl-2-phenylpropanamide (83).  A mixture of 2-
bromoacetophenone (100 mg, 0.5 mmol), methylamine (2 M in MeOH, 1.5 mL, 3 mmol) and 
molecular sieves (0.5 g) was stirred at rt for 12 h and filtered.  The filtrate was concentrated 
under reduced pressure, and the residue was dried by an oil pump.  CH2Cl2 (2 mL) and Et3N (56 
mg, 0.55 mmol) was added at rt, followed by a solution of 2-phenylpropanoyl chloride (93 mg, 
0.55 mmol) in CH2Cl2 (1 mL) slowly at 0 °C, and the mixture was stirred at rt for 5 min, 
quenched with saturated aqueous NH4Cl solution and extracted with Et2O.  The extracts were 
combined, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
= 3/1) to give 83 (160 mg, 94%) as an oil:  IR (cm
-1
) 2970, 1657, 1376, 766; 
1
H NMR (300 
MHz, CDCl3)  7.60 (d, J = 8.4 Hz, 1H), 7.32-7.14 (m, 8H), 5.37 (br, 1H), 5.16 (s, 1H); 4.18 (br, 
1H), 3.03 (br, 3H), 1.43 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  134.1, 131.0, 130.2, 
127.8, 126.9, 43.6, 21.5; HRMS (EI) m/e calcd for C18H18NOBr (M
+
) 343.0572, found 343.0572.  
[1,1'-Biphenyl]-2-amine, 2'-bromo- (86).
94
  A solution of 2-iodoaniline (3.48 g, 15.89 
mmol), 2-bromophenylboronic acid (3.67 g, 18.27 mmol), Pd(PPh3)4 (550 mg, 0.48 mmol) and 
NaHCO3 (4.0 g, 47.7 mmol) in DME (45 mL) was stirred at rt for 5 min.  H2O (23 mL) was 
added, and the resulting mixture was degassed by an oil pump in a dry ice-acetone bath, sealed 
and stirred at 120 °C for 3 h.  After being cooled to rt, the mixture was extracted with Et2O.  The 
extracts were combined, dried over MgSO4 and filtered.  After removal of volatile components 
from the filtrate, the resulting crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 3/1) to give 86 (3.53 g, 90%) as a pale yellow solid:  
1
H NMR (300 MHz, 
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CDCl3)  7.72 (d, J = 8.1 Hz, 1H), 7.47–7.31 (m, 2H), 7.27–7.19 (m, 2H), 7.06 (dd, J = 7.5, 1.5 
Hz, 1H), 6.87 (td, J = 7.5, 0.9 Hz, 1H), 6.81 (dd, J = 8.1, 0.9 Hz, 1H), 3.54 (br, 2H); 
13
C NMR 
(75 MHz, CDCl3)  143.7, 140.2, 133.3, 132.0, 130.4, 129.4, 129.3, 128.0, 127.3, 124.4, 118.4, 
115.7.  
[1,1'-Biphenyl]-2-amine, 2'-chloro- (108).
95
  A solution of 2-bromoaniline (516 mg, 3.0 
mmol), 2-chlorophenylboronic acid (562 mg, 3.6 mmol), Pd(PPh3)4 (173 mg, 0.15 mmol) and 
NaHCO3 (756 mg, 9.0 mmol) in DME (7 mL) was stirred at rt for 5 min.  H2O (7 mL) was added, 
and the resulting mixture was degassed by oil pump in a dry ice-acetone bath, sealed and stirred 
at 120 °C for 2 h.  After being cooled to rt, the mixture was extracted with Et2O.  The extracts 
were combined, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
= 3/1) to provide 108 (501 mg, 82%) as a white solid: 
1
H NMR (300 MHz, CDCl3)  7.50 (m, 
1H), 7.38–7.23 (m, 3H), 7.22 (t, J = 7.2 Hz, 1H), 7.05 (d, J = 7.5 Hz, 1H), 6.84 (t, J = 7.5 Hz, 
1H), 6.77 (d, J = 8.1 Hz, 1H), 3.52 (br, 2H); 
13
C NMR (75 MHz, CDCl3)  143.9, 138.1, 134.0, 
133.1, 131.6, 131.0, 130.3, 129.5, 128.9, 128.4, 128.2, 128.1, 126.3, 125.4, 119.5, 117.3, 116.6, 
114.6. 
General Procedure for the Acylation of 2-Arylanilines with Acyl Chlorides.  To a 
solution of 2-arylaniline (2.0 mmol) and Et3N (0.34 mL, 2.4 mmol) in CH2Cl2 (10 mL) was 
added acyl chloride (2.4 mmol) slowly at 0 °C and stirred at rt for 5 min.  Saturated aqueous 
NH4Cl solution was added, and the resulting mixture was stirred for 10 min.  The organic layer 
was separated, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography.  
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[1,1'-Biphenyl]-2-acetamide, 2'-bromo- (87).  By the general procedure, aniline 86 (1.0 
g, 4.0 mmol), Et3N (0.67 mL, 4.8 mmol), acetyl chloride (0.34 mL, 4.8 mmol) in CH2Cl2 (20 mL) 
for 5 min provided 87 (1.15 g, 99%) as an oil after flash chromatography (SiO2, hexanes/EtOAc 
= 1/1): IR (cm
-1
) 3421, 3286, 3056, 1670, 1520, 1442, 1369, 1294, 1027, 1005, 754; 
1
H NMR 
(300 MHz, CDCl3)  8.18 (d, J = 8.1 Hz, 1H), 7.71–7.69 (m, 1H), 7.42–7.37 (m, 2H), 7.29–7.25 
(m, 2H), 7.21–7.13 (m, 2H), 6.86 (br, 1H), 1.96 (s, 3H); 13C NMR (75 MHz, CDCl3)  168.4, 
138.9, 135.1, 133.3, 132.0, 130.1, 130.0, 129.3, 129.1, 128.1, 124.4, 124.0, 122.2, 24.6; HRMS 
(EI) m/e calcd for C14H12NOBr (M
+
) 289.0102, found 289.0101.  
[1,1'-Biphenyl]-2-propionamide, 2'-bromo- (89).  By the general procedure, aniline 86 
(248 mg, 1.0 mmol), Et3N (0.17 mL, 1.2 mmol), propionyl chloride (0.10 mL, 1.2 mmol) in 
CH2Cl2 (10 mL) for 5 min provided 89 (278 mg, 92%) as an oil after flash chromatography (SiO2, 
hexanes/EtOAc = 3/1): IR (cm
-1
) 3296, 2976, 1672, 1442，754; 1H NMR (300 MHz, CDCl3)  
8.21 (d, J = 7.8 Hz, 1H), 7.70–7.67 (m, 1H), 7.41–7.34 (m, 2H), 7.28–7.22 (m, 2H), 7.18–7.11(m, 
2H), 6.92 (br, 1H), 2.20 (q, J = 7.5 Hz, 2H), 1.05 (t, J = 7.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) 
 171.8, 138.8, 135.1, 133.1, 131.9, 129.9, 129.0, 128.0, 124.1, 123.9, 121.9, 30.7, 9.5; HRMS 
(EI) m/e calcd for C15H14NOBr (M
+
) 303.0259, found 303.0270. 
[1,1'-Biphenyl]-2-methoxyacetamide, 2'-bromo- (90).  By the general procedure, 
aniline 86 (248 mg, 1.0 mmol), Et3N (0.17 mL, 1.2 mmol), methoxyacetyl chloride (0.11 mL, 1.2 
mmol) in CH2Cl2 (10 mL) for 5 min provided 90 (298 mg, 93%) as an oil after flash 
chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3369, 2936, 1693, 1526, 1303, 1111, 
757; 
1
H NMR (300 MHz, CDCl3)  8.37 (d, J = 8.1 Hz, 1H), 8.08 (br, 1H), 7.71–7.68 (m, 1H), 
7.46–7.37 (m, 2H), 7.29–7.24 (m, 2H), 7.17–7.14 (m, 2H), 3.84 (d, J = 1.2 Hz, 2H), 3.14 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  167.6, 138.5,134.5,133.0, 131.7, 131.5, 129.8, 129.7, 129.0, 127.9, 
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124.2, 124.0, 120.9, 72.1, 59.3; HRMS (EI) m/e calcd for C15H14NO2Br (M
+
) 319.0208, found 
319.0207. 
[1,1'-Biphenyl]-2-isobutyramide, 2'-bromo- (91).  By the general procedure, aniline 86 
(248 mg, 1.0 mmol), Et3N (0.17 mL, 1.2 mmol), isobutyryl chloride (0.13 mL, 1.2 mmol) in 
CH2Cl2 (10 mL) for 5 min provided 91 (289 mg, 91%) as an oil after flash chromatography (SiO2, 
hexanes/EtOAc = 3/1): IR (cm
-1
) 3424, 3298, 2968, 1676, 1517, 1285, 754; 
1
H NMR (300 MHz, 
CDCl3)  8.22 (d, J = 8.1 Hz, 1H), 7.72–7.67 (m, 1H), 7.43–7.36 (m, 2H), 7.29–7.24 (m, 2H), 
7.19–7.12 (m, 2H), 6.92 (br, 1H), 2.36 (heptet, J = 6.9 Hz, 1H), 1.06 (d, J = 6.9 Hz, 3H), 1.03 (d, 
J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  174.8, 138.8, 135.1, 133.1, 132.0, 131.9, 129.9, 
129.7, 129.0, 128.0, 124.2, 123.9, 121.9, 36.5, 19.3; HRMS (EI) m/e calcd for C16H16NOBr (M
+
) 
317.0415, found 317.0410. 
[1,1'-Biphenyl]-2-acetamide, 2'-chloro- (109).  By the general procedure, aniline 108 
(475 mg, 2.33 mmol), Et3N (0.39 mL, 2.8 mmol), acetyl chloride (0.2 mL, 2.8 mmol) in CH2Cl2 
(10 mL) for 5 min provided 109 (570 mg, 99%) as an oil after flash chromatography (SiO2, 
hexanes/EtOAc = 3/1): IR (cm
-1
) 3421, 3283, 3058, 1670, 1521, 1442, 1293, 1036, 754; 
1
H 
NMR (300 MHz, CDCl3)  8.09 (d, J = 8.1 Hz, 1H), 7.49–7.46 (m, 1H), 7.39–7.23 (m, 4H), 
7.18–7.15 (m, 2H), 7.10 (br, 1H), 1.91 (s, 3H); 13C NMR (75 MHz, CDCl3)  168.4, 136.7, 135.2, 
133.5, 131.9, 130.5, 130.2, 129.8, 129.6, 128.8, 127.3, 124.4, 122.5, 24.2; HRMS (EI) m/e calcd 
for C14H12NOCl (M
+
) 245.0607, found 245.0610. 
[1,1'-Biphenyl]-2-(2-chloroacetamide), 2'-bromo- (120).  By the general procedure, 
aniline 86 (124 mg, 0.5 mmol), Et3N (60.7 mg, 0.6 mmol), 2-chloroacetyl chloride (68 mg, 0.6 
mmol) in CH2Cl2 (5 mL) for 10 min provided 120 (167 mg, 100%) as an oil after flash 
chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3378, 3058, 1689, 1529, 1446, 1307, 
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756; 
1
H NMR (300 MHz, CDCl3)  8.27 (d, J = 8.4 Hz, 1H), 8.08 (br, 1H), 7.73-7.70 (m, 1H), 
7.46-7.39 (m, 2H), 7.31-7.26 (m, 2H), 7.24-7.18 (m, 2H), 4.06 (m, 2H); 
13
C NMR (75 MHz, 
CDCl3)  163.7, 138.2, 134.3, 133.3, 132.2, 131.8, 130.2, 130.0, 129.2, 128.2, 125.1, 124.1, 
121.1, 43.1; HRMS (EI) m/e calcd for C14H11NOClBr (M
+
) 322.9713, found 322.9719.  
[1,1'-Biphenyl]-2-phenylacetamide, 2'-bromo- (88).  To a solution of aniline 86 (350 
mg, 1.4 mmol), phenylacetic acid (209 mg, 1.54 mmol) and 1-hydroxybenzotriazole (HOBT) 
(209 mg, 1.54 mmol) in CH2Cl2 (10 mL) was added a solution of DCC (318 mg, 1.54 mmol) in 
CH2Cl2 (4 mL) slowly at rt in 1 h, stirred for 36 h and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 3/1) to give 88 (490 mg, 96%) as an oil: IR (cm
-1
) 3381, 3307, 3060, 
1685, 1519, 1443, 1303, 754; 
1
H NMR (300 MHz, CDCl3) major conformer:  8.32 (d, J = 8.1 
Hz, 1H), 7.48 (dd, J = 7.5, 1.5 Hz, 1H), 7.41 (td, J = 7.2, 1.5 Hz, 1H), 7.25–7.08 (m, 6H), 7.13–
6.93 (m, 4H), 6.80 (br, 1H), 3.59 (s, 1H), 3.58 (s, 1H); 
13
C NMR (75 MHz, CDCl3)  169.0, 
138.3, 135.0, 133.7, 133.2, 131.6, 131.2, 129.7, 129.4, 129.3, 129.1, 127.8, 127.6, 124.2, 123.8, 
121.0, 45.1; HRMS (EI) m/e calcd for C20H16NOBr (M
+
) 365.0415, found 365.0410. 
[1,1'-Biphenyl]-2-benzyloxyacetamide, 2'-bromo- (92).  To a solution of aniline 86 
(744 mg, 3.0 mmol), benzyloxyacetic acid (600 mg, 3.6 mmol) and HOBT (492 mg, 3.6 mmol) 
in CH2Cl2 (24 mL) was added a solution of DCC (750 mg, 3.6 mmol) in CH2Cl2 (6 mL) slowly 
at rt in 1 h, stirred for 1 h and filtered.  After removal of volatile components from the filtrate, 
the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) 
to give 92 (1.11 g, 94%) as an oil: IR (cm
-1
) 3376, 3065, 2869, 1693, 1526, 1026, 738; 
1
H NMR 
(300 MHz, CDCl3)  8.41 (d, J = 8.1 Hz, 1H), 8.20 (br, 1H), 7.55 (dd, J = 8.1, 0.9 Hz, 1H), 7.44–
7.37 (m, 1H), 7.33–7.09 (m, 8H), 7.06–6.98 (m, 2H), 4.39–4.29 (m, 2H), 4.03–3.91 (m, 2H); 13C 
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NMR (75 MHz, CDCl3)  167.5, 138.5, 136.6, 134.6, 133.1, 131.7, 131.5, 129.9, 129.2, 128.5, 
128.0, 127.9, 127.6, 124.3, 124.0, 120.9, 73.2, 69.7; HRMS (EI) m/e calcd for C21H18NO2Br 
(M
+
) 395.0521, found 395.0538. 
[1,1'-Biphenyl]-2-dibenzylaminoacetamide, 2'-bromo- (94).  To a solution of aniline 
86 (124 mg, 0.5 mmol), dibenzylaminoacetic acid (153 mg, 0.6 mmol) and HOBT (82 mg, 0.6 
mmol) in CH2Cl2 (4 mL) was added a solution of DCC (125 mg, 0.6 mmol) in CH2Cl2 (1 mL) at 
rt in 1 h, stirred for 72 h and filtered.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to 
give 94 (176 mg, 73%) as an oil: IR (cm
-1
) 3336, 3061, 3029, 2923, 2831, 2246, 1692, 1583, 
1514, 1445, 910, 750; 
1
H NMR (300 MHz, CDCl3)  8.73 (s, 1H), 8.39 (d, J = 8.4 Hz, 1H), 7.82 
(dd, J = 7.2, 0.6 Hz, 1H), 7.54 (td, J = 6.9, 1.2 Hz, 1H), 7.43–7.33 (m, 3H), 7.31–7.19 (m, 6H), 
7.17–7.13 (m, 2H), 6.99–6.94 (m, 4H), 3.52 (d, J = 13.5 Hz, 2H), 3.44 (d, J = 13.5 Hz, 2H), 3.18 
(d, J = 16.5 Hz, 1H), 3.04 (d, J = 16.5 Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  169.3, 139.4, 
136.9, 135.2, 133.4, 132.1, 131.4, 130.3, 130.1, 129.2, 129.1, 128.7, 128.0, 127.6, 124.7, 124.1, 
121.2, 58.9, 57.6; HRMS (EI) m/e calcd for C28H26N2OBr (MH
+
) 485.1228, found 485.1217. 
[1,1'-Biphenyl]-2-(2-(4-nitrobenzyloxy)-acetamide), 2'-bromo- (93).  To a solution of 
aniline 86 (248 mg, 1 mmol), 4-nitrobenzyloxyacetic acid (254 mg, 1.2 mmol) and HOBT (163 
mg, 1.2 mmol) in CH2Cl2 (10 mL) was added DCC (248 mg, 1.2 mmol) at rt slowly, and the 
mixture was stirred for 4 h and filtered.  After removal of volatile components from the filtrate, 
the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 1/1) 
to give 93 (420 mg, 96%) as a white solid: IR (cm
-1
) 3360, 2904, 1687, 1522, 1347, 1108, 768; 
1
H NMR (300 MHz, CDCl3)  8.41 (d, J = 8.1 Hz, 1H), 8.17–8.13 (m, 3H), 7.54 (d, J = 8.1 Hz, 
1H), 7.43 (td, J = 8.1, 1.5 Hz, 1H), 7.37 (t, J = 8.4 Hz, 1H), 7.28 (dd, J = 7.8, 1.8 Hz, 1H), 7.22–
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7.11 (m, 5H), 4.56–4.45 (m, 2H), 4.12–4.02 (m, 2H); 13C NMR (75 MHz, CDCl3)  166.7, 
147.4, 144.1, 138.4, 134.3, 132.8, 131.8, 131.3, 129.9, 129.8, 129.1, 127.9, 127.4, 124.4, 123.8, 
123.7, 123.6, 120.8, 71.8, 70.2; HRMS (EI) m/e calcd for C21H17N2O4Br (M
+
) 440.0372, found 
440.0370.  
General Procedure for the Methylation of Amides with Methyl Iodide.  A mixture of 
amide (1.0 mmol) and NaH 60% in mineral oil (42 mg, 1.05 mmol) was added THF (10 mL) at rt 
and stirred for 10 min.  MeI (0.075 mL, 1.2 mmol) was added, and the resulting mixture was 
stirred for 10 min.  After removal of volatile components from the mixture, the resulting crude 
product was purified by flash chromatography. 
[1,1'-Biphenyl]-2-(N-methyl-acetamide), 2'-bromo- (95).  By the general procedure, 
amide 87 (1.01 g, 3.48 mmol), NaH 60% in mineral oil (147 mg, 3.65 mmol), MeI (593 mg, 4.18 
mmol) in THF (25 mL) for 10 min afforded 95 (1.05 g, 99%) as a white solid after flash 
chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 3066, 1658, 1467, 1373, 757; 
1
H NMR 
(300 MHz, CDCl3)  7.69–7.63 (m, 1H), 7.48–7.38 (m, 2H), 7.38–7.30 (m, 2H), 7.29–7.09 (m, 
3H), 3.09 (s, 1.04H), 2.96 (s, 0.31H), 2.84 (s, 1.65H), 2.17 (s, 0.14H), 2.01 (s, 0.32H), 1.98 (s, 
1.54H), 1.86 (s, 1.0H); 
13
C NMR (75 MHz, CDCl3)  171.3, 170.5, 142.7, 142.3, 142.0, 139.3, 
138.8, 133.6, 133.3, 132.7, 132.5, 131.9, 131.4, 130.3, 129.7, 129.5, 129.4, 129.3, 128.7, 128.5, 
128.4, 127.9, 127.7, 127.3, 123.5, 123.3, 77.43, 38.9, 38.4, 36.0, 31.1, 22.7, 22.0; HRMS (EI) 
m/e calcd for C15H14NOBr (M
+
) 303.0259, found 303.0268. 
[1,1'-Biphenyl]-2-(N-methyl-phenylacetamide), 2'-bromo- (96).  By the general 
procedure, amide 88 (480 mg, 1.32 mmol), NaH 60% in mineral oil (53 mg, 1.32 mmol), MeI 
(225 mg, 1.59 mmol) in THF (5 mL) for 10 min afforded 96 (451 mg, 90%) as a white solid after 
flash chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3060, 1658, 1373, 753; 
1
H NMR 
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(300 MHz, CDCl3)  7.71–7.58 (m, 1H), 7.45–7.09 (m, 11.4H), 6.85–6.80 (m, 0.6H), 3.70–3.50 
(m, 1.6H), 3.37–3.32 (m, 0.4H), 3.15 (s, 1 H), 2.99 (s, 0.3H), 2.86 (s, 1.7H); 13C NMR (75 MHz, 
CDCl3)  171.6, 170.9, 142.1, 142.0, 141.6, 139.1, 139.0, 138.9, 135.8, 135.3, 134.5, 133.8, 
133.2, 132.9, 132.5, 131.7, 131.4, 130.4, 129.8, 129.7, 129.5, 129.4, 129.1, 129.0, 128.8, 128.7, 
128.6, 128.4, 128.1, 127.9, 127.6, 127.5, 127.4, 127.0, 126.8, 126.6, 123.5, 123.3, 77.43, 41.1, 
41.0, 38.9, 36.4; HRMS (EI) m/e calcd for C21H18NOBr (M
+
) 379.0572, found 379.0575. 
[1,1'-Biphenyl]-2-(N-methyl-propionamide), 2'-bromo- (97).  By the general 
procedure, amide 89 (249 mg, 0.82 mmol), NaH 60% in mineral oil (35 mg, 0.86 mmol), MeI 
(140 mg, 0.99 mmol) in THF (10 mL) for 10 min afforded 97 (257 mg, 99%) as a white solid 
after flash chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 3058, 2974, 2936, 1660, 
1464, 1378, 1285, 753; 
1
H NMR (300 MHz, CDCl3)  7.67–7.60 (m, 1H), 7.45–7.37 (m, 2H), 
7.37–7.28 (m, 2H), 7.27–7.05 (m, 3H), 3.11 (s, 1.08H), 2.97 (s, 0.35H), 2.85 (s, 1.57H), 2.35–
2.18 (m, 0.7H), 2.18–2.04 (m, 1.3H), 1.14 (t, J = 7.2 Hz, 1.54H), 1.03 (t, J = 7.2 Hz, 0.40H), 
0.95 (t, J = 6.9 Hz, 1.06H); 
13
C NMR (75 MHz, CDCl3)  174.3, 173.7, 142.3, 142.2, 141.7, 
139.8, 139.1, 139.0, 138.7, 133.4, 133.1, 132.5, 132.3, 131.5, 131.2, 130.1, 129.5, 129.4, 129.2, 
129.1, 128.5, 128.3, 128.2, 127.7, 127.4, 127.1, 127.0, 123.3, 123.1, 38.3, 38.0, 35.9, 27.6, 27.4, 
26.9, 9.9, 9.7, 9.1; HRMS (EI) m/e calcd for C16H16NOBr (M
+
) 317.0415, found 317.0421. 
[1,1'-Biphenyl]-2-(N-methyl-methoxyacetamide), 2'-bromo- (98).  By the general 
procedure, amide 90 (275 mg, 0.86 mmol), NaH 60% in mineral oil (36 mg, 0.90 mmol), MeI 
(147 mg, 1.03 mmol) in THF (8 mL) for 10 min afforded 98 (286 mg, 99%) as an oil after flash 
chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 3058, 2925, 2820,1676, 1465, 1330, 
1103, 754; 
1
H NMR (300 MHz, CDCl3)  7.68–7.63 (m, 1H), 7.48–7.40 (m, 2H), 7.39–7.17 (m, 
5H), 4.09–3.93 (m, 0.75H), 3.88– 3.79 (m, 1.25H), 3.37 (s, 1.45H), 3.28 (s, 0.52H), 3.27 (s, 
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1.0H), 3.13 (s, 1.1H), 2.98 (s, 0.40H), 2.85 (s, 1.53H); 
13
C NMR (75 MHz, CDCl3)  169.3, 
168.7, 141.3, 140.3, 139.8, 139.5, 138.8, 138.6, 138.5, 138.4, 133.4, 133.0 132.6, 132.4, 131.4, 
131.2, 131.0, 129.9, 129.5, 129.2, 129.1, 129.0, 128.6, 128.1, 128.0, 127.9, 127.4, 127.1, 126.9, 
123.1, 122.8, 71.0, 70.6, 70.2, 59.1, 58.7, 38.2, 36.7, 35.7; HRMS (EI) m/e calcd for 
C16H16NO2Br (M
+
) 333.0364, found 333.0377. 
[1,1'-Biphenyl]-2-(N-methyl-isobutyramide), 2'-bromo- (99).  By the general 
procedure, amide 91 (260 mg, 0.82 mmol), NaH 60% in mineral oil (35 mg, 0.86 mmol), MeI 
(140 mg, 0.99 mmol) in THF (10 mL) for 10 min afforded 99 (268 mg, 99%) as a white solid 
after flash chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 2968, 1658, 1466, 1386, 
1102, 752; 
1
H NMR (300 MHz, CDCl3)  7.66 (m, 1H), 7.48–7.24 (m, 5H), 7.24–7.09 (m, 2H), 
3.21 (s, 1.2H), 3.07 (s, 0.3H), 2.89 (s, 1.5H), 2.76 (heptet, J = 6.9 Hz, 0.1H), 2.62–2.46 (m, 
0.9H), 1.13 (d, J = 6.6 Hz, 1.5H), 1.09 (d, J = 6.6 Hz, 1.5H), 0.94 (d, J = 6.6 Hz, 1.37H), 0.81 (d, 
J = 6.6 Hz, 0.35H), 0.69 (d, J = 6.6 Hz, 1.28H); 
13
C NMR (75 MHz, CDCl3)  177.6, 177.2, 
142.4, 142.2, 141.8, 139.8, 139.2, 138.9, 138.5, 133.5, 133.0, 132.8, 132.1,131.8, 131.3, 130.9, 
130.6, 129.6, 129.4, 129.3, 129.1, 128.0, 127.8, 127.3, 127.2, 126.9, 123.3, 38.8, 37.9, 36.2, 31.5, 
30.9, 30.3, 20.6, 20.1, 19.6,18.9,18.8, 18.7; HRMS (EI) m/e calcd for C17H18NOBr (M
+
) 
331.0572, found 331.0565. 
[1,1'-Biphenyl]-2-(N-methyl-benzyloxyacetamide), 2'-bromo- (100).  By the general 
procedure, amide 92 (1.04 g, 2.63 mmol), NaH 60% in mineral oil (110 mg, 2.77 mmol), MeI 
(448 mg, 3.16 mmol) in THF (30 mL) for 10 min afforded 100 (1.056 g, 98%) as an oil after 
flash chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3060, 2925, 1673, 1026, 751; 
1
H 
NMR (300 MHz, CDCl3)  7.65–7.58 (m, 1H), 7.42–7.14 (m, 11.4H), 7.05 (dd, J = 7.2, 1.8 Hz, 
0.6H), 4.63–4.33 (m, 2H), 4.14–3.87 (m, 2H), 3.12 (s, 1H), 3.00 (s, 0.4H), 2.86 (s, 1.6H); 13C 
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NMR (75 MHz, CDCl3)  169.7, 169.0, 141.6, 140.6, 140.2, 139.8, 139.0, 138.9, 138.7, 138.6, 
137.9, 137.5, 133.6, 133.1, 132.7, 132.5, 131.6, 131.5, 131.2, 130.3, 129.6, 129.4, 128.8, 128.4, 
128.3, 128.1, 128.0, 127.9, 127.6, 127.4, 127.3, 127.2, 123.3, 123.1, 73.2, 73.0, 72.9, 69.0, 68.2, 
38.5, 37.2, 36.0; HRMS (ES) m/e calcd for C22H20NO2NaBr (MNa
+
) 432.0575, found 432.0548. 
[1,1'-Biphenyl]-2-(2-(4-nitrobenzyloxy)-N-methyl-acetamide), 2'-bromo- (101).  By 
the general procedure, amide 93 (0.40 g, 0.91 mmol), NaH 60% in mineral oil (37 mg, 0.91 
mmol) and MeI (157 mg, 1.1 mmol) in THF (5 mL) for 5 h afforded 101 (377 mg, 92%) as a 
white solid after flash chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 3061, 2927, 
1672, 1604, 1520, 1346, 1128, 850, 770; 
1
H NMR (300 MHz, CDCl3)  8.18–8.11 (m, 2H), 7.69 
(d, J = 7.8 Hz, 0.45H), 7.62 (d, J = 9 Hz, 0.55H), 7.50–7.19 (m, 8.5H), 7.14 (dd, J = 7.2, 1.2 Hz, 
0.5H), 4.76–4.46 (m, 2H), 4.26–4.13 (m, 0.6H), 4.06–3.90 (m, 1.4H), 3.17 (s, 1.4H), 3.06 (m, 
0.3H), 2.89 (m, 1.3H); 
13
C NMR (75 MHz, CDCl3)  169.2, 168.6, 147.4, 147.3, 145.7, 145.4, 
145.3, 145.2, 141.3, 140.2, 139.9, 138.9, 138.8, 138.6, 138.5, 133.5, 133.2, 132.9, 132.6, 131.5, 
131.4, 131.2, 130.4, 130.2, 130.0, 129.8, 129.5, 129.3, 129.0, 128.8, 128.3, 128.2, 128.1, 127.9, 
127.8, 127.5, 127.4, 127.0, 123.5, 123.4, 123.3, 122.9, 72.0, 71.6, 69.2, 68.8, 68.6, 48.8, 38.5, 
37.1, 36.1, 33.9, 25.7, 25.0; HRMS (ES) m/e calcd for C22H20N2O4Br (MH
+
) 455.0606, found 
455.0576.  
[1,1'-Biphenyl]-2-(N-methyl-dibenzylaminoacetamide), 2'-bromo- (102).  By the 
general procedure, amide 94 (166 mg, 0.34 mmol), NaH 60% in mineral oil (15 mg, 0.36 mmol), 
MeI (58 mg, 0.41 mmol) in THF (4 mL) for 10 min afforded 102 (170 mg, 99%) as an oil after 
flash chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3060, 3027, 2919, 1664, 1464, 
749; 
1
H NMR (300 MHz, CDCl3)  7.60 (d, J = 7.8 Hz, 0.5H), 7.48 (d, J = 8.1 Hz, 0.3H), 7.43–
7.07 (m, 15.7H), 6.96–6.89 (m, 0.5H), 6.88 (d, J = 7.5 Hz, 0.5H), 6.60 (d, J = 7.2 Hz, 0.5H), 
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3.98–3.01 (m, 7.5H), 2.82 (s, 1.50H); 13C NMR (75 MHz, CDCl3)  171.3, 171.0, 170.7, 142.1, 
141.3, 140.6, 140.1, 139.9, 139.8, 139.1, 138.9, 138.8, 138.7, 133.7, 133.1, 132.8, 132.3, 131.5, 
131.0, 130.3, 130.1, 129.5, 129.4, 129.3, 129.0, 128.7, 128.5, 128.4, 128.3, 128.2, 127.8, 127.7, 
127.6, 127.2, 127.1, 126.8, 123.4, 123.2, 123.0, 77.4, 58.3, 58.0, 57.4, 56.2, 53.5, 53.2, 38.7, 37.9, 
35.9; HRMS (ES) m/e calcd for C29H28N2OBr (MH
+
) 499.1385, found 499.1381. 
[1,1'-Biphenyl]-2-(N-methyl-acetamide), 2'-chloro- (110).  By the general procedure, 
amide 109 (271 mg, 1.1 mmol), NaH 60% in mineral oil (47 mg, 1.155 mmol), MeI (188 mg, 
1.32 mmol) in THF (7 mL) for 10 min afforded 110 (280 mg, 98%) as a white solid after flash 
chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 3069, 1658, 1373, 1031, 760; 
1
H NMR 
(300 MHz, CDCl3)  7.48–7.33 (m, 5H), 7.33–7.23 (m, 3H), 7.15 (br, 1H), 3.04 (s, 1.15H), 2.96 
(s, 0.44H), 2.85 (s, 1.41H), 2.01–2.00 (m, 0.25H), 1.94 (s, 1.50H), 1.86 (s, 1.25H); 13C NMR (75 
MHz, CDCl3)  171.0, 170.3, 142.4, 142.0, 137.2, 136.9, 133.0, 132.2, 131.5, 131.2, 130.3, 
129.9, 129.4, 129.1, 128.4, 128.2, 127.8, 127.2, 126.9, 126.5, 37.9, 35.9, 22.5, 22.2, 21.9; HRMS 
(EI) m/e calcd for C15H14NOCl (M
+
) 259.0764, found 259.0763. 
[1,1'-Biphenyl]-2-(N-benzyl-acetamide), 2'-bromo- (103).  A mixture of amide 87 (290 
mg, 1.0 mmol) and NaH 60% in mineral oil (42 mg, 1.05 mmol) was added THF (10 mL) at rt 
and stirred for 10 min.  Benzyl bromide (205 mg, 1.2 mmol) was added, and the resulting 
mixture was stirred for 12 h.  After removal of volatile components from the mixture, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 1/1) to 
give 103 (371 mg, 99%) as a white solid: IR (cm
-1
) 3060, 1658, 1386, 751; 
1
H NMR (300 MHz, 
CDCl3)  7.74–7.65 (m, 1H), 7.40–7.32 (m, 3H), 7.32–7.22 (m, 3H), 7.21–7.16 (m, 5H), 6.88 (d, 
J = 7.8 Hz, 0.24H), 6.75 (d, J = 7.8 Hz, 0.76H), 5.44 (d, J = 18.0 Hz, 0.22H), 5.27 (d, J = 14.1 
Hz, 0.78H), 3.90 (d, J = 14.4 Hz, 0.22H), 3.45 (d, J = 14.4 Hz, 0.78H), 2.10 (s, 0.21H), 2.04 (s, 
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2.14H), 1.95 (s, 0.65H); 
13
C NMR (75 MHz, CDCl3)  170.4, 139.9, 139.1, 138.7, 137.4, 133.6, 
132.8, 131.4, 130.8, 130.4, 130.1, 129.8, 129.4, 129.1, 128.9, 128.5, 128.3, 128.0, 127.8, 127.4, 
123.4, 52.9, 50.7, 23.4, 23.0; HRMS (EI) m/e calcd for C21H18NOBr (M
+
) 379.0572, found 
379.0556. 
[1,1'-Biphenyl]-2-(N-methyl-4-hydroxypentanamide), 2'-bromo- (105).  To a solution 
of LiCl (544 mg, 12.828 mmol) and diisopropylamine (454 mg, 4.49 mmol) in THF (15 mL) in a 
dry ice-acetone bath was added n-BuLi (1.6 M in hexane, 2.8 mL, 4.49 mmol), and the resulting 
mixture was stirred at 0 °C for 10 min and cooled in the dry ice-acetone bath.  A solution of 
amide 95 (650 mg, 2.138 mmol) in THF (5 mL) was added slowly, and the resulting mixture was 
stirred in the dry ice-acetone bath for 1 h, 0 °C for 15 min, 23 °C for 5 min and cooled to 0 °C.  
Propene oxide (621 mg, 10.69 mmol) was added, and the resulting mixture was stirred at 0 °C 
for 3 h.  Saturated aqueous NH4Cl solution was added, and the mixture was extracted with 
EtOAc.  The extracts were combined, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, EtOAc) to give 105 (272 mg, 35%) as an oil: (IR (cm
-1
) 3421, 2966, 1641, 1499, 1386, 
1132, 754; 
1
H NMR (300 MHz, CDCl3)  7.67-7.62 (m, 1H), 7.45-7.14 (m, 7H), 3.76-3.53 (m, 
2H), 3.11 (s, 1H), 3.02 (s, 0.15H), 3.00 (s, 0.35H), 2.84 (s, 1.5H), 2.43-2.10 (m, 2H), 1.85-1.51 
(m, 2H), 1.16-1.12 (m, 1.8H), 1.07-1.04 (m, 1.2H); 
13
C NMR (75 MHz, CDCl3)  174.4, 174.3, 
173.7, 173.6, 141.9, 141.4, 141.3, 141.2, 139.5, 139.0, 138.8, 138.6, 138.5, 133.4, 133.0, 132.6, 
132.3, 131.5, 131.4, 131.1, 130.3, 129.6, 129.4, 129.2, 129.1, 128.9, 128.7, 128.4, 128.3, 128.2, 
128.0, 127.9, 127.7, 127.5, 127.2, 123.2, 123.0, 67.6, 67.3, 67.2, 38.6, 36.0, 34.3, 34.2, 34.1, 
33.5, 33.4, 31.4, 31.2, 31.1, 30.6, 30.3, 30.1, 23.8, 23.6, 23.4, 23.2; HRMS (EI) m/e calcd for 
C18H21NO2Br (MH
+
) 362.0756, found 362.0752.  
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[1,1'-Biphenyl]-2-(N-methyl-4-oxopentanamide), 2'-bromo- (104).  A solution of 
amide 105 (260 mg, 0.718 mmol) and PCC (310 mg, 1.436 mmol) in CH2Cl2 (7 mL) was stirred 
at rt for 3 h and filtered through celite.  After removal of volatile components from the filtrate, 
the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 1/1) 
to give 104 (249 mg, 96%) as a solid: IR (cm
-1
) 3496, 3059, 2920, 1716, 1657, 1465, 1165, 1026, 
755; 
1
H NMR (300 MHz, CDCl3)  7.66 (d, J = 8.1 Hz, 0.85H), 7.46–7.30 (m, 5.65H), 7.25–7.19 
(m, 1.5H), 3.11 (s, 0.8H), 2.99 (s, 0.13H), 2.96 (s, 0.27H), 2.80 (s, 1.8H), 2.79–2.22 (m, 4H), 
2.18 (s, 2H), 2.12 (s, 0.25H), 2.10 (s, 0.75H); 
13
C NMR (75 MHz, CDCl3)  207.5, 172.4, 171.6, 
141.9, 141.2, 139.0, 138.7, 138.4, 133.4, 133.0, 132.4, 131.6, 131.4, 131.2, 130.8, 129.6, 129.5, 
129.3, 129.0, 128.8, 128.7, 128.6, 128.5, 128.3, 127.8, 127.7, 127.2, 123.2, 38.8, 38.5, 38.3, 37.7, 
35.9, 30.2, 30.1, 29.9, 28.8, 28.4, 27.5; HRMS (EI) m/e calcd for C18H18NO2Br (M
+
) 359.0521, 
found 359.0508.  
General Procedure for the Palladium-Catalyzed Cyclization of Dibenzazepinones.  
A solution of Pd(OAc)2 (3.4 mg, 0.015 mmol), HPCy3BF4 (5.6 mg, 0.015 mmol) and NaOt-Bu 
(44 mg, 0.45 mmol) in toluene (1 mL) was stirred at rt for 10 min and cooled in a dry ice-acetone 
bath.  The amide as dibenzazepinone precursor (0.15 mmol) in toluene (0.5 mL) was added, and 
the resulting mixture was degassed by oil pump and refilled with argon.  After stirred at 100 °C 
for 10 min, the mixture was cooled to rt and purified by flash chromatography. 
5-Phenyl-N-methyl-dibenzazepin-6-one (111).  By the general procedure, amide 96 (57 
mg, 0.15 mmol) gave 111 (44.5 mg, 99%) as a film after flash chromatography (SiO2, 
hexanes/EtOAc = 3/1): IR (cm
-1
) 2920, 1662, 1366, 705; 
1
H NMR (300 MHz, CDCl3)  7.73–
7.70 (m, 0.7H), 7.66–7.59 (m, 1.3H),  7.53–7.46 (m, 2.4H), 7.46–7.28 (m, 3.6H), 7.21–7.18 (m, 
0.4H), 7.10–7.04 (m, 0.6H), 6.99–6.87 (m, 3H), 6.71–6.66 (m, 1H), 5.35 (s, 0.6H), 4.65 (s, 0.4H), 
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3.40 (s, 1.9H), 3.36 (s, 1.1H); 
13
C NMR (75 MHz, CDCl3)  172.7, 170.8, 142.2, 140.7, 139.3, 
138.0, 136.7, 136.6, 136.0, 135.7, 134.6, 134.3, 131.8, 130.7, 130.3, 129.8, 129.4,128.9, 128.7, 
128.6, 128.5, 128.2, 128.1, 127.9, 127.6, 127.3, 126.4, 126.2, 125.6, 125.0, 122.7, 122.4, 60.5, 
51.5, 37.3, 36.7, 29.9; HRMS (EI) m/e calcd for C21H17NO (M
+
) 299.1310, found 299.1309. 
5-Methoxy-N-methyl-dibenzazepin-6-one (113).  By the general procedure, amide 98 
(50 mg, 0.15 mmol) gave 113 (21 mg, 56%) as a film after flash chromatography (SiO2, 
hexanes/EtOAc = 1/2): IR (cm
-1
) 3066, 2926, 2831, 1680, 1440, 1212, 1092, 984, 767, 743; 
1
H 
NMR (300 MHz, CDCl3)  7.71 (d, J = 7.5 Hz, 1H), 7.63 (dd, J = 7.8, 1.5 Hz, 1H), 7.58 (dd, J = 
7.5, 1.2 Hz, 1H), 7.54–7.32 (m, 5H), 5.03 (s, 0.05H), 4.54 (s, 0.95H), 3.56 (s, 2.86H), 3.42 (s, 
0.14H), 3.35 (s, 2.86H), 3.03 (s, 0.14H); 
13
C NMR (75 MHz, CDCl3)  169.9, 140.8, 137.3, 
133.8, 133.5, 130.0, 129.5, 129.0, 128.9, 128.1, 127.9, 125.8, 122.9, 122.8, 78.7, 58.4, 36.5; 
HRMS (EI) m/e calcd for C16H15NO2 (M
+
) 253.1103, found 253.1100. 
5,5-Dimethyl-N-methyl-dibenzazepin-6-one (114).  By the general procedure, amide 99 
(50 mg, 0.15 mmol) gave 114 (3 mg, 8%) as a film after flash chromatography (SiO2, 
hexanes/EtOAc = 1/1): IR (cm
-1
) 2926, 1651, 1598, 758, 735; 
1
H NMR (300 MHz, CDCl3)  
7.58–7.52 (m, 3H), 7.45–7.38 (m, 3H), 7.29–7.24 (m, 2H), 3.37 (s, 3H), 1.79 (s, 3H), 0.95 (s, 
3H); 
13
C NMR (75 MHz, CDCl3)  175.4, 143.9, 141.9, 136.8, 135.4, 130.0, 129.9, 128.6, 128.5, 
127.5, 125.3, 125.1, 122.0, 46.2, 38.5, 26.8, 23.2; HRMS (EI) m/e calcd for C17H17NO (M
+
) 
251.1310, found 251.1305. 
N-benzyl-dibenzazepin-6-one (115).  By the general procedure, amide 103 (57 mg, 0.15 
mmol) gave 115 (38 mg, 84%) as a film after flash chromatography (SiO2, hexanes/EtOAc = 
3/1): IR (cm
-1
)3063， 3029， 1669， 1440， 763， 738; 1H NMR (300 MHz, CDCl3)  7.52–
7.48 (m, 2H), 7.43–7.37 (m, 3H), 7.37–7.20 (m, 3H), 7.14–7.08 (m, 3H), 6.92–6.87 (m, 2H), 
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5.19 (d, J = 15.6 Hz, 1H), 4.94 (d, J = 15.6 Hz, 1H), 3.68 (d, J = 12.3 Hz, 1H), 3.55 (d, J = 12.3 
Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  171.2, 140.7, 137.6 137.5, 136.7, 135.5, 135.4, 135.1, 
135.0, 134.9, 131.4, 131.3, 131.2, 130.1, 130.0, 129.6, 129.5, 129.2, 129.1, 129.0, 128.9, 128.2, 
128.1, 128.0, 127.8, 127.5, 127.4, 127.0, 126.9, 126.8, 126.7, 126.0, 125.9, 124.9, 124.8, 124.7, 
124.5, 124.4, 122.3, 122.2, 53.8, 51.9, 50.0, 44.1, 42.4, 42.3, 40.6; HRMS (EI) m/e calcd for 
C21H17NO (M
+
) 299.1310, found 299.1301. 
5,6-Dihydro-8-methyl-5-acetyl-dibenzazocin-7(8H)-one (116). By the general 
procedure, amide 104 (54 mg, 0.15 mmol) gave 116 (8 mg, 20%) as a film after flash 
chromatography (SiO2, hexanes/EtOAc = 1/1): IR (cm
-1
) 1714, 1661, 768; 
1
H NMR (300 MHz, 
CDCl3)  7.49–7.44 (m, 1H), 7.40–7.33 (m, 4H), 7.29–7.22 (m, 2H), 7.13 (dt, J = 6.6, 1.5 Hz, 
1H), 4.11 (t, J = 9.6 Hz, 1H), 3.20 (dd, J = 12.9, 9.0 Hz, 1H), 2.94 (s, 3H), 2.53 (dd, J = 12.9, 9.9 
Hz, 1H), 1.89 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  204.7, 172.3, 142.6, 139.8, 138.2, 135.8, 
132.6, 131.2, 130.8, 129.8, 129.2, 128.4, 128.3, 125.9, 56.5, 35.7, 35.0, 28.3; HRMS (EI) m/e 
calcd for C18H17NO2 (M
+
) 279.1259, found 279.1249. 
5-Benzyloxy-N-methyl-dibenzazepin-6-one (117).  By the general procedure, Pd(OAc)2 
(13.6 mg, 0.06 mmol), HPCy3BF4 (22.4 mg, 0.06 mmol), amide 100 (248 mg, 0.6 mmol) and 
NaOt-Bu (86.4 mg, 0.9 mmol) in toluene (6 mL) gave 117 (160 mg, 81%) as a film after flash 
chromatography (SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3063, 2926，1680，743; 1H NMR 
(300 MHz, CDCl3)  7.83 (d, J = 7.8 Hz, 1H), 7.60–7.22 (m, 12H), 4.97 (d, J = 11.7 Hz, 1H), 
4.75 (s, 1H), 4.59 (d, J = 11.7 Hz, 1H), 3.35 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  169.9, 140.8, 
138.0, 137.5, 133.8, 133.5, 130.0, 128.9, 128.9, 128.5, 128.0, 127.9, 127.9, 127.8, 125.8, 123.4, 
122.8, 76.7, 72.2, 36.6; HRMS (EI) m/e calcd for C22H19NO2 (M
+
) 329.1416, found 329.1416. 
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[1,1'-Biphenyl]-2-(N-methylformamide), 2'-bromo- (119).  By the general procedure, 
amide 101 (91 mg, 0.2 mmol) in toluene (2 mL) gave 119 (14 mg, 20%) as a film after flash 
chromatography (SiO2, hexanes/EtOAc = 1/1): 
1
H NMR (300 MHz, CDCl3)  8.19 (s, 1H), 7.67 
(dd, J = 7.8, 1.2 Hz, 1H), 7.51–7.30 (m, 5H), 7.29–7.18 (m, 2H), 2.91 (s, 3H); 13C NMR (75 
MHz, CDCl3)  163.5, 163.4, 140.4, 139.6, 133.4, 132.0, 131.8, 131.4, 129.8, 129.6, 129.0, 
128.9, 128.8, 128.4, 128.0, 127.8, 127.7, 127.6, 127.2, 123.6, 33.3; MS (ES) m/e (MNa
+
) 312.0  
5-Dibenzylamino-N-methyl-dibenzazepin-6-one (135).  By the general procedure, 
amide 102 (75 mg, 0.15 mmol) gave 135 (58 mg, 93%) as a film after flash chromatography 
(SiO2, hexanes/EtOAc = 3/1): IR (cm
-1
) 3061, 3027, 2925，2245，1656，732; 1H NMR (300 
MHz, CDCl3)  7.58–7.24 (m, 7H), 7.17–7.08 (m, 7H), 6.73–6.67 (m, 4H), 4.67 (s, 1H), 3.42 (d, 
J = 14.1 Hz, 2H), 3.19 (s, 3H), 3.17 (d, J = 14.4 Hz, 2H); 
13
C NMR (75 MHz, CDCl3)  170.7, 
141.4, 137.1, 137.0, 136.4, 134.0, 130.4, 129.8, 129.7, 129.4, 129.0, 128.7, 128.0, 127.0, 124.6, 
121.9, 77.9, 54.9, 37.5; HRMS (EI) m/e calcd for C29H26N2O (M
+
) 418.2045, found 418.2042. 
N-(2-Bromophenyl)-2-iodo-N-methylacetamide (121).  To a solution of amide 120 
(1.45 g, 5.83 mmol) and MeI (1.66 g, 11.67 mmol) in THF (30 mL) was added 60% NaH in 
mineral oil (257 mg, 6.42 mmol) slowly, and the mixture was stirred at rt for 10 min.  Saturated 
aqueous NH4Cl solution was added, and the resulting mixture was extracted with Et2O.  The 
extracts were combined, dried over MgSO4 and filtered.  After removal of volatile components 
from the filtrate, the resulting crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 3/1) to give a product (560 mg) as a mixture of N-(2-bromophenyl)-2-iodo-N-
methylacetamide and N-(2-bromophenyl)-2-chloro-N-methylacetamide.  To this mixture was 
added acetone (10 mL) and Sodium iodide (2.6 g, 17.3 mmol), and the resulting mixture was 
stirred at rt for 1 h.  The solvent was evaporated under reduced pressure, and the residue was 
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dissolved in Et2O.  The resulting solvent was dried over MgSO4 and filtered.  Removal of 
volatile components from the filtrate provided 121 (601 mg, 30%) as a colorless oil: IR (cm
-1
) 
3057, 2931, 1664, 1476, 1373, 1111, 1049, 767, 729; 
1
H NMR (300 MHz, CDCl3)  7.73 (dd, J 
= 7.8, 1.2 Hz, 1H), 7.52 (m, 2H), 7.35 (m, 1H), 3.66 (d, J = 10.2 Hz, 1H), 3.39 (d, J = 10.2 Hz, 
1H),  3.22 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  167.8, 142.0, 134.1, 130.5, 129.6, 129.2, 123.1, 
36.9, -2.5; HRMS (EI) m/e calcd for C9H9NOBrI (M
+
), 352.8912, found 352.8924.  
N-(2-Bromophenyl)-2-((2-bromophenyl)(phenyl)methoxy)-N-methylacetamide (122).  
To a solution of (2-bromophenyl)(phenyl)methanol (295 mg, 1.12 mmol) and amide 121 (396 
mg, 1.12 mmol) in THF (1 mL) was added 60% NaH in mineral oil (50 mg, 1.23 mmol) at 0 °C, 
and the mixture was stirred at rt for 1 h.  After removal of volatile components from the mixture, 
the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) 
to provide 122 (535 mg, 98%) as a colorless oil: IR (cm
-1
) 3061, 2928, 1682, 1476, 1114, 758, 
699; 
1
H NMR (300 MHz, CDCl3)  7.56–7.51 (m, 1H), 7.48–7.42 (m, 2 H), 7.37–7.33 (m, 2H), 
7.26–7.10 (m, 7H), 7.08 (td, J = 7.8, 1.5 Hz, 1H), 5.88 (s, 0.5H), 5.84 (s, 0.5H), 3.88 (m, 2H), 
3.20 (s, 1.5H), 3.19 (s, 1H); 
13
C NMR (75 MHz, CDCl3)  168.7, 168.6,  141.0, 140.9, 140.3, 
140.2, 139.8, 139.7, 134.0, 133.8, 132.6, 132.5, 130.1, 130.0, 129.8, 129.7, 129.0, 128.9, 128.7, 
128.5, 128.2, 127.8, 127.7, 127.6, 123.4, 123.2, 123.1, 123.0, 114.6, 81.7, 81.6, 67.1, 66.9, 36.0; 
HRMS (ES) m/e calcd for C22H19NO2NaBr2 (MNa
+
), 509.9680, found 509.9690.  
2-Bromo-N-(2-((2-bromophenyl)(phenyl)methoxy)ethyl)-N-methylbenzenamine 
(123).  To a solution of amide 122 (250 mg, 0.513 mmol) in THF (6 mL) was added borane-
dimethylsulfide (2 M in THF, 1 mL, 2.05 mmol) at rt, and the mixture was stirred for 2 h.  
Aqueous NaOH solution (1 M, 1 mL) was added, and the mixture was extracted with Et2O.  The 
extracts were combined, dried over MgSO4 and filtrated.  After removal of volatile components 
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from the filtrate, the resulting crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 3/1) to provide 123 (240 mg, 99%) as a colorless oil: IR (cm
-1
) 2865, 1586, 
1476, 1046, 1024, 754, 699; 
1
H NMR (300 MHz, CDCl3)  7.53–7.46 (m, 3H), 7.37–7.33 (m, 
2H), 7.29–7.15 (m, 5H), 7.09–7.03 (m, 2H), 6.86–6.80 (m, 1H), 5.75 (s, 1H), 3.68 (t, J = 6.0 Hz, 
2H), 3.36 (t, J = 6.0 Hz, 2H), 2.81 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  151.2, 141.4, 140.9, 
134.0, 133.9, 132.8, 129.1, 128.8, 128.4, 128.1, 127.9, 127.7, 127.5, 124.1, 123.5, 122.2, 119.8, 
82.1, 67.5, 55.5, 42.1; HRMS (EI) m/e calcd for C22H21NOBr2 (M
+
) 472.9990, found 472.9975.  
Ethyl 2-((2-bromophenyl)(phenyl)methoxy)acetate (124).  To a solution of (2-
bromophenyl)(phenyl)methanol (720 mg, 2.73 mmol) in THF (30 mL) was added 60% NaH in 
mineral oil (110 mg, 2.73 mmol) at 0 °C, and the mixture was stirred for 10 min.  Ethyl 2-
bromoacetate (547 mg, 3.276 mmol) was added, and the resulting mixture was stirred at rt for 30 
min.  Saturated aqueous NH4Cl solution was added, and the mixture was extracted with EtOAc.  
The extracts were combined, dried over MgSO4 and filtered.  After removal of volatile 
components from the filtrate, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 10/1) to provide 124 (501 mg, 53%) as a colorless oil: IR (cm
-1
) 1754, 
1206, 1118, 1025, 755; 
1
H NMR (300 MHz, CDCl3)  7.65 (dd, J = 7.8, 1.8 Hz, 1H), 7.54 (d, J = 
8.1 Hz, 1H), 7.44–7.41 (m, 2H), 7.37–7.23 (m, 4H), 7.17 (td, J = 7.8, 1.8 Hz, 1H), 4.25 (quartet, 
J = 7.2 Hz, 2H), 4.16 (m, 2H), 1.29 (t, J = 7.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  170.2, 
140.2, 139.8, 133.0, 129.5, 128.8, 128.6, 128.1, 128.0, 127.8, 123.7, 82.0, 66.3, 61.1, 14.3; 
HRMS (ES) m/e calcd for C17H17O3NaBr (MNa
+
) 371.0259, found 371.0262.  
Ethyl 2-((2-(2-aminophenyl)phenyl)(phenyl)methoxy)acetate (125).   To a solution of 
2-aminophenylboronicacidpinacolester (277 mg, 1.265 mmol), bromobenzene 124 (320 mg, 
0.917 mmol), chloro(di-2-norbornylphosphino)(2'-dimethylamino-1,1'-biphenyl-2-yl)palladium 
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(II) (52 mg, 0.0917 mmol) in DME (5 mL) was added a solution of NaHCO3 in H2O (5 mL), and 
the mixture was degassed by an oil pump in a dry ice-acetone bath and stirred at 80 °C overnight.  
After being cooled to rt, the mixture was extracted with EtOAc.  The extracts were combined, 
dried over MgSO4 and filtered.  After removal of volatile components from the filtrate, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to 
provide 125 (47 mg, 14%) as a colorless oil: IR (cm
-1
) 3466, 3371, 2926, 1752, 1617, 1206, 
1118, 751, 700; 
1
H NMR (300 MHz, CDCl3)  7.78-7.72 (m, 0.8H), 7.68-7.64 (m, 0.2H), 7.45-
7.30 (m, 2.7H), 7.24-7.06 (m, 6.3H), 7.02 (dd, J = 8.1, 1.2 Hz, 0.4H), 6.86-6.63 (m, 1.6H), 5.50 
(s, 0.3H), 5.44 (s, 0.4H), 4.52 (m, 0.3H), 4.17-4.12 (m, 2H), 4.05-3.96 (m, 2H), 3.45 (br, 2H), 
1.27-1.20 (m, 3H); 
13
C NMR (75 MHz, CDCl3)  170.5, 170.3, 144.7, 143.8, 140.9, 140.4, 
140.3, 138.2, 138.1, 131.1, 130.6, 130.5, 130.2, 129.1, 129.0, 128.9, 128.5, 128.4, 128.3, 128.1, 
127.9, 127.8, 127.7, 127.4, 127.2, 126.2, 118.4, 115.8, 115.4, 115.3, 80.9, 80.3, 77.4, 68.0, 66.6, 
66.2, 61.0, 60.9, 14.4; HRMS (EI) m/e calcd for C23H23NO3 (M
+
) 361.1678, found 361.1670.  
Ethyl 2-((2-(2-pivalamidophenyl)phenyl)(phenyl)methoxy)acetate (127).  A solution 
of 2-pivalamidophenylboronic acid (304 mg, 1.375 mmol), bromobenzene 124 (400 mg, 1.146 
mmol), Pd(PPh3)4 (66 mg, 0.0573 mmol) and NaHCO3 (289 mg, 3.438 mmol) in DMF (4 mL) 
and H2O (0.8 mL) was degassed by an oil pump in a dry ice-acetone bath and stirred at 150 °C 
for 15 min.  After being cooled to rt, the mixture was extracted with EtOAc.  The extracts were 
washed with water, dried over MgSO4 and filtered.  After removal of volatile components from 
the filtrate, the resulting crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 3/1) to provide 127 (456 mg, 90%) as a colorless oil: IR (cm
-1
) 3430, 2962, 
1754, 1687, 1483, 1205, 1118, 762; 
1
H NMR (300 MHz, CDCl3)  8.25 (dd, J = 8.1, 0.9 Hz, 
0.5H), 8.19 (dd, J = 8.1, 0.9 Hz, 0.5H), 8.01 (dd, J = 8.1, 0.9 Hz, 0.5H), 7.63 (dd, J = 8.1, 1.2 Hz, 
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0.5H), 7.53 (td,  J = 8.1, 1.2 Hz, 0.5H), 7.47 (br, 1H), 7.45–7.33 (m, 2H), 7.30–7.22 (m, 2.5H), 
7.19–7.07 (m, 4.5H), 6.92–6.87 (m, 1.5H), 4.21 (quartet, J = 7.2 Hz, 1H), 4.13 (quartetd, J = 
7.2,1.8 Hz, 1H), 4.03–4.89 (m, 1H), 3.89 (d, J = 15.3 Hz, 0.5H), 3.72 (d, J = 15.3 Hz, 0.5H), 
1.26 (t, J = 7.2 Hz, 1.5H), 1.20 (t, J = 7.2 Hz, 1.5H), 1.02 (s, 4.5H), 0.69 (s, 4.5H); 
13
C NMR (75 
MHz, CDCl3)  177.0, 176.0, 170.1, 169.8, 141.1, 140.1, 139.8, 139.7, 137.2, 136.5, 136.0, 
132.2, 130.5, 130.1, 130.0, 129.9, 129.8, 129.3, 129.2, 129.0, 128.8, 128.7, 128.5, 128.3, 128.2, 
128.0, 127.9, 127.8, 127.6, 126.7, 124.8, 124.2, 123.8, 122.4, 122.1, 121.3, 80.8, 80.3, 66.2, 66.0, 
61.0, 60.9, 39.7, 39.4, 27.3, 27.1, 14.4, 14.3; HRMS (ES) m/e calcd for C28H31NO4Na (MNa
+
) 
468.2151, found 468.2146. 
5,6,8,9-Tetrahydro-5-phenyl-dibenz-6-oxazonin-8-one (129).  A solution of KOH (566 
mg, 10.11 mmol), 127 (150 mg, 0.337 mmol) in 2-methoxylethanol (2 mL) and H2O (0.2 mL) 
was stirred at 130 °C for 16 h and cooled to rt.  The PH of the mixture was adjusted to 1 with 
aqueous HCl solution (2 M), and the resulting mixture was extracted with EtOAc.  The extracts 
were combined, washed with H2O, brine, dried over MgSO4 and filtered.  After removal of 
volatile components from the filtrate, the resulting crude product (80 mg) was added CH2Cl2 (2 
mL), followed by a solution of DCC (50 mg) in CH2Cl2 (1 mL).  The mixture was stirred at rt for 
30 min and filtered.  After removal of volatile components from the filtrate, the resulting crude 
product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to give 129 (21 mg, 
20%) as a colorless oil: IR (cm
-1
) 3059, 2906, 1667, 1115, 759; 
1
H NMR (300 MHz, CDCl3)  
7.48–7.45 (m, 0.5H), 7.42–7.34 (m, 2.8H), 7.32–7.16(m, 3.7H), 7.10–7.05 (m, 3.6H), 7.00 (t, J = 
7.5 Hz, 1H), 6.78–6.74 (m, 1.6H), 6.52(dd, J = 7.5, 1.2 Hz, 0.8H), 5.47 (s, 0.8H), 5.35 (s, 0.2H), 
4.75 (d, J = 17.1 Hz, 0.8H), 4.24 (d, J = 17.1 Hz, 0.8H), 4.22 (d, J = 13.2 Hz, 0.2H), 4.09 (d, J = 
13.2 Hz, 0.2H); 
13
C NMR (75 MHz, CDCl3)  171.7, 141.4, 139.0, 138.6, 135.8, 130.8, 130.1, 
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129.9, 128.8, 128.3, 128.2, 127.7, 127.0, 126.6, 126.2, 125.7, 125.0, 87.4, 71.7; HRMS (ES) m/e 
calcd for C21H17NO2Na (MNa
+
) 338.1157, found 338.1131.  
 5,6,8-Tetrahydro-5-phenyl -N-methyl-dibenz-6-oxazonin-8-one (118).  A solution of 
lactam 129 (18 mg, 0.057 mmol), 60% NaH in mineral oil (2.5 mg, 0.0627 mmol) in THF (1 
mL) was stirred at rt for 10 min.  MeI (9.7 mg, 0.0686 mmol) was added, and the resulting 
mixture was stirred at rt for 20 min.  After removal of volatile components from the mixture, the 
resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 1/1) to 
give 118 (19 mg, 100%) as a colorless oil: IR (cm
-1
) 3060, 2921, 1655, 758, 699; 
1
H NMR (300 
MHz, CDCl3)  7.54–7.52 (m, 0.4H), 7.39–7.29 (m, 4.5H), 7.22 (d, J = 8.1 Hz, 1.7H), 7.17–7.09 
(m, 3.9H), 6.88–6.82 (m, 2.5H), 5.49 (s, 0.87H), 5.23 (s, 0.13H), 4.63 (d, J = 15.6 Hz, 0.87H), 
4.23 (d, J = 15.6 Hz, 1H), 4.97 (d, J = 12.6 Hz, 0.13H), 2.91 (s, 0.4H), 2.87 (s, 2.6H); 
13
C NMR 
(75 MHz, CDCl3)  169.4, 142.2, 141.9, 139.9, 138.7, 137.0, 130.3, 129.4, 129.2, 128.9, 128.4, 
128.0, 127.5, 127.2, 126.2, 126.1, 125.2, 87.5, 73.5, 38.4; HRMS (ES) m/e calcd for 
C22H19NO2Na (MNa
+
) 352.1313, found 352.1301.  
5-Benzyl-5-hydroxy-N-methyl-dibenzazepin-6-one (130).  In the cyclization reaction 
of 100, 130 (4% yield) was separated as a film after flash chromatography (SiO2, hexanes/EtOAc 
= 3/1): IR (cm
-1
) 3387, 2926， 1644， 1352, 763, 736; 1H NMR (300 MHz, CDCl3)  8.00 (m, 
1H), 7.69 (dd, J = 7.5, 1.5 Hz, 1H), 7.60–7.41 (m, 4H), 7.41 (td, J = 8.1, 1.2 Hz, 2H), 7.17–7.12 
(m, 3H), 6.91–6.86 (m, 2H), 5.27 (s, 1H), 3.39 (s, 3H), 2.73–2.60 (m, 2H); 13C NMR (75 MHz, 
CDCl3)  174.1, 143.0, 140.6, 136.6, 135.0, 134.0, 130.4, 130.0, 129.4, 128.9, 128.9, 128.4, 
128.0, 126.8, 126.3, 125.6, 122.7, 78.2, 41.2, 38.6; HRMS (EI) m/e calcd for C22H19NO2 (M
+
) 
329.1416, found 329.1409. 
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5-Benzyloxy-N-methyl-dihydrodibenzazepine (131).  To a solution of dibenzazepinone 
117 (160 mg, 0.486 mmol) in THF (6 mL) was added a solution of BH3·Me2S in THF (2 M, 1 
mL) at rt and stirred for 2 h.  NaOH solution in H2O (1 M, 2 mL) was added, and the mixture 
was stirred for 10 min.  THF was evaporated under reduced pressure, and the residue was 
extracted with Et2O.  The extracts were combined, dried over MgSO4 and filtered.  After removal 
of volatile components from the filtrate, the resulting crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc = 3/1) to give 131 (150 mg, 98%) as an oil: IR (cm
-1
) 
3062, 2860, 1596, 1492, 1444, 1181, 755, 698; 
1
H NMR (300 MHz, CDCl3)  7.57–7.54 (m, 1H), 
7.40–7.19 (m, 10H), 7.12 (td, J = 7.5, 1.8 Hz, 1H), 7.04 (dd, J = 7.8, 0.6 Hz, 1H), 4.55 (d, J = 
11.4 Hz, 1H), 4.50 (m, 1H), 4.29 (d, J = 11.7 Hz, 1H), 3.62–3.47 (m, 2H), 2.71 (s, 3H); 13C 
NMR (75 MHz, CDCl3)  149.1, 139.2, 138.5, 138.4, 134.9, 129.0, 128.9, 128.7, 128.5, 127.8, 
127.7, 127.5, 127.4, 123.6, 122.7, 118.3, 77.4, 71.8, 68.8, 41.8; HRMS (EI) m/e calcd for 
C22H21NO (M
+
) 315.1623, found 315.1609. 
5-Hydroxy-N-methyl-dihydrodibenzazepine (132).  To a solution of dibenzazepine 
131 (90 mg, 0.285 mmol) in 95% ethanol (3 mL) was added 10% palladium on carbon (30 mg, 
0.0285 mmol) and stirred at 80 °C under H2 (1 atm) for 14 h.  After cooled to rt, the mixture was 
filtered through celite.  After removal of volatile components from the filtrate, the resulting crude 
product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) to give 132 (54 mg, 
85%) as an oil: IR (cm
-1
) 3345, 2803, 1485, 1443, 1065, 756, 733; 
1
H NMR (300 MHz, CDCl3)  
7.53–7.47 (m, 1H), 7.36–7.28 (m, 5H), 7.12 (td, J = 7.8, 1.5 Hz, 1H), 7.05 (dd, J = 8.1, 0.9 Hz, 
1H), 4.71 (m, 1H), 3.51 (m, 1H), 3.38 (m, 1H), 2.71 (s, 3H), 2.18 (br, 1H); 
13
C NMR (75 MHz, 
CDCl3)  149.1, 141.3, 137.7, 134.7, 129.3, 129.0, 128.5, 127.8, 127.7, 122.9, 122.8, 118.4, 70.2, 
70.0, 41.8; HRMS (EI) m/e calcd for C15H15NO (M
+
) 225.1154, found 225.1145. 
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N-Methyl-dibenzazepin-5-one (133).  To a solution of Dess Martin reagent (122 mg, 
0.289 mmol) in CH2Cl2 (3 mL) was added a solution of dibenzazepine 132 (50 mg, 0.22 mmol) 
in CH2Cl2 (2 mL) at 0 °C and stirred for 30 min.  NaOH solution in H2O (1 M, 1 mL) was added, 
and the resulting mixture was stirred at rt for 5 min and extracted with EtOAc.  The extracts were 
combined, dried over MgSO4 and filtered.  After removal of volatile components from the 
filtrate, the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc 
= 3/1) to give 133 (46 mg, 93%) as a solid: IR (cm
-1
) 3062, 2830, 1680, 1596, 1300, 757, 732; 
1
H 
NMR (300 MHz, CDCl3)  7.86–7.82 (m, 1H), 7.64–7.58 (m, 1H), 7.52–7.36 (m, 4H), 7.23–7.16 
(m 2H), 3.95 (s, 2H), 2.90 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  204.5, 150.2, 139.2, 137.4, 
133.6, 133.0, 130.9, 130.3, 129.6, 128.6, 127.8, 124.3, 117.3, 72.2, 42.0; HRMS (EI) m/e calcd 
for C15H13NO (M
+
) 223.0997, found 223.0995. 
5-Benzyl-5-hydroxy-N-methyl-dihydrodibenzazepine (134).  The synthesis from 
dibenzazepinone 130: to a solution of 130 (6 mg, 0.0183 mmol) in THF (0.5 mL) was added 
BH3·Me2S (7.3 μL) at rt and stirred for 1.5 h.  NaOH solution in H2O (1 M, 1 drop) was added, 
and the mixture was stirred for 10 min.  After removal of volatile components from the mixture, 
the resulting crude product was purified by flash chromatography (SiO2, hexanes/EtOAc = 3/1) 
to give 134 (5.7 mg, 99%) as an oil: IR (cm
-1
) 3556, 2924, 1496, 1443, 761, 737; 
1
H NMR (500 
MHz, CDCl3)  7.51 (d, J = 4.8 Hz, 1H), 7.47 (dd, J = 4.5, 0.6 Hz, 1H), 7.42–7.39 (m, 2H), 7.37 
(td, J = 5.1, 0.9 Hz, 1H), 7.31 (td, J = 4.8, 1.2 Hz, 1H), 7.16–7.11 (m, 4H), 7.08 (d, J = 4.8 Hz, 
1H), 6.75–6.74 (m, 2H), 3.56 (d, J = 6.9 Hz, 1H), 3.37 (d, J = 6.9 Hz, 1H), 2.98 (d, J = 8.4 Hz, 
1H), 2.78 (s, 3H), 2.69 (d, J = 8.1 Hz, 1H), 2.11 (s, 1H); 
13
C NMR (75 MHz, CDCl3)  148.9, 
143.0, 137.6, 136.4, 136.2, 130.7, 130.0, 129.2, 128.9, 128.3, 128.0, 127.5, 127.0, 124.6, 123.1, 
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118.0, 75.4, 74.2, 46.5, 42.1; HRMS (ES) m/e calcd for C22H22NO (MH
+
) 316.1701, found 
316.1692. 
The synthesis from dibenzazepinone 133: to a solution of 133 (28 mg, 0.125 mmol) in 
THF (2 mL) was added a solution of benzylmagnesium chloride (2 M in THF, 69 μL, 0.138 
mmol) slowly at rt, stirred for 15 min and added a drop of H2O.  After removal of volatile 
components from the mixture, the resulting crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc = 3/1) to give 134 (23.6 mg, 60%) as an oil. 
5-Amino-N-methyl-dibenzazepin-6-one (85).
96
  A solution of dibenzazepinone 135 (30 
mg, 0.072 mmol) and 10% palladium on carbon (6.5 mg, 0.0061 mmol) in ethanol (95%, 6 mL) 
was stirred under H2 (1 atm, balloon) at 90 °C for 12 h.  After cooled to rt, the mixture was 
filtered, and the filtrate was extracted with Et2O.  The extracts were combined, dried over 
MgSO4 and filtered.  After removal of volatile components from the filtrate, the resulting crude 
product was purified by flash chromatography (SiO2, Et2O/EtOH = 10/1) to give 85 (16.7 mg, 
98%) as an oil: 
1
H NMR (300 MHz, CDCl3)  7.65–7.30 (m, 8H), 4.36 (s, 1H), 3.35 (s, 3H), 2.25 
(br, 2H). 
5-Pivaloyl-5,6-dihydro-6-phenyl-phenanthridine.  A solution of 127 (20 mg, 0.045 
mmol) in aqueous HCl (6 M, 0.4 mL) was stirred at rt overnight.  Aqueous NaOH solution (1 M, 
2.5 mL) was added, and the mixture was extracted with ethyl acetate.  The extracts were 
combined, dried over MgSO4 and filtered.  Removal of volatile components from the filtrate 
afforded the product:  
1
H NMR (300 MHz, CDCl3)  7.86 (d, J = 7.8 Hz, 1H), 7.70–7.63 (m, 1H), 
7.50–7.44 (m, 1H), 7.40–7.38 (m, 2H), 7.35–7.32 (m, 1H), 7.18–7.07 (m, 7H) 6.70 (s, 1H), 1.30 
(s, 9H).  
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